
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4A6508AF24AC305A65000277C6A83.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="immage">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369153/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Immunity &amp; Ageing : I &amp; A">
<meta name="citation_title" content="Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease">
<meta name="citation_author" content="Irem Bayraktaroglu">
<meta name="citation_author_institution" content="Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands">
<meta name="citation_author_institution" content="Department of Neurology and Alzheimer Research Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands">
<meta name="citation_author" content="Natalia Ortí-Casañ">
<meta name="citation_author_institution" content="Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands">
<meta name="citation_author" content="Debby Van Dam">
<meta name="citation_author_institution" content="Laboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium">
<meta name="citation_author_institution" content="Department of Neurology and Alzheimer Research Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands">
<meta name="citation_author" content="Peter P De Deyn">
<meta name="citation_author_institution" content="Laboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium">
<meta name="citation_author_institution" content="Department of Neurology and Alzheimer Research Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands">
<meta name="citation_author" content="Ulrich L M Eisel">
<meta name="citation_author_institution" content="Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="22">
<meta name="citation_firstpage" content="33">
<meta name="citation_doi" content="10.1186/s12979-025-00529-5">
<meta name="citation_pmid" content="40841660">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369153/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369153/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369153/pdf/12979_2025_Article_529.pdf">
<meta name="description" content="Alzheimer’s disease (AD) is an age-related neurodegenerative disorder and the most common cause of dementia. While the amyloid cascade hypothesis has long dominated AD research, emerging evidence suggests that neuroinflammation may play a more ...">
<meta name="og:title" content="Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Alzheimer’s disease (AD) is an age-related neurodegenerative disorder and the most common cause of dementia. While the amyloid cascade hypothesis has long dominated AD research, emerging evidence suggests that neuroinflammation may play a more ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369153/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12369153">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12979-025-00529-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12979_2025_Article_529.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369153%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12369153/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12369153/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369153/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-immage.png" alt="Immunity &amp; Ageing : I &amp; A logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Immunity &amp; Ageing : I &amp; A" title="Link to Immunity &amp; Ageing : I &amp; A" shape="default" href="https://immunityageing.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Immun Ageing</button></div>. 2025 Aug 21;22:33. doi: <a href="https://doi.org/10.1186/s12979-025-00529-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12979-025-00529-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Immun%20Ageing%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Immun%20Ageing%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Immun%20Ageing%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Immun%20Ageing%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Systemic inflammation as a central player in the initiation and development of Alzheimer’s disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bayraktaroglu%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Irem Bayraktaroglu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Irem Bayraktaroglu</span></h3>
<div class="p">
<sup>1</sup>Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands </div>
<div class="p">
<sup>3</sup>Department of Neurology and Alzheimer Research Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bayraktaroglu%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Irem Bayraktaroglu</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ort%C3%AD-Casa%C3%B1%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Natalia Ortí-Casañ</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Natalia Ortí-Casañ</span></h3>
<div class="p">
<sup>1</sup>Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ort%C3%AD-Casa%C3%B1%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Natalia Ortí-Casañ</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Van%20Dam%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Debby Van Dam</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Debby Van Dam</span></h3>
<div class="p">
<sup>2</sup>Laboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium </div>
<div class="p">
<sup>3</sup>Department of Neurology and Alzheimer Research Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Van%20Dam%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Debby Van Dam</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Deyn%20PP%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Peter P De Deyn</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Peter P De Deyn</span></h3>
<div class="p">
<sup>2</sup>Laboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium </div>
<div class="p">
<sup>3</sup>Department of Neurology and Alzheimer Research Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Deyn%20PP%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter P De Deyn</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eisel%20ULM%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Ulrich L M Eisel</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Ulrich L M Eisel</span></h3>
<div class="p">
<sup>1</sup>Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eisel%20ULM%22%5BAuthor%5D" class="usa-link"><span class="name western">Ulrich L M Eisel</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands </div>
<div id="Aff2">
<sup>2</sup>Laboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium </div>
<div id="Aff3">
<sup>3</sup>Department of Neurology and Alzheimer Research Centre, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 14; Accepted 2025 Jul 18; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12369153  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841660/" class="usa-link">40841660</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Alzheimer’s disease (AD) is an age-related neurodegenerative disorder and the most common cause of dementia. While the amyloid cascade hypothesis has long dominated AD research, emerging evidence suggests that neuroinflammation may play a more central role in disease onset and progression. Increasingly, AD is recognized as a multifactorial disorder influenced by systemic inflammation and immune dysregulation, shifting focus toward peripheral immune mechanisms as potential contributors to neurodegeneration. This review explores the hypothesis that inflammaging, the age-related increase in pro-inflammatory mediators, combined with lifelong exposure to infections, injuries, metabolic changes, and chronic diseases, among others, may prime the immune system, amplifying neuroinflammation and influencing the progression and exacerbation of AD pathology. To this end, we examined how systemic immune disturbances, including chronic pain, post-operative cognitive dysfunction, viral and bacterial infections, gut microbiome dysregulation, and cardiovascular disease, may act as risk factors for AD. Overall, evidence suggests that modulating peripheral inflammation, accompanied by early diagnosis, could significantly reduce the risk of developing AD. Furthermore, we highlight key immune signaling pathways involved in both central and peripheral immune responses, such as the NLRP3 inflammasome and TREM2, which represent promising therapeutic targets for modulating inflammation while preserving protective immune functions. Strategies aimed at reducing systemic inflammation, identifying early biomarkers, and intervening before significant neurodegeneration occurs may provide novel approaches to delay or prevent AD onset. In conclusion, this review underscores the crucial role of systemic inflammation in AD pathogenesis and progression. By targeting peripheral immune dysfunction, we may advance our understanding of AD mechanisms and develop more effective therapeutic interventions to mitigate disease risk and progression.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Alzheimer’s disease (AD), Systemic inflammation, Neuroinflammation, Neurodegeneration</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par4">Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the most common form of dementia, clinically characterized by progressive memory loss and impairments in cognitive and behavioral skills [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. AD is classified into two main subtypes: sporadic or late-onset AD (LOAD) and early-onset AD (EOAD) [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The pathological features in both AD forms are generally represented by the buildup of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs), leading to synaptic dysfunction and progressive neuronal loss. As a result, AD is associated with significant brain atrophy in both cortical and hippocampal regions, accompanied by enlargement of lateral ventricles [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>].</p>
<p id="Par5">In addition to these hallmark features, alterations in the immune system and the resulting neuroinflammation have been increasingly recognized as crucial factors in AD pathology [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. However, despite these similarities, LOAD and EOAD differ in their onset, progression, and underlying mechanisms [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. LOAD, the most common form, accounts for 90–95% of all AD cases and typically develops after age 65, with a strong association with the APOE ε4 allele [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. In contrast, EOAD represents 5–10% of AD cases, develops before age 65, and is often linked to autosomal dominant mutations in APP, PSEN1, or PSEN2 genes, leading to a more aggressive disease course, characterized by higher Aβ burden and immune system hyperactivation [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par6">Importantly, despite extensive research efforts, the cause of AD remains largely unknown. To date, the amyloid cascade hypothesis, which identifies Aβ accumulation as the primary contributor to AD pathology, has been the central causative explanation of AD. According to this model, the progressive buildup of Aβ in brain tissue leads to the eventual formation of Aβ plaques, which further spread into different brain regions, resulting in neurotransmitter loss, synaptic dysfunction, and cell death [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. However, the amyloid cascade hypothesis has been challenged due to the lack of correlation between amyloid deposition and severity of cognitive deficits, as well as the relative inefficacy of the newly developed monoclonal antibodies that target Aβ [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Moreover, it has been suggested that while Aβ is an important contributor to AD pathogenesis, there is limited evidence supporting its role in the disease’s etiology [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Nevertheless, Aβ remains a central feature of AD pathology. In particular, growing evidence suggests that Aβ oligomers, rather than Aβ plaques, are the more neurotoxic species and may be involved in the early stages of the disease [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Indeed, Aβ oligomers have shown to disrupt synaptic function and activate glial cells, contributing to inflammation [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Thus, even though the amyloid cascade hypothesis may not fully explain all aspects of AD pathogenesis, the role of Aβ in in the disease progression remains critical.</p>
<p id="Par7">In parallel, other markers of progressing AD pathology, including NFTs, synaptic loss, and microglial activation, closely correlate with the disease course, indicating that, besides Aβ aggregation, additional mechanisms contribute to the disease pathogenesis [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. This has led to the emergence of alternative hypotheses, such as the neuroinflammation hypothesis, which proposes that innate immune responses may act both downstream and upstream of Aβ pathology [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Indeed, the neuroinflammation hypothesis proposes that immune activation may not only be a consequence of the pathological events present in the AD brain but could also contribute to the disease onset and progression [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. It is important to note that even though the involvement of neuroinflammation is well-supported, the possibility that peripheral inflammation may act as a trigger is still under investigation. Importantly, much of the evidence supporting this hypothesis has been shown in transgenic mouse models containing familial AD mutations, where Aβ overproduction represents the main hallmark and initiating factor. Therefore, determining whether immune activation precedes or follows Aβ accumulation remains challenging.</p>
<p id="Par8">In this review, we investigate the current evidence regarding how changes in peripheral inflammation caused by different pro-inflammatory triggers, may influence the onset and progression of AD. To this end, we will specifically focus on LOAD, as it is more stronglylinked to age-related immune dysfunction and chronic low-grade inflammation. Unlike EOAD, which is often driven by genetic mutations, LOAD is heavily influenced by systemic inflammatory processes associated with aging, metabolic disorders, and cardiovascular diseases, among others, representing key risk factors that contribute to neuroinflammation and disease progression [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Additionally, the role of systemic inflammation in LOAD has been more extensively studied, providing a stronger foundation for understanding how peripheral immune responses interact with neurodegenerative mechanisms. By focusing on LOAD, we aim to highlight the critical role of inflammatory pathways in AD onset and progression, as well as potential therapeutic strategies targeting systemic inflammation.</p>
<p id="Par9">In the following sections, we will explore the neuroinflammation hypothesis along with the proposed mechanisms and sources that contribute to its onset and its role as a triggering factor for AD.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Neuroinflammation and Alzheimer’s disease pathology</h2></section><section id="Sec3"><h2 class="pmc_sec_title">Neuroinflammation and glial cells</h2>
<p id="Par10">Neuroinflammation is initiated by the main immune cells of the brain, namely astrocytes and microglia. Astrocytes are responsible for synapse and neurotransmitter maintenance, as well as playing an essential role in forming and maintaining the blood-brain-barrier (BBB) [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. On the other hand, microglia are the first line of defense in the CNS, and their main function consists of clearing and degrading harmful agents present in the brain via phagocytosis [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. In the context of AD, microglia and astrocytes are crucial for the efficient removal of Aβ from the brain [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>–<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Indeed, one of the main mechanisms behind the increased accumulation of Aβ during AD is the reduced efficiency of its clearance from the brain, especially by microglia [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Moreover, microglia are critical for the maintenance of homeostasis and tissue repair. As mentioned, microglia also play an essential role in regulating neuroinflammation via the production of pro-inflammatory cytokines [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>].</p>
<p id="Par11">However, neuroinflammation is a double-edged sword: while microglia and astrocyte activation are initially protective and necessary for the activation of pro-survival mechanisms, as well as for uptake and degradation of Aβ, chronically activated microglia can lead to numerous adverse effects that contribute to AD pathology [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Firstly, an excessive release of pro-inflammatory cytokines by microglia has been linked to an increase in amyloid precursor protein (APP) synthesis, as well as in BACE-1 transcription, both resulting in an enhancement of Aβ production [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Chronically activated microglia can also release reactive oxygen species (ROS) and free radicals, contributing to neuronal death [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Moreover, the release of pro-inflammatory cytokines can affect neurotransmitter levels and synapse maintenance, resulting in synaptic dysfunction [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Additionally, the presence of Aβ oligomers at early stages of the disease can also trigger microglial activation and pro-inflammatory responses [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>], which in turn promotes further Aβ production and aggregation. The previously mentioned molecular mechanisms gradually result in Aβ accumulation and a vicious cycle of chronic inflammation and cell death.</p>
<p id="Par12">Altogether, maintaining optimal microglial function appears crucial for preventing Aβ accumulation and breaking the cycle of chronic inflammation in AD. Therefore, a key aspect of understanding the etiology of AD pathology may lie in uncovering the reasons and mechanisms behind the progressive chronic activation of microglia and their subsequent reduced ability to clear Aβ. In contrast to the amyloid cascade hypothesis, which suggests that microglial dysfunction is a consequence of Aβ deposits, the neuroinflammation hypothesis argues that impaired microglial function may precede and contribute to Aβ accumulation [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>].</p></section><section id="Sec4"><h2 class="pmc_sec_title">Peripheral inflammation and inflammaging</h2>
<p id="Par13">In this model, it is proposed that as we age, the immune system gradually transitions into a more pro-inflammatory state, also known as ‘’inflammaging’’, characterized by an increase in proinflammatory mediators and low-level systemic inflammation [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. It is suggested that this increase in peripheral inflammation might eventually lead to neuroinflammation and microglial dysfunction. In fact, it has been extensively shown that the systemic immune system can affect the CNS and that inflammatory mediators in the blood, such as cytokines, can enter the brain [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>–<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. For instance, increased peripheral inflammation caused by different mediators, such as infections, changes in microbiota composition, or injuries, have been proposed as major contributors to neuroinflammation and microglial overactivation [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. This immune activation may act synergistically with early Aβ pathology, exacerbating microglial responses [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. As a result, Aβ and other cellular debris will accumulate, which in turn drives further microglial activation. This excessive activation will result in the release of more pro-inflammatory factors, ultimately contributing to the production of Aβ plaques and inducing cell death [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>].</p>
<p id="Par14">Thus, while neuroinflammation driven by CNS immune cells has long been recognized as a key factor in AD pathogenesis [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>], there is a growing interest in the role of the peripheral immune system as a potential initiator of microglial dysfunction, neuroinflammation, and AD pathology. One proposed mechanism linking inflammaging, peripheral inflammation, and neuroinflammation in AD is the activation of the NOD-like receptor protein 3 (NLRP3) inflammasome. The NLRP3 inflammasome is a signaling complex present in immune cells which becomes activated after injury or cell stress [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Upon activation, it triggers the cleavage of pro-caspase-1 into caspase-1. This, in turn, leads to the release of pro-inflammatory cytokines like IL-1β and IL-18, promoting an inflammatory response [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>, <a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Inflammaging and peripheral inflammation, arising from various factors (discussed in the following sections), can result in dysregulated activity of the NLRP3 inflammasome in both the periphery and the brain [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. This activation triggers inflammatory signaling cascades and creates an inflammatory environment in the brain, leading to chronic microglial activation. Persistent activation of the NLRP3 inflammasome in microglia causes microglial dysfunction, reducing their ability to effectively clear Aβ plaques, ultimately leading to their accumulation [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Moreover, it has been demonstrated that NLRP3 inflammasome activation is essential for the development of Aβ plaques and tau pathology in AD mouse models [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>, <a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>], making the NLRP3 inflammasome an attractive therapeutic target against neuroinflammation and AD.</p></section><section id="Sec5"><h2 class="pmc_sec_title">Hypothesis</h2>
<p id="Par15">Taken together, it seems that AD may be more influenced by systemic triggers than it was initially thought. We believe that inflammaging (natural aging-related increase in pro-inflammatory mediators) along with other changes in the peripheral immune system caused by different pro-inflammatory challenges during our lifespan, such as metabolic changes, disorders like chronic pain or cardiovascular disease, injuries or infections may lead to a primed immune system that contributes to the progression and exacerbation of AD pathology. However, this hypothesis should not be interpreted as independent from Aβ-centered mechanisms. Instead, we propose that systemic inflammation may act as a primary modulator of Aβ pathology, particularly through its influence on microglial overactivation, Aβ clearance and NFT aggregation. Thus, we hypothesize that modulation of peripheral inflammation, early diagnosis, and treatment of the conditions that contribute to systemic inflammation might decrease the risk of developing AD.</p>
<p id="Par16">In the following section, we will delve into the changes in peripheral immune cells occurring during AD progression, as well as potential sources of systemic inflammation that may play a role in the priming of the immune system and the potential consequent development of AD.</p></section><section id="Sec6"><h2 class="pmc_sec_title">Systemic immunity in AD</h2></section><section id="Sec7"><h2 class="pmc_sec_title">Overview</h2>
<p id="Par17">As we discussed in previous sections, peripheral or systemic immunity may play an important role in the development and progression of AD. Direct evidence of elevated peripheral inflammation in AD patients has been demonstrated in multiple meta-analyses [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>], which show elevated levels of pro-inflammatory cytokines and other inflammatory markers compared to healthy controls. These include interleukin-12 (IL-12), IL-1β, IL-6, tumor necrosis factor-alpha (TNF-α), TNF receptors 1 and 2, as well as inflammatory molecules such as C-reactive protein and C-X-C motif chemokine-10 [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. In particular, the levels of TNF- α and IL-6 have been associated with cognitive decline and disease severity [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>].</p></section><section id="Sec8"><h2 class="pmc_sec_title">T cells</h2>
<section id="Sec9"><h3 class="pmc_sec_title">CD4 and CD8 T cells</h3>
<p id="Par18">Distinct changes in peripheral immune cells have been related to the pathophysiology of AD. For instance, adaptive immune T cells have been largely studied in the context of AD. Overall results agree that both CD8 + and CD4 + effector T cells, mainly involved in coordinating immune responses against pathogens, are elevated in AD patients [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>, <a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. In fact, a recent study performed in an AD mouse model reported a potential role of CD4 + effector T cells in contributing to AD development [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Similarly, research performed on post-mortem human AD brains, in vivo AD mouse models, and in vitro systems demonstrated that CD8 + T cells exacerbate AD pathology [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>–<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>].</p></section><section id="Sec10"><h3 class="pmc_sec_title">Regulatory T cells (Tregs)</h3>
<p id="Par19">On the other hand, regulatory T cells (Tregs) are a subset of CD4 + T cells essential for regulating immune responses, including the maintenance of immune tolerance and prevention of excessive immune reactions harmful to the host [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Tregs have been suggested to play a protective role in different neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and Parkinson’s diseases (PD). Regarding AD, previous studies have reported decreased Tregs in AD patients, which may contribute to an exacerbated immune response [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>, <a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. In animal models, it was shown that depleting Tregs from the APP/PS1 mouse model of AD resulted in an acceleration of Aβ-driven cognitive impairments [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Conversely, amplification of Tregs in the same mouse model led to an improvement in cognitive functions, as well as an increase in plaque-associated microglia [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Another study, by Yeapuri et al., also demonstrated the therapeutic benefit of Tregs on cognitive functions and neuropathology in the APP/PS1 mouse model of AD [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. These studies are supported by our own work, where we showed that immune modulation via systemic administration of a tumor necrosis factor receptor 2 (TNFR2) agonist rescued cognitive functions, decreased amyloid plaque deposition and increased plaque-associated microglia in the J20 mouse model of AD [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. Furthermore, treatment with the TNFR2 agonist promoted the expansion of Tregs, leading to an increased Treg infiltration in the brains of the mice [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. This increased Treg presence may have potentially shifted the microglial phenotype towards a more restorative, rather than inflammatory, function. Importantly, our study showed that this systemic treatment showed an equal or even superior protective effect than central administration, highlighting again the importance of the peripheral immune system in AD.</p>
<p id="Par20">Besides specific neurodegenerative diseases, Tregs have also been proven protective and essential for recovery in various conditions and disorders, such as neuropathic pain, arthritis, ischemic stroke, and traumatic brain injury [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>–<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]. Importantly, a recent study has identified age-associated subsets of Tregs with senescent features [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. Altogether, these findings emphasize the pivotal role of peripheral immune modulation, particularly through Tregs expansion, in neuroprotection and cognitive function improvement. Given the broad protective effects of Tregs across neurodegenerative and inflammatory conditions, therapeutic strategies should not only aim to increase Treg numbers but also focus on enhancing their functional quality to ensure effective immunosuppression and anti-inflammatory activity.</p></section></section><section id="Sec11"><h2 class="pmc_sec_title">Theories</h2>
<p id="Par21">After reviewing these changes in peripheral immune cells observed in AD, one important aspect would be to elucidate the origin of the observed dysregulated immune system and chronic peripheral inflammation in AD. Even though the exact etiology remains unknown, there are several factors that contribute to the increase in peripheral inflammation. First, the gut microbiome has been extensively studied, and it has recently been proposed as one of the driving mechanisms in AD (reviewed in Sect. 2.3 of this review). Briefly, disturbances and changes in the composition of the gut microbiome can increase intestinal permeability, leading to the translocation of lipopolysaccharide (LPS) into the peripheral circulation [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. In turn, LPS can have extensive effects on different subsets of immune cells. For instance, different studies have reported that translocated LPS can lead to the expansion and differentiation of CD4 T helper cells, CD8 T cells, as well as B cells [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>–<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. Furthermore, changes in the gut microbiome can also influence the differentiation trajectory of naïve CD4 T cells, potentially causing an imbalance in Tregs [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. All these abnormalities in immune cell clusters may, as previously mentioned, impact peripheral inflammation and AD development.</p>
<p id="Par22">Another point of interest has been dedicated to epigenetic dysregulation in some cell clusters. Specifically, epigenetic changes in T cells and macrophages, including increased expression of microRNA-155 (miR-155) and altered DNA methylation, have been linked to heightened peripheral inflammation in AD patients [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>, <a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. It has been proposed that one of the causes for this epigenetic dysregulation might also be linked to LPS translocation, which has been shown to increase miR-155 in immune cells, supporting a shift towards a pro-inflammatory phenotype and exacerbation of AD pathology [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. Finally, triggering receptor expressed in myeloid cells 2 (TREM2) is a receptor that, when activated, plays a key role in the induction and regulation of the immune response [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. In the brain, TREM2 is mainly expressed by microglia and regulates its functions, such as microglial activation and phagocytosis [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>]. Mounting evidence has linked mutations in TREM2 to a higher risk of developing AD, mainly due to the decreased protective role of microglia in phagocytizing Aβ plaques [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>, <a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>–<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. Furthermore, TREM2 has been suggested as a contributor to peripheral inflammation. It has been reported that in certain peripheral immune cells, such as dendritic cells, TREM2 is upregulated, which leads to the differentiation of Th2 and Th17 cells [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]. Moreover, elevated expression of TREM2 mRNA in the periphery was negatively correlated to both Mini-Mental State Examination and Montreal Cognitive Assessment scores in AD patients [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>], highlighting that peripheral immune alterations may significantly influence cognitive deficits in AD patients.</p>
<p id="Par23">Finally, an additional potential contributor to AD exacerbation is the changes in the BBB that occur due to peripheral inflammation. For instance, it has been reported that elevated levels of pro-inflammatory cytokines can lead to changes in tight junctions and damage to endothelial cells [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>–<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>], causing the disruption of the BBB. This can, in turn, lead to the infiltration of peripheral immune cells, which may also directly contribute to the activation of microglia and astrocytes [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>], further amplifying neuroinflammation.</p>
<p id="Par24">Collectively, it has become increasingly evident that systemic inflammation and changes in systemic immune responses can have long-lasting effects on the brain. Inflammaging and priming of the immune system due to pro-inflammatory stimuli occurring during an individual’s life may be key in understanding the onset and development of AD. The described changes leading to peripheral inflammation can also be influenced by different disorders and diseases, which have also been linked to the exacerbation of AD pathology.</p></section><section id="Sec13"><h2 class="pmc_sec_title">Disorders associated with systemic immunity and their link to AD</h2>
<p id="Par25">As indicated in the previous sections, it is increasingly evident that systemic inflammation may significantly influence both the development and advancement of AD. When the immune system responds to disease, infection, or injury, the changes in the immune system at the systemic level may contribute to AD. Systemic inflammation may not only serve as a driving force for AD, but is also implicated in other disorders, such as cardiovascular disorders, obesity, gut inflammation, chronic pain, and viral and bacterial infections. These disorders can collectively contribute to inflammaging [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>]. In this section, we delve into the interplay between systemic immune disorders and their potential impact on the pathology and progression of AD, proposing that chronic immune activation might serve both as an initiator and accelerator of neuroinflammation in AD. By examining these conditions, we aim to reinforce the idea that AD should be considered a systemic immune disorder rather than a purely brain-specific pathology.</p></section><section id="Sec14"><h2 class="pmc_sec_title">Systemic inflammatory insults</h2>
<p id="Par26">Several systemic events, such as chronic pain, viral and bacterial infections, surgeries, and trauma-related insults, can trigger neuroinflammation, which is a significant contributor to the development of AD (Fig. <a href="#Fig1" class="usa-link">1</a>). These conditions not only contribute to transient immune activation but may also lead to long-term changes in immune function that predispose individuals to neurodegenerative diseases like AD.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369153_12979_2025_529_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a028/12369153/644c5c5c84f4/12979_2025_529_Fig1_HTML.jpg" loading="lazy" id="d33e582" height="661" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Various systemic diseases and conditions —including oral infections, obesity, type 2 diabetes, cardiovascular diseases, gut inflammation, chronic pain, infections, and surgery— contribute to chronic inflammation, which may in turn exacerbate the pathology and progression of Alzheimer’s disease (AD). Prolonged immune activation due to these conditions can lead to persistent low-grade inflammation, which primes the immune system and increases the susceptibility to neuroinflammation in AD. These peripheral immune disturbances can compromise the blood-brain barrier (BBB), allowing inflammatory mediators to enter the brain and may contribute to microglial activation, amyloid-β plaque accumulation, neurofibrillary tangle formation, neuronal loss, and neuroinflammation. Created with BioRender</p></figcaption></figure><section id="Sec15"><h3 class="pmc_sec_title">Chronic pain – Alzheimer’s disease</h3>
<p id="Par27">Chronic pain, defined as pain lasting more than 3 months, is most commonly experienced as back, neck, or joint pain in older adults. It is associated with both cognitive and emotional decline [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>–<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. Chronic pain is commonly seen in the elderly, with a prevalence rate of 38.5%. Interestingly, this rate increases up to 45.8% in AD patients, suggesting a correlation between chronic pain and AD [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>, <a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>].</p>
<p id="Par28">Multiple studies link chronic pain to increased dementia risk in the future [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>–<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>]. For instance, a 10-year cohort study found that fibromyalgia patients, a chronic pain syndrome, had a significantly higher dementia risk [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>]. Other longitudinal studies showed that chronic pain in multiple sites (such as back, knee, head) elevates the risk of dementia and AD [<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>, <a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>] and accelerates cognitive decline [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]. Since a single chronic pain site increases the risk of getting dementia by 8% [<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>], appropriately managing chronic pain could potentially contribute to lowering the prevalence of AD.</p>
<p id="Par29">Although the link between chronic pain and AD is evident, the underlying mechanism remains unclear. Evidence increasingly suggests common factors and pathologies, including aging, reduced gray matter, and both systemic and neuroinflammation [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>–<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]. For instance, systemic inflammation in chronic pain is evidenced by elevated pro-inflammatory cytokine blood levels [<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>–<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>], which might predispose individuals to its development and pathogenesis [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Moreover, systemic inflammation can disturb pain regulation by decreasing endogenous pain inhibition and increasing pain [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>–<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>], as shown in a clinical study [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>].</p>
<p id="Par30">Neuroinflammation is another common factor between chronic pain and AD. It can be triggered by systemic inflammation [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>], and plays a role in inducing and maintaining chronic pain via microglial activation [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>, <a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>–<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]. Neuroinflammation induces chronic pain by causing central sensitization through the release of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β [<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>, <a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>, <a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]. Activated microglia are reported in brain regions like the hippocampus, prefrontal cortex, and amygdala in chronic pain [<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>], and they have a pivotal role in the transition from acute to chronic pain [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. The pro-inflammatory state of microglia and elevated release of pro-inflammatory cytokines seen in chronic pain might potentially contribute to rendering chronic pain patients more susceptible to developing dementia, including AD.</p>
<section id="Sec16"><h4 class="pmc_sec_title">Anti-inflammatory therapies targeting microglial activation</h4>
<p id="Par31">Given the shared role of systemic inflammation in both AD and chronic pain, anti-inflammatory therapies may help in managing and mitigating the progression of both diseases. One approach to reduce inflammation is to inhibit pathological activation of microglia [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>].</p>
<p id="Par32">For example, the antibiotic minocycline reduces microglial activation and exhibits neuroprotective, anti-amyloidogenic, anti-inflammatory, and antioxidant properties [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>–<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>], with studies suggesting that it may alleviate the symptoms of both AD and chronic pain [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>–<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]. In animal models, it reduced Aβ plaque deposition, hyperphosphorylation of tau, improved memory deficits, and reduced neuronal cell death [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>, <a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>, <a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>, <a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]. However, one clinical trial in AD reported no significant cognitive improvement after two years of treatment and noted side effects at higher doses [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>].</p>
<p id="Par33">Since microglial activation also contributes to central sensitization in chronic pain [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>] and the transition from acute to chronic pain [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>], reducing microglial activation may also be therapeutic for chronic pain. Supporting this, upregulation of TREM2 and its adaptor protein DNAX-activating protein of 12 (DAP12) in spinal cord microglia has been shown to induce neuropathic pain by enhancing proinflammatory cytokine release from microglia [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>]. In this manner, pharmacological inhibition of TREM2 reduced fracture-associated chronic pain [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>].</p>
<p id="Par34">Animal studies suggest minocycline`s anti-nociceptive effects in chronic pain conditions such as diabetic and chemotherapy-induced peripheral neuropathy, and visceral pain [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>–<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. Moreover, in a clinical study, patients with breast cancer receiving 200 mg of minocycline daily throughout the 12 weeks of chemotherapy reported less pain and less use of opioid pain medication than the placebo group [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. Additionally, a current clinical trial is testing the effect of a 14-day treatment with minocycline on chronic low back pain [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>].</p>
<p id="Par35">Similarly, common pain medications, including paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin, have been studied for their potential impact on AD [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. Preclinical studies suggest that ibuprofen reduces microglial activation, alleviates AD pathology, and improves cognitive function in different AD mouse models [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>–<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. Some clinical studies also indicate that long-term NSAID use may lower the risk of developing AD [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>–<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>] and prevent cognitive decline, especially when initiated in midlife (before 65 years of age) [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. However, NSAIDs may accelerate AD progression in individuals with advanced pathology [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>], suggesting that their protective effects depend on both the timing and duration of treatment [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>]. Notably, one study found that aspirin and paracetamol were linked to a higher dementia risk in people with chronic pain, whereas ibuprofen did not show a significant association [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. Moreover, another study showed that regular paracetamol use, but not ibuprofen, significantly increased dementia risk in the elderly, regardless of genetic predisposition [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. These findings highlight the importance of carefully selecting pain management strategies, as their effects on AD and cognitive health may be protective or harmful depending on the context.</p>
<p id="Par36">In conclusion, minocycline’s and NSAIDs’ potential as a treatment for AD and chronic pain remains subject to ongoing research, with certain studies suggesting their effectiveness while others raise questions about their clinical application, highlighting the need for further investigation and optimization. Some of the above-mentioned studies suggest that targeting systemic inflammation through the reduction of microglial activation may be beneficial in addressing AD and chronic pain [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>, <a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>, <a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>, <a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>, <a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>, <a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>].</p>
<p id="Par37">However, as elaborated in prior sections, microglia are essential for the uptake and clearance of Aβ and for the removal of debris from dying or damaged cells, thus playing a critical role in maintaining brain homeostasis [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>, <a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]. For example, TREM2-deficient microglia or microglial depletion have been shown to exacerbate Aβ and tau pathology in mouse models of AD [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>–<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>]. Indeed, microglia exhibit a dual role in AD, being either neuroprotective or neurotoxic depending on the disease stage and pathological insults. Consequently, interventions to reduce microglial activation, such as with minocycline, should be carefully timed to avoid exacerbating pathology.</p></section><section id="Sec17"><h4 class="pmc_sec_title">Anti-inflammatory therapies targeting TNF-α</h4>
<p id="Par38">Modulating proinflammatory cytokines like TNF-α offers another strategy to reduce systemic inflammation in AD and chronic pain.</p>
<p id="Par39">In addition to its involvement in AD as discussed in previous sections, TNF-α plays a role in both central and peripheral mechanisms underlying chronic pain [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>–<a href="#CR163" class="usa-link" aria-describedby="CR163">163</a>]. The level of TNF-α is elevated in the periphery in chronic pain [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>, <a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>, <a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>], highlighting its therapeutic potential. A study showed that both a TNF-α blocker and minocycline reduced neuropathic pain-like behavior and microglial activation after spinal cord injury [<a href="#CR165" class="usa-link" aria-describedby="CR165">165</a>].</p>
<p id="Par40">However, as discussed previously, blocking TNF-α can have detrimental effects due to the opposing functions of the TNF receptor 1 (TNFR1) and TNF-α receptor 2 (TNFR2) [<a href="#CR166" class="usa-link" aria-describedby="CR166">166</a>]. Therefore, instead of inhibiting TNFα, selectively modulating TNFR1 or TNFR2 might be a more effective approach [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>, <a href="#CR167" class="usa-link" aria-describedby="CR167">167</a>, <a href="#CR168" class="usa-link" aria-describedby="CR168">168</a>]. For instance, Fischer et al. found that i.p. administration of a TNFR2 agonist promoted long-term recovery in neuropathic pain in both sexes [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>], while TNFR1 inhibition with an antagonist was therapeutic in only male mice [<a href="#CR167" class="usa-link" aria-describedby="CR167">167</a>].</p>
<p id="Par41">Given the promising results of selective TNFR modulation in treating AD and chronic pain, further research should explore the use of a TNFR2 agonist or TNFR1 antagonist in an AD mouse model that recapitulates clinical chronic pain conditions.</p>
<p id="Par42">Overall, chronic pain and AD may be linked through shared inflammatory mechanisms. While certain therapies show promise, further research should carefully consider the dual roles of microglia and inflammation, ensuring that interventions are precisely timed and targeted to avoid unintended detrimental effects.</p></section></section><section id="Sec18"><h3 class="pmc_sec_title">Post-operative cognitive dysfunction – Alzheimer’s disease</h3>
<p id="Par43">Tissue injuries such as trauma and surgeries may also induce systemic inflammation [<a href="#CR169" class="usa-link" aria-describedby="CR169">169</a>–<a href="#CR171" class="usa-link" aria-describedby="CR171">171</a>].</p>
<p id="Par44">While acute postoperative pain is expected, over 10% of surgical patients experience chronic pain 12 months after surgery, with procedures such as orthopedic and spine surgeries, knee arthroscopy, and total knee or hip arthroplasty having a particularly high incidence [<a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>]. This prolonged pain may be linked to systemic inflammation, which plays a role in turning acute pain into chronic pain post-surgery [<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>]. Systemic inflammation is also believed to contribute to post-operative cognitive impairments following surgery. Post-operative cognitive impairments can manifest in both short-term disturbances, such as postoperative delirium, or long-term disturbances as post-operative cognitive dysfunction (POCD), on which we will focus in the next sections.</p>
<p id="Par45">Interestingly, the link between surgery and cognitive decline extends beyond POCD. For example, people over the age of 55 who underwent coronary artery bypass graft surgery showed a significantly increased risk of developing dementia [<a href="#CR174" class="usa-link" aria-describedby="CR174">174</a>, <a href="#CR175" class="usa-link" aria-describedby="CR175">175</a>], with elderly and individuals with existing cognitive impairment being particularly being vulnerable [<a href="#CR175" class="usa-link" aria-describedby="CR175">175</a>].</p>
<p id="Par46">A preclinical study found that abdominal surgery in aged wild-type mice caused spatial memory deficits and increased hippocampal Aβ levels, while younger mice were unaffected following the same surgery [<a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>]. Moreover, 9-month-old AD mice displayed increased cognitive impairment, supported by reductions in freezing time in contextual fear conditioning and increased Aβ accumulation in the hippocampus after the peripheral surgery compared to Sham AD mice at the same age. These results suggest that the combination of surgery with factors such as aging or carrying an AD gene mutation can lead to POCD [<a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>].</p>
<p id="Par47">Although mechanisms remain unclear, surgery-induced inflammation is believed to play a role in this process [<a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>]. The initiation of an inflammatory response due to surgical trauma can result in neuroinflammation and synaptic impairment, and impaired neurogenesis [<a href="#CR177" class="usa-link" aria-describedby="CR177">177</a>, <a href="#CR178" class="usa-link" aria-describedby="CR178">178</a>], which predisposes patients to POCD and dementia [<a href="#CR175" class="usa-link" aria-describedby="CR175">175</a>] as well as accelerates the disease progression of AD [<a href="#CR179" class="usa-link" aria-describedby="CR179">179</a>]. Furthermore, elevated proinflammatory cytokine levels after surgery, such as TNF-α and IL-1β, might also contribute to POCD [<a href="#CR180" class="usa-link" aria-describedby="CR180">180</a>].</p>
<p id="Par48">A recent clinical study observed that individuals undergoing major surgical procedures showed an elevation of plasma pTau181 levels [<a href="#CR181" class="usa-link" aria-describedby="CR181">181</a>], which is a key AD biomarker [<a href="#CR181" class="usa-link" aria-describedby="CR181">181</a>–<a href="#CR183" class="usa-link" aria-describedby="CR183">183</a>]. Importantly, the study highlighted that cardiopulmonary bypass surgery exhibited a heightened risk for deviant biomarker levels and postoperative neurocognitive disorder when compared to noncardiac surgery [<a href="#CR181" class="usa-link" aria-describedby="CR181">181</a>].</p>
<p id="Par49">Since neuroinflammation and systemic inflammation are shared hallmarks of both AD and POCD, mitigating inflammation may help prevent cognitive decline [<a href="#CR184" class="usa-link" aria-describedby="CR184">184</a>, <a href="#CR185" class="usa-link" aria-describedby="CR185">185</a>]. Various factors can influence neuroinflammation, including gut microbiota, which will be discussed in the following sections.</p>
<p id="Par50">Preclinical studies showed that microbiome-targeted therapies, such as supplementation with probiotics and prebiotics, decrease inflammation and improve cognition in POCD [<a href="#CR186" class="usa-link" aria-describedby="CR186">186</a>–<a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>], as well as AD models [<a href="#CR189" class="usa-link" aria-describedby="CR189">189</a>–<a href="#CR191" class="usa-link" aria-describedby="CR191">191</a>]. For example, rats that were administered the prebiotic Bimuno for three weeks before abdominal surgery displayed improved learning and memory performance in the hippocampus-dependent novel object recognition test in early post-surgery compared to the control group [<a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>]. Moreover, the surgery resulted in a significant increase in microglial activation in the hippocampus, as indicated by Iba-1 (Ionized calcium-binding adaptor molecule 1) expression. However, prebiotic administration mitigated the surgery-induced microglial overactivation [<a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>].</p>
<p id="Par51">In addition to microbiome-targeted approaches for addressing POCD, reducing microglial activation with the antibiotic minocycline also suppressed postoperative neuroinflammation and mitigated the hippocampal-dependent memory impairment caused by a non-cardiac surgery as described in an animal study [<a href="#CR192" class="usa-link" aria-describedby="CR192">192</a>].</p>
<p id="Par52">Clinically, older patients receiving probiotics before a non-cardiac surgery had lower POCD incidence, likely due to reduced inflammation and stress responses [<a href="#CR193" class="usa-link" aria-describedby="CR193">193</a>]. However, a recent clinical trial found no significant benefit of minocycline on POCD outcomes at 1 week and 3 months following a knee surgery [<a href="#CR194" class="usa-link" aria-describedby="CR194">194</a>].</p>
<p id="Par53">In conclusion, while surgery may pose a risk, particularly for the elderly and those with pre-existing cognitive deficits, a careful approach to managing excessive inflammation after surgery may offer therapeutic benefits. However, it is crucial to balance the timing and extent of anti-inflammatory interventions, as microglial activation also plays a protective role. Strategies that modulate inflammation, especially before and after surgery, without completely inhibiting beneficial immune responses, could be key in developing effective treatments for POCD.</p></section></section><section id="Sec19"><h2 class="pmc_sec_title">Infections – Alzheimer’s disease</h2>
<p id="Par54">Emerging research suggests a novel perspective on the etiology of AD by linking it to infections. One possible explanation of how the viral and bacterial agents may elevate the risk of AD is by stimulating an innate immune response and initiating inflammation [<a href="#CR195" class="usa-link" aria-describedby="CR195">195</a>]. Upon the initiation of an inflammatory cascade following an infection, amyloid production and deposition are upsurged, which then induce further inflammatory responses, ultimately leading to the development of AD pathology [<a href="#CR195" class="usa-link" aria-describedby="CR195">195</a>].</p>
<p id="Par55">Various bacterial species and several viruses have been associated with AD pathogenesis, potentially through their ability to induce neuroinflammation and Aβ production. In this section, we will explore the hypothesis that infections initiated by different bacterial and viral pathogens may serve as persistent immune stressors that prime microglia into a pro-inflammatory state, thereby contributing to the neuroinflammatory cycle in AD.</p>
<section id="Sec20"><h3 class="pmc_sec_title">Viral Infections – Alzheimer’s disease</h3>
<p id="Par56">Multiple studies have linked viral infections to neurodegenerative disorders, including AD. A recent study revealed that exposure to 45 different viral agents increased the risk of developing neurodegenerative diseases, with viral encephalitis showing the most significant association, resulting in a 30-fold increased risk of developing AD [<a href="#CR196" class="usa-link" aria-describedby="CR196">196</a>]. Several viruses, including different types of human herpesvirus (HHV), human immunodeficiency virus (HIV), and hepatitis C virus (HCV), have been associated with AD development, possibly by promoting neuroinflammatory processes.</p>
<section id="Sec21"><h4 class="pmc_sec_title">Herpes simplex virus type 1 (HSV1)</h4>
<p id="Par57">The herpesviruses are highly prevalent, infecting over 90% of adults at some point in their lives [<a href="#CR197" class="usa-link" aria-describedby="CR197">197</a>]. Herpes simplex virus type 1 (HSV1) is a common virus that might cause cold sores and persists in a latent state in the nervous system throughout life, with periodic reactivation and recurring infections in the event of immunity impairment [<a href="#CR197" class="usa-link" aria-describedby="CR197">197</a>, <a href="#CR198" class="usa-link" aria-describedby="CR198">198</a>].</p>
<p id="Par58">Cumulative HSV1 exposure diminishes cognitive performance regardless of other health status, as shown in a clinical study [<a href="#CR199" class="usa-link" aria-describedby="CR199">199</a>]. In addition to that, HSV1 exposure is linked to AD and dementia as a susceptibility factor in several studies. A 16-year study of over 30,000 individuals found that HSV infection resulted in an 2.56-fold hazard ratio for the development of dementia [<a href="#CR200" class="usa-link" aria-describedby="CR200">200</a>]. Several studies link HSV1 in the brain to AD, especially in apolipoprotein E4 (APOE4) carriers [<a href="#CR201" class="usa-link" aria-describedby="CR201">201</a>–<a href="#CR204" class="usa-link" aria-describedby="CR204">204</a>], with one study showing a 12-fold increase in AD risk when both HSV1 and APOE4 were present compared with individuals having just one or neither of these factors [<a href="#CR204" class="usa-link" aria-describedby="CR204">204</a>]. Moreover, a large cohort study revealed an increased episodic memory decline, which is an early AD-related symptom, in participants aged over 65 years old who were carriers of both HSV and the APOE4 allele, in contrast to APOE4 carriers without HSV1 infection. Furthermore, a mouse study demonstrated that HSV1 DNA levels were 13-fold lower in the brain of APOE knock-out mice compared to wild-type mice that were injected with the same dosage of HSV1 [<a href="#CR205" class="usa-link" aria-describedby="CR205">205</a>], underscoring the combined impact of HSV1 and APOE4 on AD risk [<a href="#CR201" class="usa-link" aria-describedby="CR201">201</a>–<a href="#CR205" class="usa-link" aria-describedby="CR205">205</a>].</p>
<p id="Par59">Itzhaki and colleagues suggest that HSV1 can migrate into the brain from the periphery via retrograde axonal transport, olfactory nerve route, or bloodstream [<a href="#CR206" class="usa-link" aria-describedby="CR206">206</a>–<a href="#CR208" class="usa-link" aria-describedby="CR208">208</a>] when there is a decline in the immune system function, particularly with aging [<a href="#CR209" class="usa-link" aria-describedby="CR209">209</a>, <a href="#CR210" class="usa-link" aria-describedby="CR210">210</a>]. Once in the brain, HSV1 can reactivate, and it can contribute to neuroinflammation [<a href="#CR211" class="usa-link" aria-describedby="CR211">211</a>, <a href="#CR212" class="usa-link" aria-describedby="CR212">212</a>] and Aβ aggregation [<a href="#CR213" class="usa-link" aria-describedby="CR213">213</a>], increasing AD and cognitive decline risk in those with frequent peripheral infections [<a href="#CR214" class="usa-link" aria-describedby="CR214">214</a>].</p>
<p id="Par60">HSV1 can directly stimulate Aβ production in vitro in neuronal and glial cells [<a href="#CR213" class="usa-link" aria-describedby="CR213">213</a>, <a href="#CR215" class="usa-link" aria-describedby="CR215">215</a>], but also in by upregulating the Aβ-producing enzymes, such as β-secretase 1 and γ-secretase [<a href="#CR213" class="usa-link" aria-describedby="CR213">213</a>]. While an increase in APP amyloidogenic processing may provide initial protection against HSV1, recurrent HSV1 reactivation over a lifetime can lead to Aβ accumulation in the brain [<a href="#CR216" class="usa-link" aria-describedby="CR216">216</a>]. Furthermore, as the Aβ clearance by microglia is compromised by inflammaging [<a href="#CR217" class="usa-link" aria-describedby="CR217">217</a>], elderly people become more vulnerable to Aβ production following HSV1 infection, potentially exacerbating AD pathology [<a href="#CR216" class="usa-link" aria-describedby="CR216">216</a>]. Recent evidence also showed that HSV1 infection impaired microglial antiviral defense by downregulating TREM2 expression, which disrupted interferon signaling and phagocytosis [<a href="#CR218" class="usa-link" aria-describedby="CR218">218</a>]. TREM2 deficiency increased susceptibility to HSV1 in both cell culture and mice, highlighting its crucial role in microglial antiviral response [<a href="#CR218" class="usa-link" aria-describedby="CR218">218</a>].</p>
<p id="Par61">Notably, HSV1 DNA was found in 90% of Aβ plaques in AD brains, with 72% of the viral DNA localized to plaques [<a href="#CR209" class="usa-link" aria-describedby="CR209">209</a>].</p>
<p id="Par62">While the role of herpesviruses in AD etiology remains unclear, Aβ aggregation and neuroinflammation, which are the key hallmarks of AD pathology, might be the antimicrobial response to HSV1 exposure in the brain [<a href="#CR202" class="usa-link" aria-describedby="CR202">202</a>]. Some evidence supporting this hypothesis includes the antiviral properties exhibited by Aβ oligomers against HSV1 infection in neuronal cells [<a href="#CR216" class="usa-link" aria-describedby="CR216">216</a>, <a href="#CR219" class="usa-link" aria-describedby="CR219">219</a>] and the 5xFAD mouse model [<a href="#CR219" class="usa-link" aria-describedby="CR219">219</a>].</p>
<p id="Par63">HSV1 may also trigger tau hyperphosphorylation. Human neuroblastoma cells that were treated with HSV1 had elevated levels of AD-specific tau phosphorylation [<a href="#CR220" class="usa-link" aria-describedby="CR220">220</a>]. Moreover, hyperphosphorylated tau (p-tau) expression showed a transient increase in HSV1-infected primary murine hippocampal neuronal cultures on days 1 and 3 following injection of HSV-1 [<a href="#CR221" class="usa-link" aria-describedby="CR221">221</a>]. However, the levels of p-tau diminished by day 7, whereas Aβ accumulation continued to progressively increase over the course of 7 days, with barely detectable levels of Aβ on day 1 compared to the highest levels observed on day 7 after HSV1 infection, suggesting p-tau may be an acute danger response, while Aβ provides long-term defense against a continued stressor such as an infection [<a href="#CR221" class="usa-link" aria-describedby="CR221">221</a>].</p></section><section id="Sec22"><h4 class="pmc_sec_title">Human immunodeficiency virus (HIV)</h4>
<p id="Par64">Besides HSV1, HIV, and HCV infection might be risk factors for AD, AD-type pathology, and dementia [<a href="#CR222" class="usa-link" aria-describedby="CR222">222</a>–<a href="#CR225" class="usa-link" aria-describedby="CR225">225</a>]. A recent population study reported a higher prevalence of AD and related dementias among HIV-positive individuals, particularly older women, compared to HIV-negative individuals [<a href="#CR223" class="usa-link" aria-describedby="CR223">223</a>]. HIV regulatory proteins such as trans-activator of transcription (Tat), envelope glycoprotein (Gp120), viral protein R (Vpr), and negative factor (Nef) can directly activate neuroinflammatory pathways [<a href="#CR226" class="usa-link" aria-describedby="CR226">226</a>] and induce oxidative stress through mitochondrial dysfunction, which contributes to neuronal damage [<a href="#CR227" class="usa-link" aria-describedby="CR227">227</a>]. Furthermore, the HIV-1 Gag protein has been shown to interact with APP, promoting its processing into amyloid-beta, thereby linking HIV infection to AD-like pathology [<a href="#CR228" class="usa-link" aria-describedby="CR228">228</a>]. Supporting this, Aβ has been observed in the brains of HIV patients [<a href="#CR222" class="usa-link" aria-describedby="CR222">222</a>, <a href="#CR229" class="usa-link" aria-describedby="CR229">229</a>].</p>
<p id="Par65">Moreover, inflammasomes, particularly NLRP3, have been identified as central mediators of inflammation during HIV-1 infection, with recent reviews highlighting its potential as a therapeutic target for HIV [<a href="#CR230" class="usa-link" aria-describedby="CR230">230</a>, <a href="#CR231" class="usa-link" aria-describedby="CR231">231</a>].</p></section><section id="Sec23"><h4 class="pmc_sec_title">Hepatitis C virus (HCV)</h4>
<p id="Par66">A study on bipolar disorder (BD) patients found that those with AD had a 2.3-fold higher prevalence of prior HCV infection compared to BD patients without AD [<a href="#CR224" class="usa-link" aria-describedby="CR224">224</a>]. Another population-based study identified an elevated risk of dementia among HCV-infected patients within an 11-year time frame compared to the non-HCV cohort and identified HCV infection as a risk factor for dementia [<a href="#CR225" class="usa-link" aria-describedby="CR225">225</a>]. Cognitive impairment in HCV patients may be associated with systemic inflammation caused by the virus [<a href="#CR232" class="usa-link" aria-describedby="CR232">232</a>].</p></section><section id="Sec24"><h4 class="pmc_sec_title">Antiviral therapeutic strategies targeting AD pathology</h4>
<p id="Par67">These interactions support the significant role of viral infections in AD pathology and suggest that antiviral agents or vaccination might be considered viable preventive therapeutic strategies in AD. For instance, HSV patients treated with anti-herpetic medications had a significantly reduced risk of developing AD or dementia over 10 years compared to untreated individuals [<a href="#CR200" class="usa-link" aria-describedby="CR200">200</a>]. This aligns with another cohort study involving over 200,000 individuals, which revealed that herpes zoster increased dementia risk, while antiviral treatment (acyclovir, famciclovir, or valaciclovir) significantly decreased that risk [<a href="#CR233" class="usa-link" aria-describedby="CR233">233</a>].</p>
<p id="Par68">This reduced risk of AD and dementia following an anti-herpetic treatment may be attributed to the potential of some anti-viral compounds to directly mitigate AD-related pathology. Supporting this hypothesis, different antiviral agents used for HSV1 treatment, such as acyclovir, penciclovir, and foscarnet, have been shown to significantly reduce Aβ and p-tau accumulation in HSV1-infected cells [<a href="#CR234" class="usa-link" aria-describedby="CR234">234</a>]. Given this growing body of research, some authors suggest that early-life vaccination against HSV-1 may be protective against AD [<a href="#CR235" class="usa-link" aria-describedby="CR235">235</a>].</p>
<p id="Par69">In summary, the above-mentioned findings provide evidence that viral infections, particularly HSV1, could serve as risk factors for the development of AD and dementia by contributing to AD pathology. Nevertheless, recognizing and treating viral infections promptly may mitigate the risk of AD development.</p></section></section><section id="Sec25"><h3 class="pmc_sec_title">Bacterial Infections – Alzheimer’s disease</h3>
<p id="Par70">Various bacterial species have been associated with AD pathogenesis, potentially through their ability to induce neuroinflammation and Aβ production.</p>
<section id="Sec26"><h4 class="pmc_sec_title">Borrelia burgdorferi</h4>
<p id="Par71">Over 30 years ago, <em>Borrelia burgdorferi</em>, a spirochete causing Lyme disease, was detected in the neocortex of a postmortem AD brain [<a href="#CR236" class="usa-link" aria-describedby="CR236">236</a>], underscoring additional research to explore the potential link between <em>Borrelia</em> and possibly other bacteria to dementia and AD. Like herpetic viruses, spirochetes, including <em>B. burgdorferi</em> and <em>Tropenoma pallidum</em>, can enter a latent state with persistent infection. Importantly, chronic exposure to spirochetes can lead to chronic inflammation and amyloid deposition [<a href="#CR198" class="usa-link" aria-describedby="CR198">198</a>, <a href="#CR237" class="usa-link" aria-describedby="CR237">237</a>]. To test the hypothesis, Miklossy et al. infected rat neuronal cultures with Borrelia, finding increased Aβ and p-tau levels, particularly after prolonged exposure (8 vs. 2 weeks) [<a href="#CR238" class="usa-link" aria-describedby="CR238">238</a>]. Moreover, they suggested that <em>B. burgdorferi</em> and <em>T. pallidum</em> may contribute to amyloid deposition, cortical atrophy, and dementia [<a href="#CR239" class="usa-link" aria-describedby="CR239">239</a>, <a href="#CR240" class="usa-link" aria-describedby="CR240">240</a>].</p></section><section id="Sec27"><h4 class="pmc_sec_title">C. pneumoniae</h4>
<p id="Par74"><em>C. pneumoniae</em> is an intracellular respiratory pathogen that might cause pneumonia, bronchitis, and various upper respiratory tract illnesses [<a href="#CR241" class="usa-link" aria-describedby="CR241">241</a>] and it is also associated with AD.</p>
<p id="Par75"><em>C. pneumoniae</em> can induce amyloid deposits in mice. The analysis of non-transgenic mice brains that were treated with <em>C. pneumoniae</em> demonstrated the presence of amyloid deposits, which were detected 1 month after inoculation. As the infection advanced, both the size and quantity of these deposits increased, supporting its potential to drive or accelerate AD-like pathology [<a href="#CR242" class="usa-link" aria-describedby="CR242">242</a>]. Moreover, <em>C. pneumoniae</em> can progressively increase the protein levels of BACE1 and PSEN1, which can result in further neuroinflammation and increased Aβ production [<a href="#CR243" class="usa-link" aria-describedby="CR243">243</a>].</p>
<p id="Par76">When transitioning to human studies, clinical evidence further supports the relevance of <em>C. Pneumoniae</em> in AD. A recent cohort study found a 1.6-fold increased risk of AD in patients with <em>C. Pneumoniae</em> within 8 years of tracking, which was mitigated by timely antibiotic treatment [<a href="#CR244" class="usa-link" aria-describedby="CR244">244</a>]. In a different study by Balin et al., <em>C. pneumoniae</em> was detected in 17 out of 19 AD brains in regions such as the hippocampus and temporal cortex by using PCR analysis. In contrast, no evidence of <em>C. pneumoniae</em> was found in control patients [<a href="#CR245" class="usa-link" aria-describedby="CR245">245</a>].</p>
<p id="Par77">Similarly, 20 of 27 AD brains exhibited <em>C. pneumoniae</em> DNA, whereas only 3/27 control brains were positive. Moreover, immunohistochemical analysis revealed that cells infected with <em>C. pneumoniae</em> were found in close proximity to both Aβ and NFTs in the AD brain [<a href="#CR246" class="usa-link" aria-describedby="CR246">246</a>].</p>
<p id="Par78">Although these studies point to a strong association between <em>C. pneumoniae and AD</em>, it does not prove that <em>C. pneumoniae</em> directly causes AD. The increased risk of AD and observed presence of <em>C. pneumoniae</em> in AD brains may reflect a secondary effect, where the bacterium triggers neuroinflammation, which subsequently accelerates or exacerbates AD pathology. Thus, more controlled trials are necessary to confirm this relationship.</p></section><section id="Sec28"><h4 class="pmc_sec_title">Antibacterial therapeutic strategies targeting AD pathology</h4>
<p id="Par79">Considering the potential role of bacteria in AD risk and pathogenesis, antibacterial treatments have been tested as a therapeutic strategy in AD. Antibiotics are commonly used to treat bacterial infections, and some of them have also been investigated in the context of AD. As discussed earlier, minocycline may improve cognitive impairments and AD-related pathology [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>, <a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>, <a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>].</p>
<p id="Par80">Additionally, rifampicin and doxycycline are among the antibiotics studied as a treatment approach for AD. Rifampicin exhibits anti-inflammatory, anti-oxidative, and neuroprotective properties [<a href="#CR247" class="usa-link" aria-describedby="CR247">247</a>, <a href="#CR248" class="usa-link" aria-describedby="CR248">248</a>]. It can prevent Aβ aggregation and protect neuronal cells from Aβ-induced cytotoxicity in vitro [<a href="#CR249" class="usa-link" aria-describedby="CR249">249</a>]. In AD mouse models, rifampicin reduced Aβ-oligomers, synapse loss, and microglial activation and improved spatial memory in a dose-dependent manner [<a href="#CR250" class="usa-link" aria-describedby="CR250">250</a>]. It also reduced tau pathology and improved memory in tauopathy models, likely by inhibiting protein oligomerization [<a href="#CR250" class="usa-link" aria-describedby="CR250">250</a>].</p>
<p id="Par81">Additionally, rifampicin has shown a promising effect in a retrospective FDG-PET (Fluorodeoxyglucose-Positron Emission Tomography) study in a clinical study, suggesting preventive effects on the progression of AD with a daily dose of at least 450 mg for 1 year [<a href="#CR251" class="usa-link" aria-describedby="CR251">251</a>].</p>
<p id="Par82">Similarly, doxycycline inhibits Aβ formation in vitro, highlighting its anti-amyloidogenic activity [<a href="#CR252" class="usa-link" aria-describedby="CR252">252</a>]. Furthermore, doxycycline treatment in APP/PS1 mice at 15 to 16 months of age rescued memory deficits. Surprisingly, the treatment did not affect the plaque load, suggesting that doxycycline restores memory without affecting insoluble Aβ pools. The memory recovery was linked to a reduction in glial activation and neuroinflammation, leading the authors to propose that doxycycline might operate by returning glial cells to a state that enables the regular processing of new memories or by interfering with the oligomeric Aβ species [<a href="#CR253" class="usa-link" aria-describedby="CR253">253</a>].</p>
<p id="Par83">Combined treatment with rifampicin (300 mg) and doxycycline (200 mg) over three months significantly reduced cognitive decline in patients with mild to moderate AD in a clinical study. While the authors speculated that the effect of the antibiotics might be attributed to the reduced cerebral amyloid deposition, it is noteworthy that the study did not include measurements of Aβ plaques [<a href="#CR254" class="usa-link" aria-describedby="CR254">254</a>].</p>
<p id="Par84">Yet, some studies found an association between antibiotic use and cognitive impairment, AD, and dementia risk. For example, a year of treatment with rifampicin and doxycycline led to a decline in cognition among AD patients, though the decline was not significant when both drugs were combined [<a href="#CR255" class="usa-link" aria-describedby="CR255">255</a>]. It is plausible that some properties of rifampicin and doxycycline might be beneficial in the short term, whereas other properties may have a negative impact that becomes more evident during long-term (12-month) treatment [<a href="#CR255" class="usa-link" aria-describedby="CR255">255</a>].</p>
<p id="Par85">A large retrospective cohort study in South Korea (<em>n</em> &gt; 300,000) found that antibiotic use—particularly cephalosporins—for three months or longer increased the risk of AD and dementia, with longer cumulative exposure linked to even higher risk [<a href="#CR256" class="usa-link" aria-describedby="CR256">256</a>]. This may be due to neuroinflammation and neurodegeneration induced by antibiotics through the gut microbiota-brain axis [<a href="#CR256" class="usa-link" aria-describedby="CR256">256</a>, <a href="#CR257" class="usa-link" aria-describedby="CR257">257</a>]. As will be discussed in the coming sections, changes in gut microbiota can affect the pathogenesis of neurodegenerative diseases, including AD. Prolonged antibiotic exposure can lead to short and long-term changes in gut microbiota that might induce changes in the gut-brain axis, potentially affecting the incidence of dementia [<a href="#CR256" class="usa-link" aria-describedby="CR256">256</a>, <a href="#CR257" class="usa-link" aria-describedby="CR257">257</a>]. Importantly, the authors suggest that long-term prescription of antibiotics may be attributed to the poor health status of the participants, which might be a factor in increasing their vulnerability to dementia [<a href="#CR256" class="usa-link" aria-describedby="CR256">256</a>]. While this study links cumulative antibiotic use to dementia risk, further research is needed to determine whether antibiotics are a direct cause or if underlying health conditions contribute to this association.</p>
<p id="Par86">Similarly, in a cohort study, long-term antibiotic use (minimum 2 months) in midlife was associated with cognitive impairment assessed seven years later, particularly in women treated for respiratory or urinary tract infections [<a href="#CR258" class="usa-link" aria-describedby="CR258">258</a>].</p>
<p id="Par87">Thus, the therapeutic use of antibiotics in AD remains controversial. Although eliminating chronic infections might help with disease prevention and AD pathology by reducing neuroinflammation, many antibiotics can cause changes in the composition of gut microbiota, which might worsen the disease course [<a href="#CR257" class="usa-link" aria-describedby="CR257">257</a>]. Interestingly, Aβ itself may have antimicrobial properties, suggesting its accumulation could also reflect a protective response to chronic infections [<a href="#CR259" class="usa-link" aria-describedby="CR259">259</a>].</p>
<p id="Par88">As a complementary strategy to antibiotics, targeting host immune pathways may offer additional benefits. For instance, <em>Brucella abortus</em>, a bacterium that causes chronic host infections, was shown to upregulate TREM2 expression in M2 macrophages, suppressing mitochondrial ROS production and preventing pyroptosis, thus enhancing bacterial survival [<a href="#CR259" class="usa-link" aria-describedby="CR259">259</a>]. Downregulation of TREM2 reversed these effects [<a href="#CR259" class="usa-link" aria-describedby="CR259">259</a>]. Similarly, genetically deleting or blocking TREM2 reduced the survival of <em>M. tuberculosis</em> through enhanced ROS production, which highlights TREM2 as a potential therapeutic target in infection-driven immune evasion and inflammation [<a href="#CR261" class="usa-link" aria-describedby="CR261">261</a>]. However, TREM2`s role in pathogen removal appears to show conflicting results, as it enhanced bacterial clearance in <em>S. typhimurium</em> and <em>P. aeruginosa infections</em>, suggesting that its effect may vary by microbial context and immune environment [<a href="#CR262" class="usa-link" aria-describedby="CR262">262</a>–<a href="#CR264" class="usa-link" aria-describedby="CR264">264</a>].</p>
<p id="Par89">In summary, the findings suggest that different bacteria may contribute to a sequence of processes, including neuroinflammation and amyloid accumulation, ultimately leading to AD-like pathology. This further supports the infection hypothesis of AD, which proposes that microbial factors play a role in disease onset and progression.</p></section></section><section id="Sec29"><h3 class="pmc_sec_title">Oral infections - Alzheimer’s disease</h3>
<p id="Par90">In the preceding sections, we discussed the association between non-oral bacteria and AD. We now focus on the potential etiological link between oral infections—particularly periodontitis—and AD.</p>
<p id="Par91">Periodontitis, a prevalent oral inflammatory disease that damages tooth-supporting structures and leads to tooth loss [<a href="#CR265" class="usa-link" aria-describedby="CR265">265</a>, <a href="#CR266" class="usa-link" aria-describedby="CR266">266</a>], affects around 11% of the global population [<a href="#CR268" class="usa-link" aria-describedby="CR268">268</a>].</p>
<p id="Par92">In addition to being a source of local inflammation, periodontitis can trigger systemic inflammation and act as a driver for a chronic immune response [<a href="#CR268" class="usa-link" aria-describedby="CR268">268</a>]. This occurs through the release of pro-inflammatory cytokines into the bloodstream, which can exert effects on a systemic level or enter the brain. Moreover, periodontitis can facilitate the transport of intact bacteria and viruses to the brain [<a href="#CR269" class="usa-link" aria-describedby="CR269">269</a>–<a href="#CR271" class="usa-link" aria-describedby="CR271">271</a>]. The systemic inflammation triggered by untreated periodontitis might trigger or exacerbate AD [<a href="#CR270" class="usa-link" aria-describedby="CR270">270</a>–<a href="#CR273" class="usa-link" aria-describedby="CR273">273</a>].</p>
<p id="Par93">Different population-based retrospective studies showed that chronic periodontitis patients had an increased risk of developing AD and overall dementia [<a href="#CR274" class="usa-link" aria-describedby="CR274">274</a>, <a href="#CR275" class="usa-link" aria-describedby="CR275">275</a>]. Notably, periodontitis has been observed to accelerate the cognitive decline in AD patients during a six-month follow-up period, likely due to the systemic inflammation it induced [<a href="#CR273" class="usa-link" aria-describedby="CR273">273</a>].</p>
<p id="Par94">Dysbiosis of the oral microbiome has a crucial role in the development of periodontitis and is notably evident in AD patients. Pathogenic bacteria linked to periodontitis such as <em>Porphyromonas gingivalis</em>,<em> Fusobacterium nucleatu</em>m, and <em>Actinomyces naeslundi</em>i are significantly elevated in AD patients compared to healthy controls [<a href="#CR276" class="usa-link" aria-describedby="CR276">276</a>–<a href="#CR278" class="usa-link" aria-describedby="CR278">278</a>], making them potential risk factors for AD pathogenesis.</p>
<p id="Par95">For example, <em>P. gingivalis</em>, the keystone pathogen in periodontitis, impairs spatial memory and elevates brain levels of TNF-α, IL-6, and IL-1β in wild-type mice and rats [<a href="#CR279" class="usa-link" aria-describedby="CR279">279</a>–<a href="#CR283" class="usa-link" aria-describedby="CR283">283</a>].</p>
<p id="Par96">It also increases hippocampal and cortical microglia and astrocytes [<a href="#CR281" class="usa-link" aria-describedby="CR281">281</a>, <a href="#CR284" class="usa-link" aria-describedby="CR284">284</a>, <a href="#CR285" class="usa-link" aria-describedby="CR285">285</a>], which might result from the ability of <em>P. gingivalis</em> to induce the formation of ASC specks —protein aggregates that amplify inflammasome activation and neuroinflammation— through activation of the NLRP3 inflammasome [<a href="#CR286" class="usa-link" aria-describedby="CR286">286</a>]. NLRP3 activation in periodontal tissues enhanced the secretion of proinflammatory cytokines such as IL-1β and IL-18 [<a href="#CR287" class="usa-link" aria-describedby="CR287">287</a>]. However, P. gingivalis-induced alveolar bone loss was significantly reduced in NLRP3-deficient mice, suggesting that NLRP3 inflammasome mediates the inflammatory response driving periodontal disease [<a href="#CR287" class="usa-link" aria-describedby="CR287">287</a>].</p>
<p id="Par97">Furthermore, TREM2 expression is upregulated in the alveolar bone of chronic periodontitis patients. TREM2 was found to promote osteoclast differentiation and bone resorption by enhancing intracellular ROS levels [<a href="#CR288" class="usa-link" aria-describedby="CR288">288</a>]. This effect was further exacerbated by Aβ oligomers, suggesting a potential link between amyloid pathology and periodontal bone loss via TREM2 signalling [<a href="#CR288" class="usa-link" aria-describedby="CR288">288</a>].</p>
<p id="Par98">Moreover, oral administration of <em>P. gingivalis</em> increases Aβ and p-tau in the cortex and hippocampus and upregulates APP and BACE1 in both AD and wild-type mice [<a href="#CR280" class="usa-link" aria-describedby="CR280">280</a>, <a href="#CR281" class="usa-link" aria-describedby="CR281">281</a>, <a href="#CR284" class="usa-link" aria-describedby="CR284">284</a>, <a href="#CR289" class="usa-link" aria-describedby="CR289">289</a>]. These data implicate that periodontitis might promote AD pathology in the brain.</p>
<p id="Par99">Notably, after oral administration of <em>P. gingivalis</em>, the bacterium and its toxic proteases (gingipains) were detected in the brains of the wild-type rats and wild-type and ApoE<sup>−/−</sup> mice, where they are localized in microglia, astrocytes, and neurons [<a href="#CR280" class="usa-link" aria-describedby="CR280">280</a>, <a href="#CR284" class="usa-link" aria-describedby="CR284">284</a>, <a href="#CR290" class="usa-link" aria-describedby="CR290">290</a>].</p>
<p id="Par100">DNA of <em>P. gingivalis</em> was also detected in the CSF of clinical AD patients by Dominy et al. In this study, the researchers demonstrated that gingipains were present in 96% of post-mortem AD brains. The levels were significantly higher in the AD brains, including the hippocampus, where the gingipains colocalized with neurons, astrocytes, and tau and ubiquitin pathology compared to control brains, which may provide direct evidence of the pathogen`s involvement in AD [<a href="#CR278" class="usa-link" aria-describedby="CR278">278</a>]. The presence of LPS from <em>P. gingivalis</em> in post-mortem AD brains further supports this link [<a href="#CR291" class="usa-link" aria-describedby="CR291">291</a>].</p>
<p id="Par101">Beyond <em>P. gingivalis</em>, <em>F. nucleatum</em> infection in 5xFAD mice exacerbated memory impairment, increased Aβ and p-tau, and tripled TNF-α and IL-1β levels compared to controls [<a href="#CR266" class="usa-link" aria-describedby="CR266">266</a>].</p>
<p id="Par102">These findings suggest that treating oral pathogens could reduce AD risk and pathology. In this manner Dominy et al. tested gingipain inhibitors (e.g., atuzaginstat) in <em>P. gingivalis</em>-infected mice and found reduced brain bacterial load, neuroinflammation, Aβ1–42 levels, and neuronal loss—highlighting therapeutic potential despite clinical trial challenges [<a href="#CR278" class="usa-link" aria-describedby="CR278">278</a>].</p>
<p id="Par103">In addition to bacterial protease inhibitors, targeting inflammatory pathways such as the NLRP3 inflammasome might offer therapeutic benefits. For instance, the NLRP3 inflammasome inhibitor MCC950 has been shown to reduce alveolar bone loss and osteoclast differentiation in mouse models of periodontitis [<a href="#CR292" class="usa-link" aria-describedby="CR292">292</a>]. Similarly, glyburide, a diabetes drug known to block NLRP3 activation, decreased inflammation and bone resorption in animal models [<a href="#CR293" class="usa-link" aria-describedby="CR293">293</a>, <a href="#CR294" class="usa-link" aria-describedby="CR294">294</a>].</p>
<p id="Par104">In summary, the relationship between periodontitis and AD underscores the importance of maintaining good oral health as a preventive measure against AD and neurodegenerative diseases [<a href="#CR295" class="usa-link" aria-describedby="CR295">295</a>]. By monitoring specific oral pathogens, such as <em>P. gingivalis</em>, we could potentially identify early indicators of AD before the clinical manifestations emerge.</p></section></section><section id="Sec30"><h2 class="pmc_sec_title">Gut inflammation - Alzheimer’s disease</h2>
<p id="Par106">Gut microbiota, which is the system of microorganisms colonizing the gastrointestinal tract, can interact with the brain, a phenomenon which is referred to by the term microbiota-gut-brain axis [<a href="#CR296" class="usa-link" aria-describedby="CR296">296</a>]. It has been recognized that the modulations in the gut-brain axis can affect the pathogenesis of neurodegenerative diseases, including AD. Systemic inflammation and intestinal permeability can be induced by changes in gut microbiota composition, which is also called dysbiosis. The gut dysbiosis may lead to increased gut permeability, which facilitates increased translocation of LPS and bacteria into the systemic circulation, which might trigger a persistent state of systemic inflammation [<a href="#CR297" class="usa-link" aria-describedby="CR297">297</a>, <a href="#CR298" class="usa-link" aria-describedby="CR298">298</a>]. Ultimately, systemic inflammation caused by the alterations in the gut microbiota may lead to or worsen AD pathology, including Aβ deposition and cognitive impairments [<a href="#CR299" class="usa-link" aria-describedby="CR299">299</a>]. It is suggested that this effect might be partially mediated through NLRP3 inflammasome signaling, which links gut dysbiosis to neuroinflammatory responses [<a href="#CR300" class="usa-link" aria-describedby="CR300">300</a>]. Notably, transplantation of gut microbiota from AD patients into mice activated the NLRP3 inflammasome in the intestines of mice, leading to increased peripheral inflammation and microglial activation in the brain, resulting in exacerbated cognitive impairment [<a href="#CR301" class="usa-link" aria-describedby="CR301">301</a>].</p>
<p id="Par107">Aging can influence gut microbiota composition. For example, pro-inflammatory bacterial species in the gut microbiota have been found to increase with aging, whereas beneficial bacteria with anti-inflammatory properties, such as <em>F.prausnitzii</em>, decrease [<a href="#CR302" class="usa-link" aria-describedby="CR302">302</a>].</p>
<p id="Par108">AD pathology itself influences gut microbiota composition. Additionally, lifestyle changes commonly observed in AD patients, such as altered diet, reduced physical activity and sleep disturbances, may also contribute to shifts in gut microbiota composition, further reinforcing the bidirectional relationship between AD and microbial dysbiosis [<a href="#CR259" class="usa-link" aria-describedby="CR259">259</a>]. The pro-inflammatory gut bacteria populations increase in AD patients, whereas the diversity of gut microbiota decreases [<a href="#CR303" class="usa-link" aria-describedby="CR303">303</a>]. The increased intestinal permeability induced by microbial dysbiosis elevates plasma LPS, serum IL-1, and TNF-α levels. Gut dysbiosis can occur before the onset of dementia, as shown in a study where there were no differences in microbial diversity between patients with AD and those with mild cognitive impairment (MCI) [<a href="#CR303" class="usa-link" aria-describedby="CR303">303</a>].</p>
<p id="Par109">Interestingly, recent studies indicated sex-specific differences in the gut microbiome and its impact on AD pathology. Changes in gut bacterial composition, as well as reductions in amyloid plaques and neuroinflammation following interventions such as antibiotic treatment or sodium oligomannate (GV-971), were observed mainly in male mice, but not in females [<a href="#CR304" class="usa-link" aria-describedby="CR304">304</a>, <a href="#CR305" class="usa-link" aria-describedby="CR305">305</a>]. Estrogen levels might modulate these microbiome changes and subsequent amyloid pathology, suggesting complex crosstalk between sex hormones, gut microbiota, and AD progression [<a href="#CR304" class="usa-link" aria-describedby="CR304">304</a>, <a href="#CR305" class="usa-link" aria-describedby="CR305">305</a>]. This finding highlights the importance of considering sex differences when investigating interventions for AD.</p>
<p id="Par110">Long-term antibiotic use might also result in gut dysbiosis and can alter systemic inflammatory components, impacting cognitive functions [<a href="#CR255" class="usa-link" aria-describedby="CR255">255</a>, <a href="#CR257" class="usa-link" aria-describedby="CR257">257</a>, <a href="#CR258" class="usa-link" aria-describedby="CR258">258</a>, <a href="#CR296" class="usa-link" aria-describedby="CR296">296</a>]. For example, a recent study using the 3xtg-AD mouse model demonstrated that <em>Klebsiella pneumoniae</em>, a common hospital-acquired infection, was able to translocate from the gut to the bloodstream and further reach the brain by crossing the blood-brain barrier. This effect was especially under antibiotic-induced dysbiosis, which subsequently exacerbated AD pathogenesis, neuroinflammation, and cognitive impairment [<a href="#CR306" class="usa-link" aria-describedby="CR306">306</a>].</p>
<p id="Par111">Furthermore, clinical studies revealed that microbiota dysbiosis caused by gastrointestinal tract (GT) diseases such as irritable bowel syndrome (IBS) heightens the risk of developing AD [<a href="#CR307" class="usa-link" aria-describedby="CR307">307</a>, <a href="#CR308" class="usa-link" aria-describedby="CR308">308</a>]. Therefore, identifying individuals with GT disorders is crucial as interventions to restore healthy gut microbiota can reduce the risk of future AD development.</p>
<p id="Par112">Notably, regional differences in AD prevalence have been reported. For instance, Japanese-American men in Hawaii showed higher AD rates than those in Japan, likely due to dietary differences—high fat intake being a risk factor, while fish consumption slightly reduced risk [<a href="#CR309" class="usa-link" aria-describedby="CR309">309</a>].</p>
<p id="Par113">There are some microbiome-targeted therapies to restore a healthy gut microbiota, such as dietary or non-dietary interventions to reduce neuroinflammation [<a href="#CR190" class="usa-link" aria-describedby="CR190">190</a>, <a href="#CR310" class="usa-link" aria-describedby="CR310">310</a>, <a href="#CR311" class="usa-link" aria-describedby="CR311">311</a>].</p>
<p id="Par114">Using probiotics is a promising strategy for re-establishing healthy gut microbiota and delaying AD progression [<a href="#CR190" class="usa-link" aria-describedby="CR190">190</a>, <a href="#CR312" class="usa-link" aria-describedby="CR312">312</a>]. Prebiotics and probiotics can enhance the GI barrier function, decrease intestinal permeability, and reduce inflammation [<a href="#CR310" class="usa-link" aria-describedby="CR310">310</a>].</p>
<p id="Par115">In a preclinical study, 3xTg-AD mice treated with SLAB51 (a probiotic mix of nine bacterial strains) for four months showed improved cognition, modified microbiota, and reduced Aβ plaques compared to controls [<a href="#CR190" class="usa-link" aria-describedby="CR190">190</a>].</p>
<p id="Par116">Furthermore, in a study exploring the potential impact of gut microbiota on AD pathogenesis, a transgenic AD mouse displaying both Aβ and tau pathology (ADLP<sup>APT</sup>) exhibited differences in the gut microbiota composition compared to wild-type mice [<a href="#CR311" class="usa-link" aria-describedby="CR311">311</a>]. Notably, when ADLP<sup>APT</sup> was transplanted with the faecal microbiota from healthy wild-type mice almost every day for 4 months, there was a notable reduction in Aβ and tau pathology, as well as glial activity and cognitive impairment. Consequently, the authors suggested that microbiota-mediated intestinal and systemic inflammation contribute to AD pathology, and targeting systemic factors, including the re-establishing of a healthy gut microbiota, may serve as a good therapeutic target in AD [<a href="#CR311" class="usa-link" aria-describedby="CR311">311</a>].</p>
<p id="Par117">The effect of probiotics on AD has also been investigated in a few clinical studies, although the number of studies conducted so far remains limited. For instance, AD patients supplemented with 200 ml/day probiotic milk containing <em>Lactobacillus and Bifidobacterium</em> for 12 weeks displayed a significant improvement in cognitive functions as assessed by the Mini-Mental State Examination, compared to AD patients who received a placebo [<a href="#CR313" class="usa-link" aria-describedby="CR313">313</a>]. Moreover, probiotic treatment before undergoing surgery can reduce POCD induced by surgery and reduce surgery-induced neuroinflammation by manipulating gut microbiota [<a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>, <a href="#CR193" class="usa-link" aria-describedby="CR193">193</a>].</p>
<p id="Par118">In conclusion, the interplay between gut microbiota, systemic inflammation, and AD pathology indicates the importance of therapeutic interventions targeting gut health. Gut microbiota profiling could be a potential biomarker for future AD risk association. Addressing and managing gut inflammation as a lifestyle intervention, given its ease and affordability, may help alleviate AD symptoms and could play a role in delaying or preventing the onset of the disease when combined with other therapies.</p></section><section id="Sec31"><h2 class="pmc_sec_title">Cardiovascular disease and risk factors - Alzheimer’s disease</h2>
<p id="Par119">There are several cardiovascular diseases and risk factors linked to AD risk, with systemic inflammation being the common underlying factor.</p>
<p id="Par120">For example, obesity is considered a significant risk factor for AD. Mid-life obesity, particularly characterized by a body mass index (BMI) higher than 30, increases the risk of developing AD as supported by several studies [<a href="#CR314" class="usa-link" aria-describedby="CR314">314</a>–<a href="#CR317" class="usa-link" aria-describedby="CR317">317</a>]. Interestingly, this correlation appears to reverse as people age, leading to what is known as the obesity paradox, where older obese individuals exhibit a reduced risk of AD [<a href="#CR318" class="usa-link" aria-describedby="CR318">318</a>–<a href="#CR320" class="usa-link" aria-describedby="CR320">320</a>]. Weight loss, which often occurs before cognitive decline and is considered a non-cognitive sign of preclinical AD, might help explain the obesity paradox in AD [<a href="#CR321" class="usa-link" aria-describedby="CR321">321</a>, <a href="#CR322" class="usa-link" aria-describedby="CR322">322</a>]. Weight loss has been linked to brain atrophy and appears to alter the relationship between late-life obesity and brain atrophy [<a href="#CR322" class="usa-link" aria-describedby="CR322">322</a>]. The obesity paradox may possibly result from reverse causation, where early weight loss related to preclinical AD masks the detrimental impact of obesity in older adults [<a href="#CR321" class="usa-link" aria-describedby="CR321">321</a>].</p>
<p id="Par121">Similarly, metabolic syndrome (MetS), a cluster of conditions including obesity, insulin resistance, hypertension, and dyslipidemia, has been associated with an increased risk of cognitive decline and AD [<a href="#CR323" class="usa-link" aria-describedby="CR323">323</a>–<a href="#CR327" class="usa-link" aria-describedby="CR327">327</a>]. MetS contributes to neurodegeneration through chronic systemic inflammation, vascular dysfunction, and impaired insulin signaling, which can promote Aβ accumulation and tau pathology [<a href="#CR326" class="usa-link" aria-describedby="CR326">326</a>].</p>
<p id="Par122">A recent large population-based study in the Netherlands examined whether different changes in MetS status differ in cognitive functioning, but found no significant differences between groups [<a href="#CR328" class="usa-link" aria-describedby="CR328">328</a>].</p>
<p id="Par123">Obesity triggers low-grade inflammation in peripheral tissues and the circulation, marked by elevated levels of proinflammatory cytokine levels including TNF-α and IL-1β [<a href="#CR329" class="usa-link" aria-describedby="CR329">329</a>–<a href="#CR332" class="usa-link" aria-describedby="CR332">332</a>]. For instance, a high-fat diabetogenic diet can induce AD pathogenesis through immune system activation via toll-like receptor 4 (TLR4), a key element in the inflammatory response [<a href="#CR333" class="usa-link" aria-describedby="CR333">333</a>]. The glial activation in the brain could be directly influenced by the saturated fatty acids that cross the BBB, which could be one of the mechanisms of how obesity can stimulate AD pathogenesis [<a href="#CR334" class="usa-link" aria-describedby="CR334">334</a>]. Furthermore, this inflammatory state is partly driven by NLRP3 inflammasome, which senses obesity-associated danger signals, leading to caspase-1 activation and IL-1β and IL-18 secretion [<a href="#CR335" class="usa-link" aria-describedby="CR335">335</a>]. Calorie restriction and exercise-mediated weight loss in obese individuals with the 2 diabetes significantly reduced NLRP3 expression in adipose tissue, leading to decreased inflammation and improved insulin sensitivity [<a href="#CR335" class="usa-link" aria-describedby="CR335">335</a>]. Moreover, a recent study demonstrated that NLRP3 inflammasome inhibitors NT-0249 and NT-0796 reversed high-fat-diet-induced obesity and reduced systemic inflammation and astrogliosis in mouse models [<a href="#CR336" class="usa-link" aria-describedby="CR336">336</a>]. In addition to NLRP3, macrophages expressing TREM2 have been associated with the onset and progression of obesity [<a href="#CR337" class="usa-link" aria-describedby="CR337">337</a>]. In a recent study, TREM2 was shown to regulate astrocytic lipid metabolism and reduce neuroinflammation in an AD mouse model, supporting its potential as a therapeutic target [<a href="#CR338" class="usa-link" aria-describedby="CR338">338</a>].</p>
<p id="Par124">The systemic inflammation observed in obesity can lead to insulin resistance and type 2 diabetes (T2D) [<a href="#CR334" class="usa-link" aria-describedby="CR334">334</a>]. Similar to obesity, diabetes is a cardiovascular risk factor for AD, with studies showing that T2D patients have an increased risk of developing AD [<a href="#CR339" class="usa-link" aria-describedby="CR339">339</a>–<a href="#CR342" class="usa-link" aria-describedby="CR342">342</a>]. Insulin dysfunction, a hallmark of T2D, can directly influence AD pathology by regulating amyloid-beta metabolism and tau phosphorylation [<a href="#CR343" class="usa-link" aria-describedby="CR343">343</a>–<a href="#CR345" class="usa-link" aria-describedby="CR345">345</a>]. Insulin and Aβ are both substrates for the insulin-degrading enzyme (IDE), highlighting a molecular connection between AD and T2D [<a href="#CR346" class="usa-link" aria-describedby="CR346">346</a>–<a href="#CR349" class="usa-link" aria-describedby="CR349">349</a>].</p>
<p id="Par125">Moreover, T2D induces systemic inflammation, evidenced by elevated proinflammatory cytokines, such as TNF-α, which can further exacerbate insulin resistance [<a href="#CR332" class="usa-link" aria-describedby="CR332">332</a>, <a href="#CR350" class="usa-link" aria-describedby="CR350">350</a>, <a href="#CR351" class="usa-link" aria-describedby="CR351">351</a>].</p>
<p id="Par126">In support of this, increased NLRP3 activation and IL-1β and IL-18 expression have been observed in T2D patients, suggesting an increased innate immune response that may contribute to systemic inflammation [<a href="#CR352" class="usa-link" aria-describedby="CR352">352</a>].</p>
<p id="Par127">These effects of T2D can contribute to elevating the risk of developing AD or worsening the disease.</p>
<p id="Par128">Therefore, targeting systemic inflammation could be a suitable therapeutic strategy both for T2D and AD [<a href="#CR353" class="usa-link" aria-describedby="CR353">353</a>], as certain antidiabetic medications have shown promise in mitigating AD pathology [<a href="#CR354" class="usa-link" aria-describedby="CR354">354</a>, <a href="#CR355" class="usa-link" aria-describedby="CR355">355</a>].</p>
<p id="Par129">Other cardiovascular diseases and risk factors, including coronary heart disease (CHD), stroke, hypertension, and high cholesterol, are also linked to AD, with inflammation being a significant contributor to the diseases [<a href="#CR356" class="usa-link" aria-describedby="CR356">356</a>]. A large meta-analysis study showed that individuals with CHD and heart failure had a 27% and 60% increased risk of developing dementia, respectively [<a href="#CR357" class="usa-link" aria-describedby="CR357">357</a>]. Interestingly, serum soluble TREM2 levels are increased in CHD patients and associated with several cardiovascular risk factors, suggesting that soluble TREM2 might show good diagnostic potential in identifying CHD [<a href="#CR358" class="usa-link" aria-describedby="CR358">358</a>].</p>
<p id="Par130">Additionally, hypertension and high serum cholesterol levels in midlife significantly raise the subsequent AD risk in later life, particularly when both factors are present [<a href="#CR359" class="usa-link" aria-describedby="CR359">359</a>–<a href="#CR361" class="usa-link" aria-describedby="CR361">361</a>]. Another study demonstrated that high systolic blood pressure in mid-life was linked to the formation of plaques and neurofibrillary tangles, whereas another study found that midlife hypertension might impair the clearance of Aβ plaques from the brain, suggesting a molecular connection to AD pathology [<a href="#CR362" class="usa-link" aria-describedby="CR362">362</a>, <a href="#CR363" class="usa-link" aria-describedby="CR363">363</a>].</p>
<p id="Par131">A low-grade chronic systemic and CNS inflammation is a contributing factor to the physiopathology of hypertension [<a href="#CR364" class="usa-link" aria-describedby="CR364">364</a>, <a href="#CR365" class="usa-link" aria-describedby="CR365">365</a>]. A recent review discusses that inflammation acts as a mediator between hypertension and neurodegenerative diseases, possibly through a reduction in cerebral blood flow or disruption of the BBB, which may allow inflammatory cells to enter the brain tissue [<a href="#CR365" class="usa-link" aria-describedby="CR365">365</a>].</p>
<p id="Par132">Furthermore, arterial stiffness is considered an independent risk factor for both AD and cardiovascular diseases, and it is thought to be mechanistically linked to AD through inflammation [<a href="#CR366" class="usa-link" aria-describedby="CR366">366</a>].</p>
<p id="Par133">Considering the link between cardiovascular risk factors and diseases with dementia and AD, intervention of these factors with pharmacology or lifestyle changes can be a preventative strategy against AD [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>, <a href="#CR359" class="usa-link" aria-describedby="CR359">359</a>, <a href="#CR367" class="usa-link" aria-describedby="CR367">367</a>, <a href="#CR368" class="usa-link" aria-describedby="CR368">368</a>]. Several studies showed that the use of anti-hypertensive drugs such as angiotensin-converting enzyme inhibitors, β-blockers, calcium channel blockers, and diuretics reduced the risk of AD and dementia [<a href="#CR369" class="usa-link" aria-describedby="CR369">369</a>–<a href="#CR374" class="usa-link" aria-describedby="CR374">374</a>]. Furthermore, following a healthy lifestyle including regular physical exercise and a Mediterranean diet during early and mid-adulthood can effectively lower inflammation and prevent dementia and AD [<a href="#CR375" class="usa-link" aria-describedby="CR375">375</a>–<a href="#CR379" class="usa-link" aria-describedby="CR379">379</a>].</p></section><section id="Sec32"><h2 class="pmc_sec_title">Conclusions and future perspectives</h2>
<p id="Par135">AD is increasingly recognized as a multifactorial condition involving systemic processes. We propose that inflammaging combined with various lifelong exposures to peripheral immune system challenges such as metabolic changes, injuries, infections and some diseases, may prime the immune system in ways that amplify or aggravate AD pathology. In this context, systemic inflammation emerges as a central factor connecting AD with other diseases and conditions.</p>
<p id="Par136">Cardiovascular factors, particularly obesity and T2D, are among the strongest peripheral contributors to AD risk, due to their promotion of chronic low-grade inflammation and metabolic dysfunction. Viral infections like HSV1, especially in APOE4 carriers, show a strong and well-documented link to AD risk, whereas bacterial pathogens such as <em>P. gingivalis</em> may promote direct CNS invasion and inflammatory cascades. Chronic pain is a moderate, sustained inflammatory stressor that primes the CNS over time, while POCD involves acute systemic immune activation, which might be particularly harmful in vulnerable older adults. Gut dysbiosis is emerging as a significant modulator of systemic and neuroinflammation that can impair the BBB, with growing evidence linking impaired gut-brain barrier function to AD development.</p>
<p id="Par137">These comorbidities can precede or coexist with AD, significantly impacting the disease’s clinical course and progression. Therefore, we suggest that managing peripheral inflammation, along with the early identification and treatment of the conditions that promote systemic inflammation, could potentially reduce the risk of developing AD.</p>
<p id="Par138">Even though chronic microglial overactivation can exacerbate AD and other diseases, microglia are essential for the uptake and clearance of Aβ. Therefore, when developing treatments targeting neuroinflammation and microglia, it is important to find the balance to keep the neuroprotective effect of microglia and even enhance it, while mitigating detrimental inflammation.</p>
<p id="Par139">For example, increased TREM2 is protective in AD patients [<a href="#CR380" class="usa-link" aria-describedby="CR380">380</a>–<a href="#CR382" class="usa-link" aria-describedby="CR382">382</a>], whereas loss-of-function mutations in TREM2 increase the risk for late-onset AD by impairing inflammatory processes [<a href="#CR383" class="usa-link" aria-describedby="CR383">383</a>, <a href="#CR384" class="usa-link" aria-describedby="CR384">384</a>].</p>
<p id="Par140">Considering TREM2’s role in the phagocytic activity of microglia on amyloid plaques, reduced TREM2 might result in brain damage by hindering the clearance of Aβ and other toxic substances [<a href="#CR384" class="usa-link" aria-describedby="CR384">384</a>, <a href="#CR385" class="usa-link" aria-describedby="CR385">385</a>].</p>
<p id="Par141">Hence, enhancing TREM2 signalling may be an effective therapeutic strategy to support the microglial response to the Aβ plaques and preserve the neuroprotective actions of microglia [<a href="#CR385" class="usa-link" aria-describedby="CR385">385</a>]. Studies have shown that increased TREM2 activation through TREM2 agonistic antibodies or overexpression in mouse models improves cognition and reduces amyloid pathology by enhancing microglia-mediated phagocytosis [<a href="#CR385" class="usa-link" aria-describedby="CR385">385</a>–<a href="#CR392" class="usa-link" aria-describedby="CR392">392</a>]. The stage of the disease may be a moderating factor for TREM2-associated microglial activity, with early symptomatic stages potentially being optimal for therapeutic intervention [<a href="#CR380" class="usa-link" aria-describedby="CR380">380</a>].</p>
<p id="Par142">
In addition to TREM2, modulating the TNF receptor pathways can boost the neuroprotective effects of TNFR2, while still allowing TNFR1 to maintain its role in mediating neuroinflammation. This dual approach helps in modulating neuroinflammation without completely suppressing the necessary immune responses of microglia.</p>
<p id="Par143">Another promising target for reducing detrimental microglial activation could be the NLRP3 inflammasome, as Aβ-induced NLRP3 inflammasome activation plays a key role in inflammation, AD pathology, and memory deficits [<a href="#CR393" class="usa-link" aria-describedby="CR393">393</a>–<a href="#CR397" class="usa-link" aria-describedby="CR397">397</a>]. NLRP3 inhibitors or Nlrp3-/- mice models have demonstrated neuroprotective effects and reduced neurodegeneration [<a href="#CR393" class="usa-link" aria-describedby="CR393">393</a>, <a href="#CR398" class="usa-link" aria-describedby="CR398">398</a>–<a href="#CR401" class="usa-link" aria-describedby="CR401">401</a>].</p>
<p id="Par144">All these approaches could help modulate detrimental inflammation while keeping the neuroprotective effects of microglia. Targeting downstream molecules in inflammatory mechanisms can be a good option instead of inhibiting final cytokines and molecules, as they might have beneficial effects [<a href="#CR394" class="usa-link" aria-describedby="CR394">394</a>]. Moreover, as the dynamic of microglia changes during disease progression, it is crucial to determine the optimal intervention time before or during the disease course, as inappropriate modifications might lead to even harmful effects.</p>
<p id="Par145">
Given the therapeutic relevance of TREM2 and NLRP3 in AD, future research should aim to validate these pathways as clinically useful biomarkers. A prospective longitudinal study could recruit individuals at risk for AD, such as APOE4 carriers, those with mild cognitive impairment, or individuals with comorbidities described in this review, and perform regular measurements of soluble TREM2 and NLRP3-related markers (such as IL-1β, ASC specks, caspase-1 activity) in CSF or plasma. These biomarkers could be tracked together with cognitive outcomes and neuroimaging to assess their relevance as predictive indicators and potential clinical trial endpoints [<a href="#CR402" class="usa-link" aria-describedby="CR402">402</a>–<a href="#CR406" class="usa-link" aria-describedby="CR406">406</a>].</p>
<p id="Par146">A limitation of the evidence shown in this review is that most studies supporting the involvement of peripheral immune alterations in AD pathogenesis have been performed in transgenic mouse models carrying familial AD mutations. In these models, Aβ overproduction represents the primary and initiating pathological hallmark. Consequently, the use of these mouse models limits our ability to determine the sequence of events leading to the disease onset and progression. Specifically, it remains unclear whether inflammaging and neuroinflammation act as upstream triggers that lead to Aβ accumulation or whether they arise as a secondary response to Aβ aggregation. This distinction is critical for understanding the disease etiology and for developing effective therapeutic approaches. Future research employing alternative models, such as sporadic AD models or human-based studies, is essential to clarify whether immune dysregulation precedes or follows Aβ pathology in the context of AD.</p>
<p id="Par147">Furthermore, future human studies must also address the challenges of proving causality between peripheral immune challenges and AD pathology. This requires designing longitudinal studies, establishing well-defined inclusion and exclusion criteria, accounting for variables such as age, sex, comorbidities, and history of systemic inflammation, such as surgeries and infections [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Baseline cognitive status, APOE genotype, peripheral inflammation markers, and lifestyle factors might further help control for heterogeneity and identify individuals at greater risk for AD and neurodegeneration following peripheral immune insults. Yet, proving causation remains difficult due to AD`s long latency period, its multifactorial etiology, and the confounding effects of comorbidities and reverse causation [<a href="#CR407" class="usa-link" aria-describedby="CR407">407</a>].</p>
<p id="Par148">In conclusion, viewing AD as a systemic disease involving dynamic interactions within peripheral and central immune compartments offers a comprehensive perspective. This approach deepens our understanding of disease pathogenesis and risk factors and may facilitate the development of improved diagnostics and novel therapeutics. Early diagnosis and modulation of the diseases and factors that contribute to peripheral inflammation could mitigate the risk of developing AD. This insight is crucial for advancing AD research and care, highlighting the importance of addressing systemic inflammation and comorbidities in managing AD.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>Aβ</dt>
<dd><p id="Par152">Amyloid-beta</p></dd>
<dt>AD</dt>
<dd><p id="Par153">Alzheimer’s disease</p></dd>
<dt>ALS</dt>
<dd><p id="Par154">Amyotrophic lateral sclerosis</p></dd>
<dt>APP</dt>
<dd><p id="Par155">Amyloid precursor protein</p></dd>
<dt>APOE4</dt>
<dd><p id="Par156">Apolipoprotein E4</p></dd>
<dt>BBB</dt>
<dd><p id="Par157">Blood-brain barrier</p></dd>
<dt>BACE1</dt>
<dd><p id="Par158">Beta-site amyloid precursor protein cleaving enzyme 1</p></dd>
<dt>BD</dt>
<dd><p id="Par159">Bipolar disorder</p></dd>
<dt>CNS</dt>
<dd><p id="Par160">Central nervous system</p></dd>
<dt>CHD</dt>
<dd><p id="Par161">Coronary heart disease</p></dd>
<dt>CSF</dt>
<dd><p id="Par162">Cerebrospinal fluid</p></dd>
<dt>FACS</dt>
<dd><p id="Par163">Fluorescence-activated cell sorting (Flow Cytometry)</p></dd>
<dt>HCV</dt>
<dd><p id="Par164">Hepatitis C virus</p></dd>
<dt>HIV</dt>
<dd><p id="Par165">Human immunodeficiency virus</p></dd>
<dt>HSV1</dt>
<dd><p id="Par166">Herpes simplex virus type 1</p></dd>
<dt>IDE</dt>
<dd><p id="Par167">Insulin-degrading enzyme</p></dd>
<dt>IL-1β</dt>
<dd><p id="Par168">Interleukin-1 beta</p></dd>
<dt>IL-6</dt>
<dd><p id="Par169">Interleukin-6</p></dd>
<dt>IL-12</dt>
<dd><p id="Par170">Interleukin-12</p></dd>
<dt>LPS</dt>
<dd><p id="Par171">Lipopolysaccharide</p></dd>
<dt>MetS</dt>
<dd><p id="Par172">Metabolic syndrome</p></dd>
<dt>MGB axis</dt>
<dd><p id="Par173">Microbiota-gut-brain axis</p></dd>
<dt>MCI</dt>
<dd><p id="Par174">Mild cognitive impairment</p></dd>
<dt>MRI</dt>
<dd><p id="Par175">Magnetic resonance imaging</p></dd>
<dt>MWM</dt>
<dd><p id="Par176">Morris Water Maze</p></dd>
<dt>NFTs</dt>
<dd><p id="Par177">Neurofibrillary tangles</p></dd>
<dt>NLRP3</dt>
<dd><p id="Par178">NOD-like receptor protein 3</p></dd>
<dt>NSAIDs</dt>
<dd><p id="Par179">Nonsteroidal anti-inflammatory drugs</p></dd>
<dt>pTau</dt>
<dd><p id="Par180">Phosphorylated tau</p></dd>
<dt>POCD</dt>
<dd><p id="Par181">Post-operative cognitive dysfunction</p></dd>
<dt>PD</dt>
<dd><p id="Par182">Parkinson’s disease</p></dd>
<dt>ROS</dt>
<dd><p id="Par183">Reactive oxygen species</p></dd>
<dt>T2D</dt>
<dd><p id="Par184">Type 2 diabetes</p></dd>
<dt>Tat</dt>
<dd><p id="Par185">Trans-activator of transcription (HIV protein)</p></dd>
<dt>TREM2</dt>
<dd><p id="Par186">Triggering receptor expressed on myeloid cells 2</p></dd>
<dt>TNF-α</dt>
<dd><p id="Par187">Tumor necrosis factor-alpha</p></dd>
<dt>TNFR1</dt>
<dd><p id="Par188">Tumor necrosis factor receptor 1</p></dd>
<dt>TNFR2</dt>
<dd><p id="Par189">Tumor necrosis factor receptor 2</p></dd>
<dt>Tregs</dt>
<dd><p id="Par190">Regulatory T cells</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>I.B. and N.O-C. wrote the manuscript. D.V.D, P.D.D. and U.E. reviewed it. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The work in this review was funded by a grant received from Alzheimer Nederland (WE.03-2021-05) granted to P.D.D and U.E.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar2"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par149">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par150">Not applicable.</p></section><section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par151">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Irem Bayraktaroglu, Natalia Ortí-Casañ contributed equally to this work.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Reddy Hemachandra P, Flint Beal M. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and alzheimer’s disease. Trends Mol Med. 2008;14:45–53.
</cite> [<a href="https://doi.org/10.1016/j.molmed.2007.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3107703/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18218341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reddy%20Hemachandra%20P,%20Flint%20Beal%20M.%20Amyloid%20beta,%20mitochondrial%20dysfunction%20and%20synaptic%20damage:%20implications%20for%20cognitive%20decline%20in%20aging%20and%20alzheimer%E2%80%99s%20disease.%20Trends%20Mol%20Med.%202008;14:45%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Reitz C, Brayne C, Mayeux R. Epidemiology of alzheimer disease. Nat Rev Neurol. 2011;7:137–52.
</cite> [<a href="https://doi.org/10.1038/nrneurol.2011.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3339565/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21304480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reitz%20C,%20Brayne%20C,%20Mayeux%20R.%20Epidemiology%20of%20alzheimer%20disease.%20Nat%20Rev%20Neurol.%202011;7:137%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Selkoe DJ. Alzheimer’s disease. Cold Spring Harb Perspect Biol. 2011;3:a004457.
</cite> [<a href="https://doi.org/10.1101/cshperspect.a004457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3119915/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21576255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Selkoe%20DJ.%20Alzheimer%E2%80%99s%20disease.%20Cold%20Spring%20Harb%20Perspect%20Biol.%202011;3:a004457." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Heneka MT, Carson MJ, Khoury J, El, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in alzheimer’s disease. Lancet Neurol. 2015;14:388–405.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(15)70016-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5909703/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25792098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heneka%20MT,%20Carson%20MJ,%20Khoury%20J,%20El,%20Landreth%20GE,%20Brosseron%20F,%20Feinstein%20DL,%20et%20al.%20Neuroinflammation%20in%20alzheimer%E2%80%99s%20disease.%20Lancet%20Neurol.%202015;14:388%E2%80%93405." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C. Early-Onset alzheimer’s disease: what is missing in research?? Curr Neurol Neurosci Rep. 2021;2:4.</cite> [<a href="https://doi.org/10.1007/s11910-020-01090-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7815616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33464407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ayodele%20T,%20Rogaeva%20E,%20Kurup%20JT,%20Beecham%20G,%20Reitz%20C.%20Early-Onset%20alzheimer%E2%80%99s%20disease:%20what%20is%20missing%20in%20research??%20Curr%20Neurol%20Neurosci%20Rep.%202021;2:4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Ertekin-Taner N. Genetics of alzheimer’s disease: A centennial review. Neurol Clin. 2007;25:611–v.
</cite> [<a href="https://doi.org/10.1016/j.ncl.2007.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2735049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17659183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ertekin-Taner%20N.%20Genetics%20of%20alzheimer%E2%80%99s%20disease:%20A%20centennial%20review.%20Neurol%20Clin.%202007;25:611%E2%80%93v." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM. The complex genetic architecture of alzheimer’s disease: novel insights and future directions. EbioMedicine. 2023;90:104511.
</cite> [<a href="https://doi.org/10.1016/j.ebiom.2023.104511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10024184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36907103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andrews%20SJ,%20Renton%20AE,%20Fulton-Howard%20B,%20Podlesny-Drabiniok%20A,%20Marcora%20E,%20Goate%20AM.%20The%20complex%20genetic%20architecture%20of%20alzheimer%E2%80%99s%20disease:%20novel%20insights%20and%20future%20directions.%20EbioMedicine.%202023;90:104511." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, et al. Early-Onset autosomal dominant alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65:664–70.
</cite> [<a href="https://doi.org/10.1086/302553" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1377972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10441572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Campion%20D,%20Dumanchin%20C,%20Hannequin%20D,%20Dubois%20B,%20Belliard%20S,%20Puel%20M,%20et%20al.%20Early-Onset%20autosomal%20dominant%20alzheimer%20disease:%20prevalence,%20genetic%20heterogeneity,%20and%20mutation%20spectrum.%20Am%20J%20Hum%20Genet.%201999;65:664%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Hardy J, Selkoe DJ. The amyloid hypothesis of alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353–6.
</cite> [<a href="https://doi.org/10.1126/science.1072994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12130773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hardy%20J,%20Selkoe%20DJ.%20The%20amyloid%20hypothesis%20of%20alzheimer%E2%80%99s%20disease:%20progress%20and%20problems%20on%20the%20road%20to%20therapeutics.%20Science.%202002;297:353%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Fedele E. Anti-Amyloid therapies for alzheimer’s disease and the amyloid cascade hypothesis. Int J Mol Sci. 2023;24:14499.
</cite> [<a href="https://doi.org/10.3390/ijms241914499" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10578107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37833948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fedele%20E.%20Anti-Amyloid%20therapies%20for%20alzheimer%E2%80%99s%20disease%20and%20the%20amyloid%20cascade%20hypothesis.%20Int%20J%20Mol%20Sci.%202023;24:14499." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Behl C. In. 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more. Front Aging Neurosci. 2024;16:1459224.</cite> [<a href="https://doi.org/10.3389/fnagi.2024.1459224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11408168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39295642/" class="usa-link">PubMed</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Kepp KP, Robakis NK, Høilund-Carlsen PF, Sensi SL, Vissel B. The amyloid cascade hypothesis: an updated critical review. Brain. 2023;146:3969–90.
</cite> [<a href="https://doi.org/10.1093/brain/awad159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37183523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kepp%20KP,%20Robakis%20NK,%20H%C3%B8ilund-Carlsen%20PF,%20Sensi%20SL,%20Vissel%20B.%20The%20amyloid%20cascade%20hypothesis:%20an%20updated%20critical%20review.%20Brain.%202023;146:3969%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Blömeke L, Rehn F, Kraemer-Schulien V, Kutzsche J, Pils M, Bujnicki T, et al. Aβ oligomers peak in early stages of alzheimer’s disease preceding Tau pathology. Alzheimer’s Dementia: Diagnosis Assess Disease Monit. 2024;16:e12589.</cite> [<a href="https://doi.org/10.1002/dad2.12589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11044868/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38666085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bl%C3%B6meke%20L,%20Rehn%20F,%20Kraemer-Schulien%20V,%20Kutzsche%20J,%20Pils%20M,%20Bujnicki%20T,%20et%20al.%20A%CE%B2%20oligomers%20peak%20in%20early%20stages%20of%20alzheimer%E2%80%99s%20disease%20preceding%20Tau%20pathology.%20Alzheimer%E2%80%99s%20Dementia:%20Diagnosis%20Assess%20Disease%20Monit.%202024;16:e12589." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Cacciaglia R, Falcón C, Benavides GS, Brugulat-Serrat A, Alomà MM, Calvet MS, et al. Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest alzheimer’s continuum: evidence across two independent cohorts. Alzheimer’s Dement. 2025;21:e14415.
</cite> [<a href="https://doi.org/10.1002/alz.14415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11848178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39898436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cacciaglia%20R,%20Falc%C3%B3n%20C,%20Benavides%20GS,%20Brugulat-Serrat%20A,%20Alom%C3%A0%20MM,%20Calvet%20MS,%20et%20al.%20Soluble%20A%CE%B2%20pathology%20predicts%20neurodegeneration%20and%20cognitive%20decline%20independently%20on%20p-tau%20in%20the%20earliest%20alzheimer%E2%80%99s%20continuum:%20evidence%20across%20two%20independent%20cohorts.%20Alzheimer%E2%80%99s%20Dement.%202025;21:e14415." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Zou J, McNair E, DeCastro S, Lyons SP, Mordant A, Herring LE, et al. Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1– 42 oligomers. J Neuroinflammation. 2024;21:215.
</cite> [<a href="https://doi.org/10.1186/s12974-024-03208-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11367981/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39218898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zou%20J,%20McNair%20E,%20DeCastro%20S,%20Lyons%20SP,%20Mordant%20A,%20Herring%20LE,%20et%20al.%20Microglia%20either%20promote%20or%20restrain%20TRAIL-mediated%20excitotoxicity%20caused%20by%20A%CE%B21%E2%80%93%E2%80%8942%20oligomers.%20J%20Neuroinflammation.%202024;21:215." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Ingelsson M, Fukumoto H, Newell K, Growdon J, Hedley-Whyte E, Frosch M, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 2004;62:925–31.
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000115115.98960.37" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15037694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ingelsson%20M,%20Fukumoto%20H,%20Newell%20K,%20Growdon%20J,%20Hedley-Whyte%20E,%20Frosch%20M,%20et%20al.%20Early%20Abeta%20accumulation%20and%20progressive%20synaptic%20loss,%20gliosis,%20and%20tangle%20formation%20in%20AD%20brain.%20Neurology.%202004;62:925%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Ghimire A, Rehman SA, Subhani A, Khan MA, Rahman Z, Iqubal MK, et al. Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in alzheimer’s disease. hLife. 2025;3:64–81.</cite> [<a href="https://scholar.google.com/scholar_lookup?Ghimire%20A,%20Rehman%20SA,%20Subhani%20A,%20Khan%20MA,%20Rahman%20Z,%20Iqubal%20MK,%20et%20al.%20Mechanism%20of%20microglia-mediated%20neuroinflammation,%20associated%20cognitive%20dysfunction,%20and%20therapeutic%20updates%20in%20alzheimer%E2%80%99s%20disease.%20hLife.%202025;3:64%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJM, Van Gool WA, Hoozemans JJM. The significance of neuroinflammation in Understanding alzheimer’s disease. J Neural Transm. 2006;113:1685–95.
</cite> [<a href="https://doi.org/10.1007/s00702-006-0575-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17036175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eikelenboom%20P,%20Veerhuis%20R,%20Scheper%20W,%20Rozemuller%20AJM,%20Van%20Gool%20WA,%20Hoozemans%20JJM.%20The%20significance%20of%20neuroinflammation%20in%20Understanding%20alzheimer%E2%80%99s%20disease.%20J%20Neural%20Transm.%202006;113:1685%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Lutshumba J, Nikolajczyk BS, Bachstetter AD. Dysregulation of systemic immunity in aging and dementia. Front Cell Neurosci. 2021;15:652111.
</cite> [<a href="https://doi.org/10.3389/fncel.2021.652111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8258160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34239415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lutshumba%20J,%20Nikolajczyk%20BS,%20Bachstetter%20AD.%20Dysregulation%20of%20systemic%20immunity%20in%20aging%20and%20dementia.%20Front%20Cell%20Neurosci.%202021;15:652111." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C. Early-Onset alzheimer’s disease: what is missing in research?? Curr Neurol Neurosci Rep. 2021;21:4.
</cite> [<a href="https://doi.org/10.1007/s11910-020-01090-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7815616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33464407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ayodele%20T,%20Rogaeva%20E,%20Kurup%20JT,%20Beecham%20G,%20Reitz%20C.%20Early-Onset%20alzheimer%E2%80%99s%20disease:%20what%20is%20missing%20in%20research??%20Curr%20Neurol%20Neurosci%20Rep.%202021;21:4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset alzheimer disease - A distinction without a difference? Neurol Genet. 2020;6:e512.
</cite> [<a href="https://doi.org/10.1212/NXG.0000000000000512" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7673282/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33225065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reitz%20C,%20Rogaeva%20E,%20Beecham%20GW.%20Late-onset%20vs%20nonmendelian%20early-onset%20alzheimer%20disease%20-%20A%20distinction%20without%20a%20difference?%20Neurol%20Genet.%202020;6:e512." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Nudelman KNH, Jackson T, Rumbaugh M, Eloyan A, Abreu M, Dage JL, et al. Pathogenic variants in the longitudinal Early-onset alzheimer’s disease study cohort. Alzheimer’s Dement. 2023;19:S64–73.
</cite> [<a href="https://doi.org/10.1002/alz.13482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10783439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37801072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nudelman%20KNH,%20Jackson%20T,%20Rumbaugh%20M,%20Eloyan%20A,%20Abreu%20M,%20Dage%20JL,%20et%20al.%20Pathogenic%20variants%20in%20the%20longitudinal%20Early-onset%20alzheimer%E2%80%99s%20disease%20study%20cohort.%20Alzheimer%E2%80%99s%20Dement.%202023;19:S64%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Allen NJ, Eroglu C. Cell biology of astrocyte-synapse interactions. Neuron. 2017;96:697–708.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2017.09.056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5687890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29096081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Allen%20NJ,%20Eroglu%20C.%20Cell%20biology%20of%20astrocyte-synapse%20interactions.%20Neuron.%202017;96:697%E2%80%93708." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia. 2010;58:1094–103.
</cite> [<a href="https://doi.org/10.1002/glia.20990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20468051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mathiisen%20TM,%20Lehre%20KP,%20Danbolt%20NC,%20Ottersen%20OP.%20The%20perivascular%20astroglial%20sheath%20provides%20a%20complete%20covering%20of%20the%20brain%20microvessels:%20an%20electron%20microscopic%203D%20reconstruction.%20Glia.%202010;58:1094%E2%80%93103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Kierdorf K, Prinz M. Microglia in steady state. Jorunal Clin Invest. 2017;9:3201–9.</cite> [<a href="https://doi.org/10.1172/JCI90602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5669563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28714861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kierdorf%20K,%20Prinz%20M.%20Microglia%20in%20steady%20state.%20Jorunal%20Clin%20Invest.%202017;9:3201%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Herber DL, Mercer M, Roth LM, Symmonds K, Maloney J, Wilson N, et al. Microglial activation is required for Aβ clearance after intracranial injection of lipopolysaccharide in APP Transgenic mice. J Neuroimmune Pharmacol. 2007;2:222–31.
</cite> [<a href="https://doi.org/10.1007/s11481-007-9069-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18040847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Herber%20DL,%20Mercer%20M,%20Roth%20LM,%20Symmonds%20K,%20Maloney%20J,%20Wilson%20N,%20et%20al.%20Microglial%20activation%20is%20required%20for%20A%CE%B2%20clearance%20after%20intracranial%20injection%20of%20lipopolysaccharide%20in%20APP%20Transgenic%20mice.%20J%20Neuroimmune%20Pharmacol.%202007;2:222%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, et al. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism. J Neurosci. 2006;26(43):10939–48.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.2085-06.2006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6674654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17065436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20KJ,%20Cirrito%20JR,%20Yan%20P,%20Hu%20X,%20Xiao%20Q,%20Pan%20X,%20et%20al.%20Matrix%20metalloproteinases%20expressed%20by%20astrocytes%20mediate%20extracellular%20amyloid-%CE%B2%20peptide%20catabolism.%20J%20Neurosci.%202006;26(43):10939%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>van Olst L, Simonton B, Edwards AJ, Forsyth AV, Boles J, Jamshidi P et al. Microglial mechanisms drive amyloid-β clearance in immunized patients with alzheimer’s disease. Nat Med. 2025;s41591-025-03574–1.</cite> [<a href="https://doi.org/10.1038/s41591-025-03574-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12092304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40050704/" class="usa-link">PubMed</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS Amyloid-β in alzheimer’s disease. Science. 2010;330:1774.
</cite> [<a href="https://doi.org/10.1126/science.1197623" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3073454/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21148344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mawuenyega%20KG,%20Sigurdson%20W,%20Ovod%20V,%20Munsell%20L,%20Kasten%20T,%20Morris%20JC,%20et%20al.%20Decreased%20clearance%20of%20CNS%20Amyloid-%CE%B2%20in%20alzheimer%E2%80%99s%20disease.%20Science.%202010;330:1774." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Wolf SA, Boddeke HWGM, Kettenmann H. Microglia in physiology and disease. Annual Rev Physiol. 2017;79:619–43.
</cite> [<a href="https://doi.org/10.1146/annurev-physiol-022516-034406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27959620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wolf%20SA,%20Boddeke%20HWGM,%20Kettenmann%20H.%20Microglia%20in%20physiology%20and%20disease.%20Annual%20Rev%20Physiol.%202017;79:619%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Mattson MP, Meffert MK. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006;13:852–60.
</cite> [<a href="https://doi.org/10.1038/sj.cdd.4401837" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16397579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mattson%20MP,%20Meffert%20MK.%20Roles%20for%20NF-kappaB%20in%20nerve%20cell%20survival,%20plasticity,%20and%20disease.%20Cell%20Death%20Differ.%202006;13:852%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Ghosal K, Vogt DL, Liang M, Shen Y, Lamb BT, Pimplikar SW. Alzheimer’s disease-like pathological features in Transgenic mice expressing the APP intracellular domain. Proc Natl Acad Sci U S A. 2009;106:18372.</cite> [<a href="https://doi.org/10.1073/pnas.0907652106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2762847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19837693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghosal%20K,%20Vogt%20DL,%20Liang%20M,%20Shen%20Y,%20Lamb%20BT,%20Pimplikar%20SW.%20Alzheimer%E2%80%99s%20disease-like%20pathological%20features%20in%20Transgenic%20mice%20expressing%20the%20APP%20intracellular%20domain.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202009;106:18372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS. Tumor necrosis Factor-α, Interleukin-1β, and Interferon-γ stimulate γ-Secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004;19:279:49523–32.</cite> [<a href="https://doi.org/10.1074/jbc.M402034200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15347683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liao%20YF,%20Wang%20BJ,%20Cheng%20HT,%20Kuo%20LH,%20Wolfe%20MS.%20Tumor%20necrosis%20Factor-%CE%B1,%20Interleukin-1%CE%B2,%20and%20Interferon-%CE%B3%20stimulate%20%CE%B3-Secretase-mediated%20cleavage%20of%20amyloid%20precursor%20protein%20through%20a%20JNK-dependent%20MAPK%20pathway.%20J%20Biol%20Chem.%202004;19:279:49523%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Inflammation and alzheimer’s disease. Arch Pharm Res. 2010;33:1539–56.
</cite> [<a href="https://doi.org/10.1007/s12272-010-1006-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21052932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20YJ,%20Han%20SB,%20Nam%20SY,%20Oh%20KW,%20Hong%20JT.%20Inflammation%20and%20alzheimer%E2%80%99s%20disease.%20Arch%20Pharm%20Res.%202010;33:1539%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Lyman M, Lloyd DG, Ji X, Vizcaychipi MO, Ma D. Neuroinflammation: the role and consequences. Neurosci Res. 2014;79:1–12.
</cite> [<a href="https://doi.org/10.1016/j.neures.2013.10.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24144733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lyman%20M,%20Lloyd%20DG,%20Ji%20X,%20Vizcaychipi%20MO,%20Ma%20D.%20Neuroinflammation:%20the%20role%20and%20consequences.%20Neurosci%20Res.%202014;79:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Herrup K. Reimagining alzheimer’s disease–an age-based hypothesis. J Neurosci. 2010;30:16755–62.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.4521-10.2010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3004746/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21159946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Herrup%20K.%20Reimagining%20alzheimer%E2%80%99s%20disease%E2%80%93an%20age-based%20hypothesis.%20J%20Neurosci.%202010;30:16755%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Milner MT, Maddugoda M, Götz J, Burgener SS, Schroder K. The NLRP3 inflammasome triggers sterile neuroinflammation and alzheimer’s disease. Curr Opin Immunol. 2021;68:116–24.
</cite> [<a href="https://doi.org/10.1016/j.coi.2020.10.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33181351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Milner%20MT,%20Maddugoda%20M,%20G%C3%B6tz%20J,%20Burgener%20SS,%20Schroder%20K.%20The%20NLRP3%20inflammasome%20triggers%20sterile%20neuroinflammation%20and%20alzheimer%E2%80%99s%20disease.%20Curr%20Opin%20Immunol.%202021;68:116%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007;7:161–7.
</cite> [<a href="https://doi.org/10.1038/nri2015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17220915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perry%20VH,%20Cunningham%20C,%20Holmes%20C.%20Systemic%20infections%20and%20inflammation%20affect%20chronic%20neurodegeneration.%20Nat%20Rev%20Immunol.%202007;7:161%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Norden DM, Muccigrosso MM, Godbout JP. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease. Neuropharmacology. 2015;96:29–41.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2014.10.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4430467/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25445485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Norden%20DM,%20Muccigrosso%20MM,%20Godbout%20JP.%20Microglial%20priming%20and%20enhanced%20reactivity%20to%20secondary%20insult%20in%20aging,%20and%20traumatic%20CNS%20injury,%20and%20neurodegenerative%20disease.%20Neuropharmacology.%202015;96:29%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Erickson MA, Wilson ML, Banks WA. In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS. 2020;17:26.
</cite> [<a href="https://doi.org/10.1186/s12987-020-00187-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7106666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32228633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Erickson%20MA,%20Wilson%20ML,%20Banks%20WA.%20In%20vitro%20modeling%20of%20blood-brain%20barrier%20and%20interface%20functions%20in%20neuroimmune%20communication.%20Fluids%20Barriers%20CNS.%202020;17:26." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut Microbiome alterations in alzheimer’s disease. Sci Rep. 2017;7:13537.
</cite> [<a href="https://doi.org/10.1038/s41598-017-13601-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5648830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29051531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vogt%20NM,%20Kerby%20RL,%20Dill-McFarland%20KA,%20Harding%20SJ,%20Merluzzi%20AP,%20Johnson%20SC,%20et%20al.%20Gut%20Microbiome%20alterations%20in%20alzheimer%E2%80%99s%20disease.%20Sci%20Rep.%202017;7:13537." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Walker KA, Le Page LM, Terrando N, Duggan MR, Heneka MT, Bettcher BM. The role of peripheral inflammatory insults in alzheimer’s disease: a review and research roadmap. Mol Neurodegeneration. 2023;18:37.</cite> [<a href="https://doi.org/10.1186/s13024-023-00627-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10240487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37277738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walker%20KA,%20Le%20Page%20LM,%20Terrando%20N,%20Duggan%20MR,%20Heneka%20MT,%20Bettcher%20BM.%20The%20role%20of%20peripheral%20inflammatory%20insults%20in%20alzheimer%E2%80%99s%20disease:%20a%20review%20and%20research%20roadmap.%20Mol%20Neurodegeneration.%202023;18:37." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18:2114–27.
</cite> [<a href="https://doi.org/10.1038/s41423-021-00740-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8429580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34321623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Xu%20W,%20Zhou%20R.%20NLRP3%20inflammasome%20activation%20and%20cell%20death.%20Cell%20Mol%20Immunol.%202021;18:2114%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013–22.
</cite> [<a href="https://doi.org/10.1016/j.cell.2014.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24855941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lamkanfi%20M,%20Dixit%20VM.%20Mechanisms%20and%20functions%20of%20inflammasomes.%20Cell.%202014;157:1013%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Wen H, Miao EA, Ting JPY. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity. 2013;39:432–41.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2013.08.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3835203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24054327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wen%20H,%20Miao%20EA,%20Ting%20JPY.%20Mechanisms%20of%20NOD-like%20receptor-associated%20inflammasome%20activation.%20Immunity.%202013;39:432%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks crossseed amyloid-β in alzheimer’s disease. Nature. 2017;552:355–61.
</cite> [<a href="https://doi.org/10.1038/nature25158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29293211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Venegas%20C,%20Kumar%20S,%20Franklin%20BS,%20Dierkes%20T,%20Brinkschulte%20R,%20Tejera%20D,%20et%20al.%20Microglia-derived%20ASC%20specks%20crossseed%20amyloid-%CE%B2%20in%20alzheimer%E2%80%99s%20disease.%20Nature.%202017;552:355%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives Tau pathology. Nature. 2020;575:669–73.</cite> [<a href="https://doi.org/10.1038/s41586-019-1769-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7324015/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31748742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ising%20C,%20Venegas%20C,%20Zhang%20S,%20Scheiblich%20H,%20Schmidt%20SV,%20Vieira-Saecker%20A,%20et%20al.%20NLRP3%20inflammasome%20activation%20drives%20Tau%20pathology.%20Nature.%202020;575:669%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Lai KSP, Liu CS, Rau A, Lanctôt KL, Köhler CA, Pakosh M, et al. Peripheral inflammatory markers in alzheimer’s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry. 2017;88(10):876–82.
</cite> [<a href="https://doi.org/10.1136/jnnp-2017-316201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28794151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lai%20KSP,%20Liu%20CS,%20Rau%20A,%20Lanct%C3%B4t%20KL,%20K%C3%B6hler%20CA,%20Pakosh%20M,%20et%20al.%20Peripheral%20inflammatory%20markers%20in%20alzheimer%E2%80%99s%20disease:%20a%20systematic%20review%20and%20meta-analysis%20of%20175%20studies.%20J%20Neurol%20Neurosurg%20Psychiatry.%202017;88(10):876%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Swardfager W, Lanctt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A Meta-Analysis of cytokines in alzheimer’s disease. Biol Psychiatry. 2010;68:930–41.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2010.06.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20692646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Swardfager%20W,%20Lanctt%20K,%20Rothenburg%20L,%20Wong%20A,%20Cappell%20J,%20Herrmann%20N.%20A%20Meta-Analysis%20of%20cytokines%20in%20alzheimer%E2%80%99s%20disease.%20Biol%20Psychiatry.%202010;68:930%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, et al. Systemic inflammation and disease progression in alzheimer disease. Neurology. 2009;73:774.</cite> [<a href="https://doi.org/10.1212/WNL.0b013e3181b6bb95" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2848584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19738171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Holmes%20C,%20Cunningham%20C,%20Zotova%20E,%20Woolford%20J,%20Dean%20C,%20Kerr%20S,%20et%20al.%20Systemic%20inflammation%20and%20disease%20progression%20in%20alzheimer%20disease.%20Neurology.%202009;73:774." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH. Proinflammatory cytokines, sickness behavior, and alzheimer disease. Neurology. 2011;77:212–8.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e318225ae07" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3136056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21753171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Holmes%20C,%20Cunningham%20C,%20Zotova%20E,%20Culliford%20D,%20Perry%20VH.%20Proinflammatory%20cytokines,%20sickness%20behavior,%20and%20alzheimer%20disease.%20Neurology.%202011;77:212%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in alzheimer’s disease. Nature. 2020;577:404.</cite> [<a href="https://doi.org/10.1038/s41586-019-1895-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7445078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31915375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gate%20D,%20Saligrama%20N,%20Leventhal%20O,%20Yang%20AC,%20Unger%20MS,%20Middeldorp%20J,%20et%20al.%20Clonally%20expanded%20CD8%20T%20cells%20patrol%20the%20cerebrospinal%20fluid%20in%20alzheimer%E2%80%99s%20disease.%20Nature.%202020;577:404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, et al. Dramatic shifts in Circulating CD4 but not CD8 T cell subsets in mild alzheimer’s disease. J Alzheimer’s Disease. 2009;17:91–103.
</cite> [<a href="https://doi.org/10.3233/JAD-2009-1015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19494434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Larbi%20A,%20Pawelec%20G,%20Witkowski%20JM,%20Schipper%20HM,%20Derhovanessian%20E,%20Goldeck%20D,%20et%20al.%20Dramatic%20shifts%20in%20Circulating%20CD4%20but%20not%20CD8%20T%20cell%20subsets%20in%20mild%20alzheimer%E2%80%99s%20disease.%20J%20Alzheimer%E2%80%99s%20Disease.%202009;17:91%E2%80%93103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Machhi J, Yeapuri P, Lu Y, Foster E, Chikhale R, Herskovitz J, et al. CD4 + effector T cells accelerate alzheimer’s disease in mice. J Neuroinflammation. 2021;18:272.
</cite> [<a href="https://doi.org/10.1186/s12974-021-02308-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8603581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34798897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Machhi%20J,%20Yeapuri%20P,%20Lu%20Y,%20Foster%20E,%20Chikhale%20R,%20Herskovitz%20J,%20et%20al.%20CD4%20+%20effector%20T%20cells%20accelerate%20alzheimer%E2%80%99s%20disease%20in%20mice.%20J%20Neuroinflammation.%202021;18:272." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Unger MS, Li E, Scharnagl L, Poupardin R, Altendorfer B, Mrowetz H, et al. CD8 + T-cells infiltrate alzheimer’s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 Transgenic mice. Brain Behav Immun. 2020;89:67–86.
</cite> [<a href="https://doi.org/10.1016/j.bbi.2020.05.070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32479993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Unger%20MS,%20Li%20E,%20Scharnagl%20L,%20Poupardin%20R,%20Altendorfer%20B,%20Mrowetz%20H,%20et%20al.%20CD8%20+%20T-cells%20infiltrate%20alzheimer%E2%80%99s%20disease%20brains%20and%20regulate%20neuronal-%20and%20synapse-related%20gene%20expression%20in%20APP-PS1%20Transgenic%20mice.%20Brain%20Behav%20Immun.%202020;89:67%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Jorfi M, Park J, Hall CK, Lin CCJ, Chen M, von Maydell D, et al. Infiltrating CD8 + T cells exacerbate alzheimer’s disease pathology in a 3D human neuroimmune axis model. Nat Neurosci. 2023;26:1504.</cite> [<a href="https://doi.org/10.1038/s41593-023-01415-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11184920/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37620442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jorfi%20M,%20Park%20J,%20Hall%20CK,%20Lin%20CCJ,%20Chen%20M,%20von%20Maydell%20D,%20et%20al.%20Infiltrating%20CD8%20+%20T%20cells%20exacerbate%20alzheimer%E2%80%99s%20disease%20pathology%20in%20a%203D%20human%20neuroimmune%20axis%20model.%20Nat%20Neurosci.%202023;26:1504." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Panwar A, Rentsendorj A, Jhun M, Cohen RM, Cordner R, Gull N, et al. Antigen-specific age-related memory CD8 T cells induce and track Alzheimer’s-like neurodegeneration. Proc Natl Acad Sci U S A. 2024;121:e2401420121.
</cite> [<a href="https://doi.org/10.1073/pnas.2401420121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11260139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38995966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Panwar%20A,%20Rentsendorj%20A,%20Jhun%20M,%20Cohen%20RM,%20Cordner%20R,%20Gull%20N,%20et%20al.%20Antigen-specific%20age-related%20memory%20CD8%20T%20cells%20induce%20and%20track%20Alzheimer%E2%80%99s-like%20neurodegeneration.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202024;121:e2401420121." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87.
</cite> [<a href="https://doi.org/10.1016/j.cell.2008.05.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18510923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sakaguchi%20S,%20Yamaguchi%20T,%20Nomura%20T,%20Ono%20M.%20Regulatory%20T%20cells%20and%20immune%20tolerance.%20Cell.%202008;133:775%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, et al. The characterization of regulatory T-Cell profiles in alzheimer’s disease and multiple sclerosis. Sci Rep. 2019;9:8788.
</cite> [<a href="https://doi.org/10.1038/s41598-019-45433-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6584558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31217537/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ciccocioppo%20F,%20Lanuti%20P,%20Pierdomenico%20L,%20Simeone%20P,%20Bologna%20G,%20Ercolino%20E,%20et%20al.%20The%20characterization%20of%20regulatory%20T-Cell%20profiles%20in%20alzheimer%E2%80%99s%20disease%20and%20multiple%20sclerosis.%20Sci%20Rep.%202019;9:8788." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Dansokho C, Ahmed DA, Aid S, Cile Toly-Ndour C, Chaigneau T, Calle V, et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain. 2016;139:1237–51.
</cite> [<a href="https://doi.org/10.1093/brain/awv408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26912648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dansokho%20C,%20Ahmed%20DA,%20Aid%20S,%20Cile%20Toly-Ndour%20C,%20Chaigneau%20T,%20Calle%20V,%20et%20al.%20Regulatory%20T%20cells%20delay%20disease%20progression%20in%20Alzheimer-like%20pathology.%20Brain.%202016;139:1237%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Yeapuri P, Machhi J, Lu Y, Abdelmoaty MM, Kadry R, Patel M, et al. Amyloid-β specific regulatory T cells attenuate alzheimer’s disease pathobiology in APP/PS1 mice. Mol Neurodegener. 2023;18:97.
</cite> [<a href="https://doi.org/10.1186/s13024-023-00692-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10729469/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38111016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yeapuri%20P,%20Machhi%20J,%20Lu%20Y,%20Abdelmoaty%20MM,%20Kadry%20R,%20Patel%20M,%20et%20al.%20Amyloid-%CE%B2%20specific%20regulatory%20T%20cells%20attenuate%20alzheimer%E2%80%99s%20disease%20pathobiology%20in%20APP/PS1%20mice.%20Mol%20Neurodegener.%202023;18:97." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Ortí-Casañ N, Wajant H, Kuiperij HB, Hooijsma A, Tromp L, Poortman IL, et al. Activation of TNF receptor 2 improves synaptic plasticity and enhances Amyloid-β clearance in an alzheimer’s disease mouse model with humanized TNF receptor 2. J Alzheimers Dis. 2023;94:977–91.
</cite> [<a href="https://doi.org/10.3233/JAD-221230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10578215/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37355890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ort%C3%AD-Casa%C3%B1%20N,%20Wajant%20H,%20Kuiperij%20HB,%20Hooijsma%20A,%20Tromp%20L,%20Poortman%20IL,%20et%20al.%20Activation%20of%20TNF%20receptor%202%20improves%20synaptic%20plasticity%20and%20enhances%20Amyloid-%CE%B2%20clearance%20in%20an%20alzheimer%E2%80%99s%20disease%20mouse%20model%20with%20humanized%20TNF%20receptor%202.%20J%20Alzheimers%20Dis.%202023;94:977%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Ortí-Casañ N, Zuhorn IS, Naudé PJW, Deyn PP, van De, Schaik PEM, Wajant H, et al. A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an alzheimer’s disease mouse model. Proc Natl Acad Sci U S A. 2022;119:e2201137119.
</cite> [<a href="https://doi.org/10.1073/pnas.2201137119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9482428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36037389/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ort%C3%AD-Casa%C3%B1%20N,%20Zuhorn%20IS,%20Naud%C3%A9%20PJW,%20Deyn%20PP,%20van%20De,%20Schaik%20PEM,%20Wajant%20H,%20et%20al.%20A%20TNF%20receptor%202%20agonist%20ameliorates%20neuropathology%20and%20improves%20cognition%20in%20an%20alzheimer%E2%80%99s%20disease%20mouse%20model.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202022;119:e2201137119." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Vargas JG, Wagner J, Shaikh H, Lang I, Medler J, Anany M, et al. A TNFR2-Specific TNF fusion protein with improved in vivo activity. Front Immunol. 2022;13:888274.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.888274" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9234581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35769484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vargas%20JG,%20Wagner%20J,%20Shaikh%20H,%20Lang%20I,%20Medler%20J,%20Anany%20M,%20et%20al.%20A%20TNFR2-Specific%20TNF%20fusion%20protein%20with%20improved%20in%20vivo%20activity.%20Front%20Immunol.%202022;13:888274." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Shi L, Sun Z, Su W, Xu F, Xie D, Zhang Q, et al. Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke. Immunity. 2021;54:1527–42.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2021.04.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8282725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34015256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20L,%20Sun%20Z,%20Su%20W,%20Xu%20F,%20Xie%20D,%20Zhang%20Q,%20et%20al.%20Treg%20cell-derived%20osteopontin%20promotes%20microglia-mediated%20white%20matter%20repair%20after%20ischemic%20stroke.%20Immunity.%202021;54:1527%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Lamontain V, Schmid T, Weber-Steffens D, Zeller D, Jenei-Lanzl Z, Wajant H, et al. Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice. Cell Mol Immunol. 2018;14:1–10.</cite> [<a href="https://doi.org/10.1038/cmi.2017.138" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6318277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29375132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lamontain%20V,%20Schmid%20T,%20Weber-Steffens%20D,%20Zeller%20D,%20Jenei-Lanzl%20Z,%20Wajant%20H,%20et%20al.%20Stimulation%20of%20TNF%20receptor%20type%202%20expands%20regulatory%20T%20cells%20and%20ameliorates%20established%20collagen-induced%20arthritis%20in%20mice.%20Cell%20Mol%20Immunol.%202018;14:1%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Caplan HW, Prabhakara KS, Toledano Furman NE, Zorofchian S, Kumar A, Martin C, et al. Combination therapy with Treg and MSC enhances potency and Attenuation of inflammation after traumatic brain injury compared to monotherapy. Stem Cells. 2021;39:370.</cite> [<a href="https://doi.org/10.1002/stem.3320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8634698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33368792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Caplan%20HW,%20Prabhakara%20KS,%20Toledano%20Furman%20NE,%20Zorofchian%20S,%20Kumar%20A,%20Martin%20C,%20et%20al.%20Combination%20therapy%20with%20Treg%20and%20MSC%20enhances%20potency%20and%20Attenuation%20of%20inflammation%20after%20traumatic%20brain%20injury%20compared%20to%20monotherapy.%20Stem%20Cells.%202021;39:370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Fischer R, Sendetski M, del Rivero T, Martinez GF, Bracchi-Ricard V, Swanson KA, et al. TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes. Proc Natl Acad Sci U S A. 2019;116:17045–50.
</cite> [<a href="https://doi.org/10.1073/pnas.1902091116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6708347/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31391309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fischer%20R,%20Sendetski%20M,%20del%20Rivero%20T,%20Martinez%20GF,%20Bracchi-Ricard%20V,%20Swanson%20KA,%20et%20al.%20TNFR2%20promotes%20Treg-mediated%20recovery%20from%20neuropathic%20pain%20across%20sexes.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202019;116:17045%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Soto-Heredero G, Gabandé-Rodríguez E, Carrasco E, Escrig-Larena JI, de las Gómez MM, Delgado-Pulido S et al. KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging. Nat Aging. 2025;17.</cite> [<a href="https://doi.org/10.1038/s43587-025-00855-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12092250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40307497/" class="usa-link">PubMed</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Zhao Y, Cong L, Jaber V, Lukiw WJ. Microbiome-Derived lipopolysaccharide enriched in the perinuclear region of alzheimer’s disease brain. Front Immunol. 2017;8:1064.
</cite> [<a href="https://doi.org/10.3389/fimmu.2017.01064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5591429/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28928740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Y,%20Cong%20L,%20Jaber%20V,%20Lukiw%20WJ.%20Microbiome-Derived%20lipopolysaccharide%20enriched%20in%20the%20perinuclear%20region%20of%20alzheimer%E2%80%99s%20disease%20brain.%20Front%20Immunol.%202017;8:1064." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>McAleer JP, Vella AT. Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends Immunol. 2010;31:435.</cite> [<a href="https://doi.org/10.1016/j.it.2010.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2967613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20880743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McAleer%20JP,%20Vella%20AT.%20Educating%20CD4%20T%20cells%20with%20vaccine%20adjuvants:%20lessons%20from%20lipopolysaccharide.%20Trends%20Immunol.%202010;31:435." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Xu H, Liew LN, Kuo IC, Huang CH, Goh DLM, Chua KY. The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization. Immunology. 2008;125:218–28.
</cite> [<a href="https://doi.org/10.1111/j.1365-2567.2008.02832.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2561127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18355243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20H,%20Liew%20LN,%20Kuo%20IC,%20Huang%20CH,%20Goh%20DLM,%20Chua%20KY.%20The%20modulatory%20effects%20of%20lipopolysaccharide-stimulated%20B%20cells%20on%20differential%20T-cell%20polarization.%20Immunology.%202008;125:218%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Cui W, Joshi NS, Liu Y, Meng H, Kleinstein SH, Kaech SM. TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8 + T cell differentiation. J Immunol. 2014;192:4221–32.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1302569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4071140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24659688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cui%20W,%20Joshi%20NS,%20Liu%20Y,%20Meng%20H,%20Kleinstein%20SH,%20Kaech%20SM.%20TLR4%20ligands%20lipopolysaccharide%20and%20monophosphoryl%20lipid%20a%20differentially%20regulate%20effector%20and%20memory%20CD8%20+%20T%20cell%20differentiation.%20J%20Immunol.%202014;192:4221%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe. 2012;12:496–508.
</cite> [<a href="https://doi.org/10.1016/j.chom.2012.09.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3516493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23084918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ivanov%20II,%20Honda%20K.%20Intestinal%20commensal%20microbes%20as%20immune%20modulators.%20Cell%20Host%20Microbe.%202012;12:496%E2%80%93508." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Li H, Guo Z, Guo Y, Li M, Yan H, Cheng J, et al. Common DNA methylation alterations of alzheimer’s disease and aging in peripheral whole blood. Oncotarget. 2016;7:19089–98.
</cite> [<a href="https://doi.org/10.18632/oncotarget.7862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4991367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26943045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20H,%20Guo%20Z,%20Guo%20Y,%20Li%20M,%20Yan%20H,%20Cheng%20J,%20et%20al.%20Common%20DNA%20methylation%20alterations%20of%20alzheimer%E2%80%99s%20disease%20and%20aging%20in%20peripheral%20whole%20blood.%20Oncotarget.%202016;7:19089%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Song J, Lee JE. miR-155 is involved in alzheimer’s disease by regulating T lymphocyte function. Front Aging Neurosci. 2015;7:61.
</cite> [<a href="https://doi.org/10.3389/fnagi.2015.00061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4415416/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25983691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song%20J,%20Lee%20JE.%20miR-155%20is%20involved%20in%20alzheimer%E2%80%99s%20disease%20by%20regulating%20T%20lymphocyte%20function.%20Front%20Aging%20Neurosci.%202015;7:61." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Naqvi AR, Zhong S, Dang H, Fordham JB, Nares S, Khan A. Expression profiling of LPS responsive MiRNA in primary human macrophages. J Microb Biochem Technol. 2016;8:136–43.
</cite> [<a href="https://doi.org/10.4172/1948-5948.1000276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4905593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27307950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naqvi%20AR,%20Zhong%20S,%20Dang%20H,%20Fordham%20JB,%20Nares%20S,%20Khan%20A.%20Expression%20profiling%20of%20LPS%20responsive%20MiRNA%20in%20primary%20human%20macrophages.%20J%20Microb%20Biochem%20Technol.%202016;8:136%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Kulkarni B, Kumar D, Cruz-Martins N, Sellamuthu S. Role of TREM2 in alzheimer’s disease: A long road ahead. Mol Neurobiol. 2021;58:5239–52.
</cite> [<a href="https://doi.org/10.1007/s12035-021-02477-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34275100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kulkarni%20B,%20Kumar%20D,%20Cruz-Martins%20N,%20Sellamuthu%20S.%20Role%20of%20TREM2%20in%20alzheimer%E2%80%99s%20disease:%20A%20long%20road%20ahead.%20Mol%20Neurobiol.%202021;58:5239%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Deczkowska A, Weiner A, Amit I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell. 2020;181:1207–17.
</cite> [<a href="https://doi.org/10.1016/j.cell.2020.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32531244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deczkowska%20A,%20Weiner%20A,%20Amit%20I.%20The%20physiology,%20pathology,%20and%20potential%20therapeutic%20applications%20of%20the%20TREM2%20signaling%20pathway.%20Cell.%202020;181:1207%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724–39.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2016.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4898967/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27196974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan%20P,%20Condello%20C,%20Keene%20CD,%20Wang%20Y,%20Bird%20TD,%20Paul%20SM,%20et%20al.%20TREM2%20haplodeficiency%20in%20mice%20and%20humans%20impairs%20the%20microglia%20barrier%20function%20leading%20to%20decreased%20amyloid%20compaction%20and%20severe%20axonal%20dystrophy.%20Neuron.%202016;90:724%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Giraldo M, Lopera F, Siniard AL, Corneveaux JJ, Schrauwen I, Carvajal J, et al. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal Lobar degeneration and alzheimer’s disease. Neurobiol Aging. 2013;34:10.</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2013.02.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3830921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23582655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giraldo%20M,%20Lopera%20F,%20Siniard%20AL,%20Corneveaux%20JJ,%20Schrauwen%20I,%20Carvajal%20J,%20et%20al.%20Variants%20in%20triggering%20receptor%20expressed%20on%20myeloid%20cells%202%20are%20associated%20with%20both%20behavioral%20variant%20frontotemporal%20Lobar%20degeneration%20and%20alzheimer%E2%80%99s%20disease.%20Neurobiol%20Aging.%202013;34:10." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Brendel M, Kleinberger G, Probst F, Jaworska A, Overhoff F, Blume T, et al. Increase of TREM2 during aging of an alzheimer’s disease mouse model is paralleled by microglial activation and amyloidosis. Front Aging Neurosci. 2017;9:8.
</cite> [<a href="https://doi.org/10.3389/fnagi.2017.00008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5282474/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28197095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brendel%20M,%20Kleinberger%20G,%20Probst%20F,%20Jaworska%20A,%20Overhoff%20F,%20Blume%20T,%20et%20al.%20Increase%20of%20TREM2%20during%20aging%20of%20an%20alzheimer%E2%80%99s%20disease%20mouse%20model%20is%20paralleled%20by%20microglial%20activation%20and%20amyloidosis.%20Front%20Aging%20Neurosci.%202017;9:8." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Ito H, Hamerman JA. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol. 2012;42:176–85.
</cite> [<a href="https://doi.org/10.1002/eji.201141679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3444819/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21956652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ito%20H,%20Hamerman%20JA.%20TREM-2,%20triggering%20receptor%20expressed%20on%20myeloid%20cell-2,%20negatively%20regulates%20TLR%20responses%20in%20dendritic%20cells.%20Eur%20J%20Immunol.%202012;42:176%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Tan YJ, Ng ASL, Vipin A, Lim JKW, Chander RJ, Ji F, et al. Higher peripheral TREM2 mRNA levels relate to cognitive deficits and hippocampal atrophy in alzheimer’s disease and amnestic mild cognitive impairment. J Alzheimer’s Disease. 2017;58:413–23.
</cite> [<a href="https://doi.org/10.3233/JAD-161277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28453482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tan%20YJ,%20Ng%20ASL,%20Vipin%20A,%20Lim%20JKW,%20Chander%20RJ,%20Ji%20F,%20et%20al.%20Higher%20peripheral%20TREM2%20mRNA%20levels%20relate%20to%20cognitive%20deficits%20and%20hippocampal%20atrophy%20in%20alzheimer%E2%80%99s%20disease%20and%20amnestic%20mild%20cognitive%20impairment.%20J%20Alzheimer%E2%80%99s%20Disease.%202017;58:413%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Labus J, Häckel S, Lucka L, Danker K. Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood–brain barrier model. J Neurosci Methods. 2014;228:35–45.
</cite> [<a href="https://doi.org/10.1016/j.jneumeth.2014.03.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24631939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Labus%20J,%20H%C3%A4ckel%20S,%20Lucka%20L,%20Danker%20K.%20Interleukin-1%CE%B2%20induces%20an%20inflammatory%20response%20and%20the%20breakdown%20of%20the%20endothelial%20cell%20layer%20in%20an%20improved%20human%20THBMEC-based%20in%20vitro%20blood%E2%80%93brain%20barrier%20model.%20J%20Neurosci%20Methods.%202014;228:35%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Tan S, Shan Y, Lin Y, Liao S, Zhang B, Zeng Q, et al. Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A. FASEB J. 2019;33:4376–87.
</cite> [<a href="https://doi.org/10.1096/fj.201801595RR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30694693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tan%20S,%20Shan%20Y,%20Lin%20Y,%20Liao%20S,%20Zhang%20B,%20Zeng%20Q,%20et%20al.%20Neutralization%20of%20interleukin-9%20ameliorates%20experimental%20stroke%20by%20repairing%20the%20blood-brain%20barrier%20via%20down-regulation%20of%20astrocyte-derived%20vascular%20endothelial%20growth%20factor-A.%20FASEB%20J.%202019;33:4376%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Presta I, Vismara M, Novellino F, Donato A, Zaffino P, Scali E, et al. Innate immunity cells and the neurovascular unit. Int J Mol Sci. 2018;19:3856.
</cite> [<a href="https://doi.org/10.3390/ijms19123856" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6321635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30513991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Presta%20I,%20Vismara%20M,%20Novellino%20F,%20Donato%20A,%20Zaffino%20P,%20Scali%20E,%20et%20al.%20Innate%20immunity%20cells%20and%20the%20neurovascular%20unit.%20Int%20J%20Mol%20Sci.%202018;19:3856." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther. 2021;27:36–47.
</cite> [<a href="https://doi.org/10.1111/cns.13569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7804893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33381913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20X,%20Hussain%20B,%20Chang%20J.%20Peripheral%20inflammation%20and%20blood-brain%20barrier%20disruption:%20effects%20and%20mechanisms.%20CNS%20Neurosci%20Ther.%202021;27:36%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Santiago JA, Potashkin JA. The impact of disease comorbidities in alzheimer’s disease. Front Aging Neurosci. 2021;13:631770.
</cite> [<a href="https://doi.org/10.3389/fnagi.2021.631770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7906983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33643025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Santiago%20JA,%20Potashkin%20JA.%20The%20impact%20of%20disease%20comorbidities%20in%20alzheimer%E2%80%99s%20disease.%20Front%20Aging%20Neurosci.%202021;13:631770." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Husky MM, Ferdous Farin F, Compagnone P, Fermanian C, Kovess-Masfety V. Chronic back pain and its association with quality of life in a large French population survey. Health Qual Life Outcomes. 2018;16:195.
</cite> [<a href="https://doi.org/10.1186/s12955-018-1018-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6158815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30257670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Husky%20MM,%20Ferdous%20Farin%20F,%20Compagnone%20P,%20Fermanian%20C,%20Kovess-Masfety%20V.%20Chronic%20back%20pain%20and%20its%20association%20with%20quality%20of%20life%20in%20a%20large%20French%20population%20survey.%20Health%20Qual%20Life%20Outcomes.%202018;16:195." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Cao S, Fisher DW, Yu T, Dong H. The link between chronic pain and alzheimer’s disease. J Neuroinflamm. 2019;16:1–11.</cite> [<a href="https://doi.org/10.1186/s12974-019-1608-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6836339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31694670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao%20S,%20Fisher%20DW,%20Yu%20T,%20Dong%20H.%20The%20link%20between%20chronic%20pain%20and%20alzheimer%E2%80%99s%20disease.%20J%20Neuroinflamm.%202019;16:1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Blanton H, Reddy PH, Benamar K. Chronic pain in alzheimer’s disease: endocannabinoid system. Exp Neurol. 2023;360:114287.
</cite> [<a href="https://doi.org/10.1016/j.expneurol.2022.114287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9789196/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36455638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Blanton%20H,%20Reddy%20PH,%20Benamar%20K.%20Chronic%20pain%20in%20alzheimer%E2%80%99s%20disease:%20endocannabinoid%20system.%20Exp%20Neurol.%202023;360:114287." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Larsson C, Hansson EE, Sundquist K, Jakobsson U. Chronic pain in older adults: prevalence, incidence, and risk factors. Scand J Rheumatol. 2017;46:317–25.
</cite> [<a href="https://doi.org/10.1080/03009742.2016.1218543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27885914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Larsson%20C,%20Hansson%20EE,%20Sundquist%20K,%20Jakobsson%20U.%20Chronic%20pain%20in%20older%20adults:%20prevalence,%20incidence,%20and%20risk%20factors.%20Scand%20J%20Rheumatol.%202017;46:317%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Van Kooten J, Van Der Binnekade TT, Stek ML, Scherder EJA, Husebø BS, et al. A review of pain prevalence in alzheimer’s, vascular, frontotemporal and lewy body dementias. Dement Geriatr Cogn Disord. 2016;41:220–32.
</cite> [<a href="https://doi.org/10.1159/000444791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27160163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Van%20Kooten%20J,%20Van%20Der%20Binnekade%20TT,%20Stek%20ML,%20Scherder%20EJA,%20Huseb%C3%B8%20BS,%20et%20al.%20A%20review%20of%20pain%20prevalence%20in%20alzheimer%E2%80%99s,%20vascular,%20frontotemporal%20and%20lewy%20body%20dementias.%20Dement%20Geriatr%20Cogn%20Disord.%202016;41:220%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Huang SW, Wang W, Te, Chou LC, Liao C, De, Liou TH, Lin HW. Osteoarthritis increases the risk of dementia: A nationwide cohort study in Taiwan. Sci Rep. 2015;5:1–7.</cite> [<a href="https://doi.org/10.1038/srep10145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4434986/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25984812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20SW,%20Wang%20W,%20Te,%20Chou%20LC,%20Liao%20C,%20De,%20Liou%20TH,%20Lin%20HW.%20Osteoarthritis%20increases%20the%20risk%20of%20dementia:%20A%20nationwide%20cohort%20study%20in%20Taiwan.%20Sci%20Rep.%202015;5:1%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Whitlock EL, Diaz-Ramirez LG, Glymour MM, Boscardin WJ, Covinsky KE, Smith AK. Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. JAMA Intern Med. 2017;177:1146.
</cite> [<a href="https://doi.org/10.1001/jamainternmed.2017.1622" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5588896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28586818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whitlock%20EL,%20Diaz-Ramirez%20LG,%20Glymour%20MM,%20Boscardin%20WJ,%20Covinsky%20KE,%20Smith%20AK.%20Association%20between%20persistent%20pain%20and%20memory%20decline%20and%20dementia%20in%20a%20longitudinal%20cohort%20of%20elders.%20JAMA%20Intern%20Med.%202017;177:1146." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Tzeng NS, Chung CH, Liu FC, Chiu YH, Chang HA, Yeh C, Bin, et al. Fibromyalgia and risk of Dementia—A nationwide, Population-Based, cohort study. Am J Med Sci. 2018;355:153–61.
</cite> [<a href="https://doi.org/10.1016/j.amjms.2017.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29406043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tzeng%20NS,%20Chung%20CH,%20Liu%20FC,%20Chiu%20YH,%20Chang%20HA,%20Yeh%20C,%20Bin,%20et%20al.%20Fibromyalgia%20and%20risk%20of%20Dementia%E2%80%94A%20nationwide,%20Population-Based,%20cohort%20study.%20Am%20J%20Med%20Sci.%202018;355:153%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Tian J, Jones G, Lin X, Zhou Y, King A, Vickers J, et al. Association between chronic pain and risk of incident dementia: findings from a prospective cohort. BMC Med. 2023;21:1–13.
</cite> [<a href="https://doi.org/10.1186/s12916-023-02875-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10161483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37143042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20J,%20Jones%20G,%20Lin%20X,%20Zhou%20Y,%20King%20A,%20Vickers%20J,%20et%20al.%20Association%20between%20chronic%20pain%20and%20risk%20of%20incident%20dementia:%20findings%20from%20a%20prospective%20cohort.%20BMC%20Med.%202023;21:1%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Zhao W, Zhao L, Chang X, Lu X, Tu Y. Elevated dementia risk, cognitive decline, and hippocampal atrophy in multisite chronic pain. Proc Natl Acad Sci U S A. 2023;120:e2215192120.
</cite> [<a href="https://doi.org/10.1073/pnas.2215192120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9992778/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36802440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20W,%20Zhao%20L,%20Chang%20X,%20Lu%20X,%20Tu%20Y.%20Elevated%20dementia%20risk,%20cognitive%20decline,%20and%20hippocampal%20atrophy%20in%20multisite%20chronic%20pain.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202023;120:e2215192120." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Zhang X, Gao R, Zhang C, Chen H, Wang R, Zhao Q, et al. Evidence for cognitive decline in chronic pain: A systematic review and Meta-Analysis. Front Neurosci. 2021;15:737874.
</cite> [<a href="https://doi.org/10.3389/fnins.2021.737874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8492915/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34630023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20X,%20Gao%20R,%20Zhang%20C,%20Chen%20H,%20Wang%20R,%20Zhao%20Q,%20et%20al.%20Evidence%20for%20cognitive%20decline%20in%20chronic%20pain:%20A%20systematic%20review%20and%20Meta-Analysis.%20Front%20Neurosci.%202021;15:737874." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Kang D, McAuley JH, Kassem MS, Gatt JM, Gustin SM. What does the grey matter decrease in the medial prefrontal cortex reflect in people with chronic pain? Eur J Pain. 2019;23:203–19.
</cite> [<a href="https://doi.org/10.1002/ejp.1304" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30101509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kang%20D,%20McAuley%20JH,%20Kassem%20MS,%20Gatt%20JM,%20Gustin%20SM.%20What%20does%20the%20grey%20matter%20decrease%20in%20the%20medial%20prefrontal%20cortex%20reflect%20in%20people%20with%20chronic%20pain?%20Eur%20J%20Pain.%202019;23:203%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23:1018–27.
</cite> [<a href="https://doi.org/10.1038/nm.4397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28886007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Salter%20MW,%20Stevens%20B.%20Microglia%20emerge%20as%20central%20players%20in%20brain%20disease.%20Nat%20Med.%202017;23:1018%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, et al. Chronic back pain is associated with decreased prefrontal and thalamic Gray matter density. J Neurosci. 2004;24:10410.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.2541-04.2004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6730296/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15548656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Apkarian%20AV,%20Sosa%20Y,%20Sonty%20S,%20Levy%20RM,%20Harden%20RN,%20Parrish%20TB,%20et%20al.%20Chronic%20back%20pain%20is%20associated%20with%20decreased%20prefrontal%20and%20thalamic%20Gray%20matter%20density.%20J%20Neurosci.%202004;24:10410." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, Centeno MV, et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci. 2012;32:5747.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.0587-12.2012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3365570/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22539837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mutso%20AA,%20Radzicki%20D,%20Baliki%20MN,%20Huang%20L,%20Banisadr%20G,%20Centeno%20MV,%20et%20al.%20Abnormalities%20in%20hippocampal%20functioning%20with%20persistent%20pain.%20J%20Neurosci.%202012;32:5747." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Alivernini S, MacDonald L, Elmesmari A, Finlay S, Tolusso B, Gigante MR, et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat Med. 2020;26:1295–306.
</cite> [<a href="https://doi.org/10.1038/s41591-020-0939-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32601335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alivernini%20S,%20MacDonald%20L,%20Elmesmari%20A,%20Finlay%20S,%20Tolusso%20B,%20Gigante%20MR,%20et%20al.%20Distinct%20synovial%20tissue%20macrophage%20subsets%20regulate%20inflammation%20and%20remission%20in%20rheumatoid%20arthritis.%20Nat%20Med.%202020;26:1295%E2%80%93306." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Hysing EB, Smith L, Thulin M, Karlsten R, Bothelius K, Gordh T. Detection of systemic inflammation in severely impaired chronic pain patients and effects of a multimodal pain rehabilitation program. Scand J Pain. 2019;19:235–44.
</cite> [<a href="https://doi.org/10.1515/sjpain-2018-0340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30893060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hysing%20EB,%20Smith%20L,%20Thulin%20M,%20Karlsten%20R,%20Bothelius%20K,%20Gordh%20T.%20Detection%20of%20systemic%20inflammation%20in%20severely%20impaired%20chronic%20pain%20patients%20and%20effects%20of%20a%20multimodal%20pain%20rehabilitation%20program.%20Scand%20J%20Pain.%202019;19:235%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Bäckryd E, Tanum L, Lind AL, Larsson A, Gordh T. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res. 2017;10:515–25.
</cite> [<a href="https://doi.org/10.2147/JPR.S128508" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5344444/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28424559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?B%C3%A4ckryd%20E,%20Tanum%20L,%20Lind%20AL,%20Larsson%20A,%20Gordh%20T.%20Evidence%20of%20both%20systemic%20inflammation%20and%20neuroinflammation%20in%20fibromyalgia%20patients,%20as%20assessed%20by%20a%20multiplex%20protein%20panel%20applied%20to%20the%20cerebrospinal%20fluid%20and%20to%20plasma.%20J%20Pain%20Res.%202017;10:515%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Fang XX, Zhai MN, Zhu M, He C, Wang H, Wang J, et al. Inflammation in pathogenesis of chronic pain: foe and friend. Mol Pain. 2023;19:1–15.</cite> [<a href="https://doi.org/10.1177/17448069231178176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10214073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37220667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fang%20XX,%20Zhai%20MN,%20Zhu%20M,%20He%20C,%20Wang%20H,%20Wang%20J,%20et%20al.%20Inflammation%20in%20pathogenesis%20of%20chronic%20pain:%20foe%20and%20friend.%20Mol%20Pain.%202023;19:1%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Zhou WBS, Meng JW, Zhang J. Does low grade systemic inflammation have a role in chronic pain?? Front Mol Neurosci. 2021;14:785214.
</cite> [<a href="https://doi.org/10.3389/fnmol.2021.785214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8631544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34858140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20WBS,%20Meng%20JW,%20Zhang%20J.%20Does%20low%20grade%20systemic%20inflammation%20have%20a%20role%20in%20chronic%20pain??%20Front%20Mol%20Neurosci.%202021;14:785214." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>De Goeij M, Van Eijk LT, Vanelderen P, Wilder-Smith OH, Van Der Vissers KC, et al. Systemic inflammation decreases pain threshold in humans in vivo. PLoS ONE. 2013;8:e84159.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0084159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3866228/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24358337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Goeij%20M,%20Van%20Eijk%20LT,%20Vanelderen%20P,%20Wilder-Smith%20OH,%20Van%20Der%20Vissers%20KC,%20et%20al.%20Systemic%20inflammation%20decreases%20pain%20threshold%20in%20humans%20in%20vivo.%20PLoS%20ONE.%202013;8:e84159." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain States. Curr Opin Anaesthesiol. 2010;23:611–5.
</cite> [<a href="https://doi.org/10.1097/ACO.0b013e32833c348b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20543676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yarnitsky%20D.%20Conditioned%20pain%20modulation%20(the%20diffuse%20noxious%20inhibitory%20control-like%20effect):%20its%20relevance%20for%20acute%20and%20chronic%20pain%20States.%20Curr%20Opin%20Anaesthesiol.%202010;23:611%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Karshikoff B, Jensen KB, Kosek E, Kalpouzos G, Soop A, Ingvar M, et al. Why sickness hurts: A central mechanism for pain induced by peripheral inflammation. Brain Behav Immun. 2016;57:38–46.
</cite> [<a href="https://doi.org/10.1016/j.bbi.2016.04.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27058164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Karshikoff%20B,%20Jensen%20KB,%20Kosek%20E,%20Kalpouzos%20G,%20Soop%20A,%20Ingvar%20M,%20et%20al.%20Why%20sickness%20hurts:%20A%20central%20mechanism%20for%20pain%20induced%20by%20peripheral%20inflammation.%20Brain%20Behav%20Immun.%202016;57:38%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Sun Y, Koyama Y, Shimada S. Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation?? Front Aging Neurosci. 2022;14:903455.
</cite> [<a href="https://doi.org/10.3389/fnagi.2022.903455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9244793/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35783147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20Y,%20Koyama%20Y,%20Shimada%20S.%20Inflammation%20from%20peripheral%20organs%20to%20the%20brain:%20how%20does%20systemic%20inflammation%20cause%20neuroinflammation??%20Front%20Aging%20Neurosci.%202022;14:903455." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron. 2018;100:1292.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2018.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6312407/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30571942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20G,%20Zhang%20YQ,%20Qadri%20YJ,%20Serhan%20CN,%20Ji%20RR.%20Microglia%20in%20pain:%20detrimental%20and%20protective%20roles%20in%20pathogenesis%20and%20resolution%20of%20pain.%20Neuron.%202018;100:1292." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018;129:343.
</cite> [<a href="https://doi.org/10.1097/ALN.0000000000002130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6051899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29462012/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ji%20RR,%20Nackley%20A,%20Huh%20Y,%20Terrando%20N,%20Maixner%20W.%20Neuroinflammation%20and%20central%20sensitization%20in%20chronic%20and%20widespread%20pain.%20Anesthesiology.%202018;129:343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>De Logu F, Boccella S, Guida F, Editorial. The role of neuroinflammation in chronic pain development and maintenance. Front Pharmacol. 2021;12:821534.
</cite> [<a href="https://doi.org/10.3389/fphar.2021.821534" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8733678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35002746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Logu%20F,%20Boccella%20S,%20Guida%20F,%20Editorial.%20The%20role%20of%20neuroinflammation%20in%20chronic%20pain%20development%20and%20maintenance.%20Front%20Pharmacol.%202021;12:821534." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Liu Y, Zhou LJ, Wang J, Li D, Ren WJ, Peng J, et al. TNF-α differentially regulates synaptic plasticity in the Hippocampus and spinal cord by Microglia-Dependent mechanisms after peripheral nerve injury. J Neurosci. 2017;37:871.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.2235-16.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5296781/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28123022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Zhou%20LJ,%20Wang%20J,%20Li%20D,%20Ren%20WJ,%20Peng%20J,%20et%20al.%20TNF-%CE%B1%20differentially%20regulates%20synaptic%20plasticity%20in%20the%20Hippocampus%20and%20spinal%20cord%20by%20Microglia-Dependent%20mechanisms%20after%20peripheral%20nerve%20injury.%20J%20Neurosci.%202017;37:871." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Mailhot B, Christin M, Tessandier N, Sotoudeh C, Bretheau F, Turmel R, et al. Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med. 2020;217:e20191430.
</cite> [<a href="https://doi.org/10.1084/jem.20191430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7478735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32573694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mailhot%20B,%20Christin%20M,%20Tessandier%20N,%20Sotoudeh%20C,%20Bretheau%20F,%20Turmel%20R,%20et%20al.%20Neuronal%20interleukin-1%20receptors%20mediate%20pain%20in%20chronic%20inflammatory%20diseases.%20J%20Exp%20Med.%202020;217:e20191430." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Barcelon EE, Cho WH, Jun SB, Lee SJ. Brain microglial activation in chronic pain-associated affective disorder. Front Neurosci. 2019;13:213.
</cite> [<a href="https://doi.org/10.3389/fnins.2019.00213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6436078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30949019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barcelon%20EE,%20Cho%20WH,%20Jun%20SB,%20Lee%20SJ.%20Brain%20microglial%20activation%20in%20chronic%20pain-associated%20affective%20disorder.%20Front%20Neurosci.%202019;13:213." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A. 2015;112:12468.
</cite> [<a href="https://doi.org/10.1073/pnas.1511003112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4603509/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26385967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sandiego%20CM,%20Gallezot%20JD,%20Pittman%20B,%20Nabulsi%20N,%20Lim%20K,%20Lin%20SF,%20et%20al.%20Imaging%20robust%20microglial%20activation%20after%20lipopolysaccharide%20administration%20in%20humans%20with%20PET.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202015;112:12468." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MRP, Blurton-Jones M, et al. Eliminating microglia in alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology. Brain. 2016;139:1265–81.
</cite> [<a href="https://doi.org/10.1093/brain/aww016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5006229/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26921617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spangenberg%20EE,%20Lee%20RJ,%20Najafi%20AR,%20Rice%20RA,%20Elmore%20MRP,%20Blurton-Jones%20M,%20et%20al.%20Eliminating%20microglia%20in%20alzheimer%E2%80%99s%20mice%20prevents%20neuronal%20loss%20without%20modulating%20amyloid-%CE%B2%20pathology.%20Brain.%202016;139:1265%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Morrissey EJ, Alshelh Z, Knight PC, Saha A, Kim M, Torrado-Carvajal A, et al. Assessing the potential Anti-Neuroinflammatory effect of Minocycline in chronic low back pain: protocol for a randomized, double-blind, placebo-controlled trial. Contemp Clin Trials. 2023;126:107087.
</cite> [<a href="https://doi.org/10.1016/j.cct.2023.107087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36657520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morrissey%20EJ,%20Alshelh%20Z,%20Knight%20PC,%20Saha%20A,%20Kim%20M,%20Torrado-Carvajal%20A,%20et%20al.%20Assessing%20the%20potential%20Anti-Neuroinflammatory%20effect%20of%20Minocycline%20in%20chronic%20low%20back%20pain:%20protocol%20for%20a%20randomized,%20double-blind,%20placebo-controlled%20trial.%20Contemp%20Clin%20Trials.%202023;126:107087." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Shin DA, Kim TU, Chang MC. Minocycline for controlling neuropathic pain: A systematic narrative review of studies in humans. J Pain Res. 2021;14:139–45.
</cite> [<a href="https://doi.org/10.2147/JPR.S292824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7849188/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33536779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shin%20DA,%20Kim%20TU,%20Chang%20MC.%20Minocycline%20for%20controlling%20neuropathic%20pain:%20A%20systematic%20narrative%20review%20of%20studies%20in%20humans.%20J%20Pain%20Res.%202021;14:139%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Shultz RB, Zhong Y. Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury. Neural Regen Res. 2017;12:702–13.
</cite> [<a href="https://doi.org/10.4103/1673-5374.206633" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5461601/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28616020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shultz%20RB,%20Zhong%20Y.%20Minocycline%20targets%20multiple%20secondary%20injury%20mechanisms%20in%20traumatic%20spinal%20cord%20injury.%20Neural%20Regen%20Res.%202017;12:702%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Abdo Qaid EY, Abdullah Z, Zakaria R, Long I. Minocycline mitigates Tau pathology via modulating the TLR-4/NF-кβ signalling pathway in the hippocampus of neuroinflammation rat model. Neurol Res. 2024;46:261–71.</cite> [<a href="https://doi.org/10.1080/01616412.2023.2296754" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38122814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abdo%20Qaid%20EY,%20Abdullah%20Z,%20Zakaria%20R,%20Long%20I.%20Minocycline%20mitigates%20Tau%20pathology%20via%20modulating%20the%20TLR-4/NF-%D0%BA%CE%B2%20signalling%20pathway%20in%20the%20hippocampus%20of%20neuroinflammation%20rat%20model.%20Neurol%20Res.%202024;46:261%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Zhao Y, Wang C, He W, Cai Z. Ameliorating Alzheimer’s-like pathology by Minocycline via inhibiting Cdk5/p25 signaling. Curr Neuropharmacol. 2022;20:1783–92.
</cite> [<a href="https://doi.org/10.2174/1570159X19666211202124925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9881058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34856907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20Y,%20Wang%20C,%20He%20W,%20Cai%20Z.%20Ameliorating%20Alzheimer%E2%80%99s-like%20pathology%20by%20Minocycline%20via%20inhibiting%20Cdk5/p25%20signaling.%20Curr%20Neuropharmacol.%202022;20:1783%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Gholami Mahmoudian Z, komaki A, Rashidi I, Amiri I, Ghanbari A. The effect of Minocycline on beta-amyloid-induced memory and learning deficit in male rats: A behavioral, biochemical, and histological study. J Chem Neuroanat. 2022;125:102158.
</cite> [<a href="https://doi.org/10.1016/j.jchemneu.2022.102158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36084891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gholami%20Mahmoudian%20Z,%20komaki%20A,%20Rashidi%20I,%20Amiri%20I,%20Ghanbari%20A.%20The%20effect%20of%20Minocycline%20on%20beta-amyloid-induced%20memory%20and%20learning%20deficit%20in%20male%20rats:%20A%20behavioral,%20biochemical,%20and%20histological%20study.%20J%20Chem%20Neuroanat.%202022;125:102158." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Choi Y, Kim HS, Shin KY, Kim EM, Kim M, Kim HS, et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in alzheimer’s disease models. Neuropsychopharmacology. 2007;32:2393–404.
</cite> [<a href="https://doi.org/10.1038/sj.npp.1301377" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17406652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Choi%20Y,%20Kim%20HS,%20Shin%20KY,%20Kim%20EM,%20Kim%20M,%20Kim%20HS,%20et%20al.%20Minocycline%20attenuates%20neuronal%20cell%20death%20and%20improves%20cognitive%20impairment%20in%20alzheimer%E2%80%99s%20disease%20models.%20Neuropsychopharmacology.%202007;32:2393%E2%80%93404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Biscaro B, Lindvall O, Tesco G, Ekdahl CT, Nitsch RM. Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a Transgenic mouse model for alzheimer’s disease. Neurodegener Dis. 2012;9:187–98.
</cite> [<a href="https://doi.org/10.1159/000330363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7068786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22584394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Biscaro%20B,%20Lindvall%20O,%20Tesco%20G,%20Ekdahl%20CT,%20Nitsch%20RM.%20Inhibition%20of%20microglial%20activation%20protects%20hippocampal%20neurogenesis%20and%20improves%20cognitive%20deficits%20in%20a%20Transgenic%20mouse%20model%20for%20alzheimer%E2%80%99s%20disease.%20Neurodegener%20Dis.%202012;9:187%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Cai Z, Yan Y, Wang Y. Clinical interventions in aging Dovepress Minocycline alleviates beta-amyloid protein and Tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Clin Interv Aging. 2013;8:1089–95.
</cite> [<a href="https://doi.org/10.2147/CIA.S46536" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3749817/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23983461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cai%20Z,%20Yan%20Y,%20Wang%20Y.%20Clinical%20interventions%20in%20aging%20Dovepress%20Minocycline%20alleviates%20beta-amyloid%20protein%20and%20Tau%20pathology%20via%20restraining%20neuroinflammation%20induced%20by%20diabetic%20metabolic%20disorder.%20Clin%20Interv%20Aging.%202013;8:1089%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Gholami Mahmoudian Z, Ghanbari A, Rashidi I, Amiri I, Komaki A. Minocycline effects on memory and learning impairment in the beta-amyloid-induced alzheimer’s disease model in male rats using behavioral, biochemical, and histological methods. Eur J Pharmacol. 2023;953:175784.
</cite> [<a href="https://doi.org/10.1016/j.ejphar.2023.175784" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37179042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gholami%20Mahmoudian%20Z,%20Ghanbari%20A,%20Rashidi%20I,%20Amiri%20I,%20Komaki%20A.%20Minocycline%20effects%20on%20memory%20and%20learning%20impairment%20in%20the%20beta-amyloid-induced%20alzheimer%E2%80%99s%20disease%20model%20in%20male%20rats%20using%20behavioral,%20biochemical,%20and%20histological%20methods.%20Eur%20J%20Pharmacol.%202023;953:175784." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Howard R, Zubko O, Bradley R, Harper E, Pank L, O’Brien J, et al. Minocycline at 2 different dosages vs placebo for patients with mild alzheimer disease: A randomized clinical trial. JAMA Neurol. 2020;77:164–74.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2019.3762" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6865324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31738372/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Howard%20R,%20Zubko%20O,%20Bradley%20R,%20Harper%20E,%20Pank%20L,%20O%E2%80%99Brien%20J,%20et%20al.%20Minocycline%20at%202%20different%20dosages%20vs%20placebo%20for%20patients%20with%20mild%20alzheimer%20disease:%20A%20randomized%20clinical%20trial.%20JAMA%20Neurol.%202020;77:164%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Jha MK, Jeon S, Suk K. Glia as a link between neuroinflammation and neuropathic pain. Immune Netw. 2012;12:41–7.
</cite> [<a href="https://doi.org/10.4110/in.2012.12.2.41" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3382663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22740789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jha%20MK,%20Jeon%20S,%20Suk%20K.%20Glia%20as%20a%20link%20between%20neuroinflammation%20and%20neuropathic%20pain.%20Immune%20Netw.%202012;12:41%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Kobayashi M, Konishi H, Sayo A, Takai T, Kiyama H. TREM2/DAP12 signal elicits Proinflammatory response in microglia and exacerbates neuropathic pain. J Neurosci. 2016;36:11138–50.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.1238-16.2016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6705657/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27798193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kobayashi%20M,%20Konishi%20H,%20Sayo%20A,%20Takai%20T,%20Kiyama%20H.%20TREM2/DAP12%20signal%20elicits%20Proinflammatory%20response%20in%20microglia%20and%20exacerbates%20neuropathic%20pain.%20J%20Neurosci.%202016;36:11138%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Zhang L, Li N, Zhang H, Wang Y, Gao T, Zhao Y, et al. Artesunate therapy alleviates Fracture-Associated chronic pain after orthopedic surgery by suppressing CCL21-Dependent TREM2/DAP12 inflammatory signaling in mice. Front Pharmacol. 2022;13:894963.
</cite> [<a href="https://doi.org/10.3389/fphar.2022.894963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9202025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35721188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Li%20N,%20Zhang%20H,%20Wang%20Y,%20Gao%20T,%20Zhao%20Y,%20et%20al.%20Artesunate%20therapy%20alleviates%20Fracture-Associated%20chronic%20pain%20after%20orthopedic%20surgery%20by%20suppressing%20CCL21-Dependent%20TREM2/DAP12%20inflammatory%20signaling%20in%20mice.%20Front%20Pharmacol.%202022;13:894963." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Aishah C, Ismail N, Suppian R, Badariah C, Aziz A, Long I. Minocycline attenuates the development of diabetic neuropathy by modulating DREAM and BDNF protein expression in rat spinal cord. J Diabetes Metabolic Disorders. 2019;18:181–90.</cite> [<a href="https://doi.org/10.1007/s40200-019-00411-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6582076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31275889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aishah%20C,%20Ismail%20N,%20Suppian%20R,%20Badariah%20C,%20Aziz%20A,%20Long%20I.%20Minocycline%20attenuates%20the%20development%20of%20diabetic%20neuropathy%20by%20modulating%20DREAM%20and%20BDNF%20protein%20expression%20in%20rat%20spinal%20cord.%20J%20Diabetes%20Metabolic%20Disorders.%202019;18:181%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Sun JS, Yang YJ, Zhang YZ, Huang W, Li ZS, Zhang Y. Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol Med Rep. 2015;12:2677–82.
</cite> [<a href="https://doi.org/10.3892/mmr.2015.3735" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25955348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20JS,%20Yang%20YJ,%20Zhang%20YZ,%20Huang%20W,%20Li%20ZS,%20Zhang%20Y.%20Minocycline%20attenuates%20pain%20by%20inhibiting%20spinal%20microglia%20activation%20in%20diabetic%20rats.%20Mol%20Med%20Rep.%202015;12:2677%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Sałat K, Furgała-Wojas A, Sałat R. The microglial activation inhibitor minocycline, used alone and in combination with duloxetine, attenuates pain caused by oxaliplatin in mice. Molecules. 2021;26:3577.
</cite> [<a href="https://doi.org/10.3390/molecules26123577" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8230860/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34208184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sa%C5%82at%20K,%20Furga%C5%82a-Wojas%20A,%20Sa%C5%82at%20R.%20The%20microglial%20activation%20inhibitor%20minocycline,%20used%20alone%20and%20in%20combination%20with%20duloxetine,%20attenuates%20pain%20caused%20by%20oxaliplatin%20in%20mice.%20Molecules.%202021;26:3577." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Vezza T, Molina-Tijeras JA, González-Cano R, Rodríguez-Nogales A, García F, Gálvez J, et al. Minocycline prevents the development of key features of inflammation and pain in DSS-induced colitis in mice. J Pain. 2023;24:304–19.
</cite> [<a href="https://doi.org/10.1016/j.jpain.2022.09.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36183969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vezza%20T,%20Molina-Tijeras%20JA,%20Gonz%C3%A1lez-Cano%20R,%20Rodr%C3%ADguez-Nogales%20A,%20Garc%C3%ADa%20F,%20G%C3%A1lvez%20J,%20et%20al.%20Minocycline%20prevents%20the%20development%20of%20key%20features%20of%20inflammation%20and%20pain%20in%20DSS-induced%20colitis%20in%20mice.%20J%20Pain.%202023;24:304%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Cho IH, Lee MJ, Jang M, Gwak NG, Lee KY, Jung HS. Minocycline markedly reduces acute visceral nociception via inhibiting neuronal ERK phosphorylation. Mol Pain. 2012;8:13.
</cite> [<a href="https://doi.org/10.1186/1744-8069-8-13" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3342906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22364340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cho%20IH,%20Lee%20MJ,%20Jang%20M,%20Gwak%20NG,%20Lee%20KY,%20Jung%20HS.%20Minocycline%20markedly%20reduces%20acute%20visceral%20nociception%20via%20inhibiting%20neuronal%20ERK%20phosphorylation.%20Mol%20Pain.%202012;8:13." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Pachman DR, Dockter T, Zekan PJ, Fruth B, Ruddy KJ, Ta LE, et al. A pilot study of Minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I. Support Care Cancer. 2017;25:3407–16.
</cite> [<a href="https://doi.org/10.1007/s00520-017-3760-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28551844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pachman%20DR,%20Dockter%20T,%20Zekan%20PJ,%20Fruth%20B,%20Ruddy%20KJ,%20Ta%20LE,%20et%20al.%20A%20pilot%20study%20of%20Minocycline%20for%20the%20prevention%20of%20paclitaxel-associated%20neuropathy:%20ACCRU%20study%20RU221408I.%20Support%20Care%20Cancer.%202017;25:3407%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Moore RA, Derry S, Wiffen PJ, Straube S, Aldington DJ. Overview review: comparative efficacy of oral ibuprofen and Paracetamol (acetaminophen) across acute and chronic pain conditions. Eur J Pain. 2015;19:1213–23.
</cite> [<a href="https://doi.org/10.1002/ejp.649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25530283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moore%20RA,%20Derry%20S,%20Wiffen%20PJ,%20Straube%20S,%20Aldington%20DJ.%20Overview%20review:%20comparative%20efficacy%20of%20oral%20ibuprofen%20and%20Paracetamol%20(acetaminophen)%20across%20acute%20and%20chronic%20pain%20conditions.%20Eur%20J%20Pain.%202015;19:1213%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, et al. Ibuprofen reduces Aβ, hyperphosphorylated Tau and memory deficits in alzheimer mice. Brain Res. 2008;1207:225.
</cite> [<a href="https://doi.org/10.1016/j.brainres.2008.01.095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2587244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18374906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McKee%20AC,%20Carreras%20I,%20Hossain%20L,%20Ryu%20H,%20Klein%20WL,%20Oddo%20S,%20et%20al.%20Ibuprofen%20reduces%20A%CE%B2,%20hyperphosphorylated%20Tau%20and%20memory%20deficits%20in%20alzheimer%20mice.%20Brain%20Res.%202008;1207:225." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for alzheimer’s disease. J Neurosci. 2000;20:5709.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.20-15-05709.2000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6772529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10908610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20GP,%20Yang%20F,%20Chu%20T,%20Chen%20P,%20Beech%20W,%20Teter%20B,%20et%20al.%20Ibuprofen%20suppresses%20plaque%20pathology%20and%20inflammation%20in%20a%20mouse%20model%20for%20alzheimer%E2%80%99s%20disease.%20J%20Neurosci.%202000;20:5709." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Brownell AL, Jokivarsi K, Dedeoglu A. Ibuprofen reduces inflammatory response in alzheimer mice. J Nucl Med. 2012;53:415–415.22323782
</cite> [<a href="https://scholar.google.com/scholar_lookup?Brownell%20AL,%20Jokivarsi%20K,%20Dedeoglu%20A.%20Ibuprofen%20reduces%20inflammatory%20response%20in%20alzheimer%20mice.%20J%20Nucl%20Med.%202012;53:415%E2%80%93415.22323782" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>Van Dam D, Coen K, De Deyn PP. Ibuprofen modifies cognitive disease progression in an alzheimer’s mouse model. Psychopharm. 2008;24:383–8.</cite> [<a href="https://doi.org/10.1177/0269881108097630" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18957478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Van%20Dam%20D,%20Coen%20K,%20De%20Deyn%20PP.%20Ibuprofen%20modifies%20cognitive%20disease%20progression%20in%20an%20alzheimer%E2%80%99s%20mouse%20model.%20Psychopharm.%202008;24:383%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>’t Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer’s Disease, et al. editors. New England Journal of Medicine. 2001;345:1515–21.</cite> [<a href="https://doi.org/10.1056/NEJMoa010178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11794217/" class="usa-link">PubMed</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Breitner JCS, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, et al. Delayed onset of alzheimer’s disease with nonsteroidal anti-inflammatory and Histamine H2 blocking drugs. Neurobiol Aging. 1995;16:523–30.
</cite> [<a href="https://doi.org/10.1016/0197-4580(95)00049-k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8544901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Breitner%20JCS,%20Welsh%20KA,%20Helms%20MJ,%20Gaskell%20PC,%20Gau%20BA,%20Roses%20AD,%20et%20al.%20Delayed%20onset%20of%20alzheimer%E2%80%99s%20disease%20with%20nonsteroidal%20anti-inflammatory%20and%20Histamine%20H2%20blocking%20drugs.%20Neurobiol%20Aging.%201995;16:523%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Zhang C, Wang Y, Wang D, Zhang J, Zhang F. NSAID exposure and risk of alzheimer’s disease: an updated meta-analysis from cohort studies. Front Aging Neurosci. 2018;10:83.
</cite> [<a href="https://doi.org/10.3389/fnagi.2018.00083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5882872/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29643804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20C,%20Wang%20Y,%20Wang%20D,%20Zhang%20J,%20Zhang%20F.%20NSAID%20exposure%20and%20risk%20of%20alzheimer%E2%80%99s%20disease:%20an%20updated%20meta-analysis%20from%20cohort%20studies.%20Front%20Aging%20Neurosci.%202018;10:83." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>Vlad SC, Miller DR, Kowall NW, Felson DT. Protective effects of NSAIDs on the development of alzheimer disease. Neurology. 2008;70:1672–7.
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000311269.57716.63" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2758242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18458226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vlad%20SC,%20Miller%20DR,%20Kowall%20NW,%20Felson%20DT.%20Protective%20effects%20of%20NSAIDs%20on%20the%20development%20of%20alzheimer%20disease.%20Neurology.%202008;70:1672%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Hayden K, Zandi P, Khachaturian A, Szekely C, Fotuhi M, Norton M, et al. Does NSAID use modify cognitive trajectories in the elderly? Cache Cty Study. 2007;69:275–82.</cite> [<a href="https://doi.org/10.1212/01.wnl.0000265223.25679.2a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17636065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hayden%20K,%20Zandi%20P,%20Khachaturian%20A,%20Szekely%20C,%20Fotuhi%20M,%20Norton%20M,%20et%20al.%20Does%20NSAID%20use%20modify%20cognitive%20trajectories%20in%20the%20elderly?%20Cache%20Cty%20Study.%202007;69:275%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>Breitner JCS, Haneuse SJPA, Walker R, Dublin S, Crane PK, Gray SL, et al. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology. 2009;72:1899–905.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e3181a18691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2690966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19386997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Breitner%20JCS,%20Haneuse%20SJPA,%20Walker%20R,%20Dublin%20S,%20Crane%20PK,%20Gray%20SL,%20et%20al.%20Risk%20of%20dementia%20and%20AD%20with%20prior%20exposure%20to%20NSAIDs%20in%20an%20elderly%20community-based%20cohort.%20Neurology.%202009;72:1899%E2%80%93905." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Sastre M, Gentleman SM, NSAIDs. How they work and their prospects as therapeutics in alzheimer’s disease. Front Aging Neurosci. 2010;2:1555.</cite> [<a href="https://doi.org/10.3389/fnagi.2010.00020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2893374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20589102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sastre%20M,%20Gentleman%20SM,%20NSAIDs.%20How%20they%20work%20and%20their%20prospects%20as%20therapeutics%20in%20alzheimer%E2%80%99s%20disease.%20Front%20Aging%20Neurosci.%202010;2:1555." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Yuan S, Ling Y, Huang X, Tan S, Li W, Xu A, et al. Associations between the use of common nonsteroidal anti-inflammatory drugs, genetic susceptibility and dementia in participants with chronic pain: A prospective study based on 194,758 participants from the UK biobank. J Psychiatr Res. 2024;169:152–9.
</cite> [<a href="https://doi.org/10.1016/j.jpsychires.2023.11.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38039689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan%20S,%20Ling%20Y,%20Huang%20X,%20Tan%20S,%20Li%20W,%20Xu%20A,%20et%20al.%20Associations%20between%20the%20use%20of%20common%20nonsteroidal%20anti-inflammatory%20drugs,%20genetic%20susceptibility%20and%20dementia%20in%20participants%20with%20chronic%20pain:%20A%20prospective%20study%20based%20on%20194,758%20participants%20from%20the%20UK%20biobank.%20J%20Psychiatr%20Res.%202024;169:152%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR155">
<span class="label">155.</span><cite>Zhang Y, Zhou C, Yang S, Zhang Y, Ye Z, He P, et al. Association of regular use of ibuprofen and paracetamol, genetic susceptibility, and new-onset dementia in the older population. Gen Hosp Psychiatry. 2023;84:226–33.
</cite> [<a href="https://doi.org/10.1016/j.genhosppsych.2023.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37633120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Zhou%20C,%20Yang%20S,%20Zhang%20Y,%20Ye%20Z,%20He%20P,%20et%20al.%20Association%20of%20regular%20use%20of%20ibuprofen%20and%20paracetamol,%20genetic%20susceptibility,%20and%20new-onset%20dementia%20in%20the%20older%20population.%20Gen%20Hosp%20Psychiatry.%202023;84:226%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Guan YH, Zhang LJ, Wang SY, Deng YD, Zhou HS, Chen DQ, et al. The role of microglia in alzheimer’s disease and progress of treatment. Ibrain. 2022;8:37–47.
</cite> [<a href="https://doi.org/10.1002/ibra.12023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10529349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37786418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guan%20YH,%20Zhang%20LJ,%20Wang%20SY,%20Deng%20YD,%20Zhou%20HS,%20Chen%20DQ,%20et%20al.%20The%20role%20of%20microglia%20in%20alzheimer%E2%80%99s%20disease%20and%20progress%20of%20treatment.%20Ibrain.%202022;8:37%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Yin J, Valin KL, Dixon ML, Leavenworth JW. The role of microglia and macrophages in CNS homeostasis, autoimmunity, and Cancer. J Immunol Res. 2017;2017:5150678.
</cite> [<a href="https://doi.org/10.1155/2017/5150678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5749282/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29410971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20J,%20Valin%20KL,%20Dixon%20ML,%20Leavenworth%20JW.%20The%20role%20of%20microglia%20and%20macrophages%20in%20CNS%20homeostasis,%20autoimmunity,%20and%20Cancer.%20J%20Immunol%20Res.%202017;2017:5150678." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Bemiller SM, McCray TJ, Allan K, Formica SV, Xu G, Wilson G, et al. TREM2 deficiency exacerbates Tau pathology through dysregulated kinase signaling in a mouse model of Tauopathy. Mol Neurodegener. 2017;12:1–12.
</cite> [<a href="https://doi.org/10.1186/s13024-017-0216-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5644120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29037207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bemiller%20SM,%20McCray%20TJ,%20Allan%20K,%20Formica%20SV,%20Xu%20G,%20Wilson%20G,%20et%20al.%20TREM2%20deficiency%20exacerbates%20Tau%20pathology%20through%20dysregulated%20kinase%20signaling%20in%20a%20mouse%20model%20of%20Tauopathy.%20Mol%20Neurodegener.%202017;12:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, et al. TREM2 function impedes Tau seeding in neuritic plaques. Nat Neurosci. 2019;22:1217–22.
</cite> [<a href="https://doi.org/10.1038/s41593-019-0433-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6660358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31235932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leyns%20CEG,%20Gratuze%20M,%20Narasimhan%20S,%20Jain%20N,%20Koscal%20LJ,%20Jiang%20H,%20et%20al.%20TREM2%20function%20impedes%20Tau%20seeding%20in%20neuritic%20plaques.%20Nat%20Neurosci.%202019;22:1217%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566–81.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2017.08.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5719893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28930663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Krasemann%20S,%20Madore%20C,%20Cialic%20R,%20Baufeld%20C,%20Calcagno%20N,%20El%20Fatimy%20R,%20et%20al.%20The%20TREM2-APOE%20pathway%20drives%20the%20transcriptional%20phenotype%20of%20dysfunctional%20microglia%20in%20neurodegenerative%20diseases.%20Immunity.%202017;47:566%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Andrade P, Visser-Vandewalle V, Hoffmann C, Steinbusch HWM, Daemen MA, Hoogland G. Role of TNF-alpha during central sensitization in preclinical studies. Neurol Sci. 2011;32:757–71.
</cite> [<a href="https://doi.org/10.1007/s10072-011-0599-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3171667/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21559854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andrade%20P,%20Visser-Vandewalle%20V,%20Hoffmann%20C,%20Steinbusch%20HWM,%20Daemen%20MA,%20Hoogland%20G.%20Role%20of%20TNF-alpha%20during%20central%20sensitization%20in%20preclinical%20studies.%20Neurol%20Sci.%202011;32:757%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR162">
<span class="label">162.</span><cite>Leung L, Cahill CM. TNF-α and neuropathic pain - a review. J Neuroinflammation. 2010;7:27.
</cite> [<a href="https://doi.org/10.1186/1742-2094-7-27" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2861665/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20398373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leung%20L,%20Cahill%20CM.%20TNF-%CE%B1%20and%20neuropathic%20pain%20-%20a%20review.%20J%20Neuroinflammation.%202010;7:27." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR163">
<span class="label">163.</span><cite>Maguire AD, Bethea JR, Kerr BJ. TNFα in MS and its animal models: implications for chronic pain in the disease. Front Neurol. 2021;12:780876.
</cite> [<a href="https://doi.org/10.3389/fneur.2021.780876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8686517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34938263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maguire%20AD,%20Bethea%20JR,%20Kerr%20BJ.%20TNF%CE%B1%20in%20MS%20and%20its%20animal%20models:%20implications%20for%20chronic%20pain%20in%20the%20disease.%20Front%20Neurol.%202021;12:780876." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR164">
<span class="label">164.</span><cite>Ribeiro CM, Oliveira SR, Alfieri DF, Flauzino T, Kaimen-Maciel DR, Simão ANC, et al. Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis. Inflamm Res. 2019;68:1049–59.
</cite> [<a href="https://doi.org/10.1007/s00011-019-01286-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31559449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ribeiro%20CM,%20Oliveira%20SR,%20Alfieri%20DF,%20Flauzino%20T,%20Kaimen-Maciel%20DR,%20Sim%C3%A3o%20ANC,%20et%20al.%20Tumor%20necrosis%20factor%20alpha%20(TNF-%CE%B1)%20and%20its%20soluble%20receptors%20are%20associated%20with%20disability,%20disability%20progression%20and%20clinical%20forms%20of%20multiple%20sclerosis.%20Inflamm%20Res.%202019;68:1049%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR165">
<span class="label">165.</span><cite>Marchand F, Tsantoulas C, Singh D, Grist J, Clark AK, Bradbury EJ, et al. Effects of etanercept and Minocycline in a rat model of spinal cord injury. Eur J Pain. 2009;13:673–81.
</cite> [<a href="https://doi.org/10.1016/j.ejpain.2008.08.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18849175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marchand%20F,%20Tsantoulas%20C,%20Singh%20D,%20Grist%20J,%20Clark%20AK,%20Bradbury%20EJ,%20et%20al.%20Effects%20of%20etanercept%20and%20Minocycline%20in%20a%20rat%20model%20of%20spinal%20cord%20injury.%20Eur%20J%20Pain.%202009;13:673%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR166">
<span class="label">166.</span><cite>Schwid SR, Noseworthy JH. Targeting immunotherapy in multiple sclerosis: A near hit and a clear miss. Neurology. 1999;53:444–5.
</cite> [<a href="https://doi.org/10.1212/wnl.53.3.444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10449101/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schwid%20SR,%20Noseworthy%20JH.%20Targeting%20immunotherapy%20in%20multiple%20sclerosis:%20A%20near%20hit%20and%20a%20clear%20miss.%20Neurology.%201999;53:444%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR167">
<span class="label">167.</span><cite>Del Rivero T, Fischer R, Yang F, Swanson KA, Bethea JR. Tumor necrosis factor receptor 1 Inhibition is therapeutic for neuropathic pain in males but not in females. Pain. 2019;160:922–31.
</cite> [<a href="https://doi.org/10.1097/j.pain.0000000000001470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30586024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Del%20Rivero%20T,%20Fischer%20R,%20Yang%20F,%20Swanson%20KA,%20Bethea%20JR.%20Tumor%20necrosis%20factor%20receptor%201%20Inhibition%20is%20therapeutic%20for%20neuropathic%20pain%20in%20males%20but%20not%20in%20females.%20Pain.%202019;160:922%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR168">
<span class="label">168.</span><cite>Ortí-Casañ N, Wu Y, Naudé PJW, De Deyn PP, Zuhorn IS, Eisel ULM. Targeting TNFR2 as a novel therapeutic strategy for alzheimer’s disease. Front Neurosci. 2019;13:49.
</cite> [<a href="https://doi.org/10.3389/fnins.2019.00049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6369349/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30778285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ort%C3%AD-Casa%C3%B1%20N,%20Wu%20Y,%20Naud%C3%A9%20PJW,%20De%20Deyn%20PP,%20Zuhorn%20IS,%20Eisel%20ULM.%20Targeting%20TNFR2%20as%20a%20novel%20therapeutic%20strategy%20for%20alzheimer%E2%80%99s%20disease.%20Front%20Neurosci.%202019;13:49." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR169">
<span class="label">169.</span><cite>Bain CR, Myles PS, Corcoran T, Dieleman JM. Postoperative systemic inflammatory dysregulation and corticosteroids: a narrative review. Anaesthesia. 2023;78:356–70.
</cite> [<a href="https://doi.org/10.1111/anae.15896" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10092416/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36308338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bain%20CR,%20Myles%20PS,%20Corcoran%20T,%20Dieleman%20JM.%20Postoperative%20systemic%20inflammatory%20dysregulation%20and%20corticosteroids:%20a%20narrative%20review.%20Anaesthesia.%202023;78:356%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR170">
<span class="label">170.</span><cite>Toft P, Tønnesen E. The systemic inflammatory response to anaesthesia and surgery. Curr Anaesth Crit Care. 2008;19:349–53.</cite> [<a href="https://scholar.google.com/scholar_lookup?Toft%20P,%20T%C3%B8nnesen%20E.%20The%20systemic%20inflammatory%20response%20to%20anaesthesia%20and%20surgery.%20Curr%20Anaesth%20Crit%20Care.%202008;19:349%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR171">
<span class="label">171.</span><cite>Alhayyan A, McSorley S, Roxburgh C, Kearns R, Horgan P, McMillan D. The effect of anesthesia on the postoperative systemic inflammatory response in patients undergoing surgery: A systematic review and meta-analysis. Surg Open Sci. 2020;2:1–21.
</cite> [<a href="https://doi.org/10.1016/j.sopen.2019.06.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7391900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32754703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alhayyan%20A,%20McSorley%20S,%20Roxburgh%20C,%20Kearns%20R,%20Horgan%20P,%20McMillan%20D.%20The%20effect%20of%20anesthesia%20on%20the%20postoperative%20systemic%20inflammatory%20response%20in%20patients%20undergoing%20surgery:%20A%20systematic%20review%20and%20meta-analysis.%20Surg%20Open%20Sci.%202020;2:1%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR172">
<span class="label">172.</span><cite>Fletcher D, Stamer UM, Pogatzki-Zahn E, Zaslansky R, Tanase NV, Perruchoud C, et al. Chronic postsurgical pain in europe: an observational study. Eur J Anaesthesiol. 2015;32:725–34.
</cite> [<a href="https://doi.org/10.1097/EJA.0000000000000319" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26241763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fletcher%20D,%20Stamer%20UM,%20Pogatzki-Zahn%20E,%20Zaslansky%20R,%20Tanase%20NV,%20Perruchoud%20C,%20et%20al.%20Chronic%20postsurgical%20pain%20in%20europe:%20an%20observational%20study.%20Eur%20J%20Anaesthesiol.%202015;32:725%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR173">
<span class="label">173.</span><cite>Voscopoulos C, Lema M. When does acute pain become chronic? Br J Anaesth. 2010;105:69–85.
</cite> [<a href="https://doi.org/10.1093/bja/aeq323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21148657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Voscopoulos%20C,%20Lema%20M.%20When%20does%20acute%20pain%20become%20chronic?%20Br%20J%20Anaesth.%202010;105:69%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR174">
<span class="label">174.</span><cite>Lee TA, Wolozin B, Weiss KB, Bednar MM. Assessment of the emergence of alzheimer’s disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimer’s Disease. 2016;7:319–24.</cite> [<a href="https://doi.org/10.3233/jad-2005-7408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16131734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20TA,%20Wolozin%20B,%20Weiss%20KB,%20Bednar%20MM.%20Assessment%20of%20the%20emergence%20of%20alzheimer%E2%80%99s%20disease%20following%20coronary%20artery%20bypass%20graft%20surgery%20or%20percutaneous%20transluminal%20coronary%20angioplasty.%20J%20Alzheimer%E2%80%99s%20Disease.%202016;7:319%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR175">
<span class="label">175.</span><cite>Vanderweyde T, Bednar MM, Forman SA, Wolozin B. Iatrogenic risk factors for alzheimer’s disease: surgery and anesthesia. J Alzheimers Dis. 2010;22(Suppl 3):91–104.
</cite> [<a href="https://doi.org/10.3233/JAD-2010-100843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3108154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20858967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vanderweyde%20T,%20Bednar%20MM,%20Forman%20SA,%20Wolozin%20B.%20Iatrogenic%20risk%20factors%20for%20alzheimer%E2%80%99s%20disease:%20surgery%20and%20anesthesia.%20J%20Alzheimers%20Dis.%202010;22(Suppl%203):91%E2%80%93104." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR176">
<span class="label">176.</span><cite>Xu Z, Dong Y, Wang H, Culley DJ, Marcantonio ER, Crosby G, et al. Age-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice. Sci Rep. 2014;4:1–10.</cite> [<a href="https://doi.org/10.1038/srep03766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3895908/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24441878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20Z,%20Dong%20Y,%20Wang%20H,%20Culley%20DJ,%20Marcantonio%20ER,%20Crosby%20G,%20et%20al.%20Age-dependent%20postoperative%20cognitive%20impairment%20and%20Alzheimer-related%20neuropathology%20in%20mice.%20Sci%20Rep.%202014;4:1%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR177">
<span class="label">177.</span><cite>Wan Y, Xu J, Ma D, Zeng Y, Cibelli M, Maze M. Postoperative impairment of cognitive function in RatsA possible role for Cytokine-mediated inflammation in the Hippocampus. Anesthesiology. 2007;106:436–43.
</cite> [<a href="https://doi.org/10.1097/00000542-200703000-00007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17325501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wan%20Y,%20Xu%20J,%20Ma%20D,%20Zeng%20Y,%20Cibelli%20M,%20Maze%20M.%20Postoperative%20impairment%20of%20cognitive%20function%20in%20RatsA%20possible%20role%20for%20Cytokine-mediated%20inflammation%20in%20the%20Hippocampus.%20Anesthesiology.%202007;106:436%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR178">
<span class="label">178.</span><cite>Yang Y, Wang B, Jiang Y, Fu W. Tanshinone IIA mitigates postoperative cognitive dysfunction in aged rats by inhibiting hippocampal inflammation and ferroptosis: role of Nrf2/SLC7A11/GPX4 axis activation. Neurotoxicology. 2025;107:62–73.
</cite> [<a href="https://doi.org/10.1016/j.neuro.2025.02.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39965709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20Y,%20Wang%20B,%20Jiang%20Y,%20Fu%20W.%20Tanshinone%20IIA%20mitigates%20postoperative%20cognitive%20dysfunction%20in%20aged%20rats%20by%20inhibiting%20hippocampal%20inflammation%20and%20ferroptosis:%20role%20of%20Nrf2/SLC7A11/GPX4%20axis%20activation.%20Neurotoxicology.%202025;107:62%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR179">
<span class="label">179.</span><cite>Cunningham C, Campion S, Lunnon K, Murray CL, Woods JFC, Deacon RMJ, et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry. 2009;65:304–12.
</cite> [<a href="https://doi.org/10.1016/j.biopsych.2008.07.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2633437/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18801476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cunningham%20C,%20Campion%20S,%20Lunnon%20K,%20Murray%20CL,%20Woods%20JFC,%20Deacon%20RMJ,%20et%20al.%20Systemic%20inflammation%20induces%20acute%20behavioral%20and%20cognitive%20changes%20and%20accelerates%20neurodegenerative%20disease.%20Biol%20Psychiatry.%202009;65:304%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR180">
<span class="label">180.</span><cite>Terrando N, Monaco C, Ma D, Foxwell BMJ, Feldmannc M, Maze M. Tumor necrosis factor-a triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A. 2010;107:20518–22.
</cite> [<a href="https://doi.org/10.1073/pnas.1014557107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2996666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21041647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Terrando%20N,%20Monaco%20C,%20Ma%20D,%20Foxwell%20BMJ,%20Feldmannc%20M,%20Maze%20M.%20Tumor%20necrosis%20factor-a%20triggers%20a%20cytokine%20cascade%20yielding%20postoperative%20cognitive%20decline.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202010;107:20518%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR181">
<span class="label">181.</span><cite>Feinstein I, Wilson EN, Swarovski MS, Andreasson KI, Angst MS, Greicius MD. Plasma biomarkers of Tau and neurodegeneration during major cardiac and noncardiac surgery. JAMA Neurol. 2021;78:1407–9.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2021.2823" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8453356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34542578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feinstein%20I,%20Wilson%20EN,%20Swarovski%20MS,%20Andreasson%20KI,%20Angst%20MS,%20Greicius%20MD.%20Plasma%20biomarkers%20of%20Tau%20and%20neurodegeneration%20during%20major%20cardiac%20and%20noncardiac%20surgery.%20JAMA%20Neurol.%202021;78:1407%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR182">
<span class="label">182.</span><cite>Tissot C, Benedet L, Therriault A, Pascoal J, Lussier TA, Saha-Chaudhuri FZ. Plasma pTau181 predicts cortical brain atrophy in aging and alzheimer’s disease. Alzheimers Res Ther. 2021;13:1–11.
</cite> [<a href="https://doi.org/10.1186/s13195-021-00802-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8008680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33781319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tissot%20C,%20Benedet%20L,%20Therriault%20A,%20Pascoal%20J,%20Lussier%20TA,%20Saha-Chaudhuri%20FZ.%20Plasma%20pTau181%20predicts%20cortical%20brain%20atrophy%20in%20aging%20and%20alzheimer%E2%80%99s%20disease.%20Alzheimers%20Res%20Ther.%202021;13:1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR183">
<span class="label">183.</span><cite>Meng J, Lei P. Plasma pTau181 as a biomarker for alzheimer’s disease. MedComm (Beijing). 2020;1:74–6.</cite> [<a href="https://doi.org/10.1002/mco2.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8489665/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34766110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meng%20J,%20Lei%20P.%20Plasma%20pTau181%20as%20a%20biomarker%20for%20alzheimer%E2%80%99s%20disease.%20MedComm%20(Beijing).%202020;1:74%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR184">
<span class="label">184.</span><cite>Sugita S, Tahir P, Kinjo S. The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction—A systematic review. PLoS ONE. 2023;18:e0281049.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0281049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9904456/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36749772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sugita%20S,%20Tahir%20P,%20Kinjo%20S.%20The%20effects%20of%20microbiome-targeted%20therapy%20on%20cognitive%20impairment%20and%20postoperative%20cognitive%20dysfunction%E2%80%94A%20systematic%20review.%20PLoS%20ONE.%202023;18:e0281049." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR185">
<span class="label">185.</span><cite>Subramaniyan S, Terrando N. Neuroinflammation and perioperative neurocognitive disorders. Anesth Analg. 2019;128:781–8.
</cite> [<a href="https://doi.org/10.1213/ANE.0000000000004053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6437083/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30883423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Subramaniyan%20S,%20Terrando%20N.%20Neuroinflammation%20and%20perioperative%20neurocognitive%20disorders.%20Anesth%20Analg.%202019;128:781%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR186">
<span class="label">186.</span><cite>Wen J, Ding Y, Wang L, Xiao Y. Gut Microbiome improves postoperative cognitive function by decreasing permeability of the blood-brain barrier in aged mice. Brain Res Bull. 2020;164:249–56.
</cite> [<a href="https://doi.org/10.1016/j.brainresbull.2020.08.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32896587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wen%20J,%20Ding%20Y,%20Wang%20L,%20Xiao%20Y.%20Gut%20Microbiome%20improves%20postoperative%20cognitive%20function%20by%20decreasing%20permeability%20of%20the%20blood-brain%20barrier%20in%20aged%20mice.%20Brain%20Res%20Bull.%202020;164:249%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR187">
<span class="label">187.</span><cite>Jiang XL, Gu XY, Zhou XX, Chen XM, Zhang X, Yang YT, et al. Intestinal dysbacteriosis mediates the reference memory deficit induced by anaesthesia/surgery in aged mice. Brain Behav Immun. 2019;80:605–15.
</cite> [<a href="https://doi.org/10.1016/j.bbi.2019.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31063849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20XL,%20Gu%20XY,%20Zhou%20XX,%20Chen%20XM,%20Zhang%20X,%20Yang%20YT,%20et%20al.%20Intestinal%20dysbacteriosis%20mediates%20the%20reference%20memory%20deficit%20induced%20by%20anaesthesia/surgery%20in%20aged%20mice.%20Brain%20Behav%20Immun.%202019;80:605%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR188">
<span class="label">188.</span><cite>Yang XD, Wang LK, Wu HY, Jiao L. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis. BMC Anesthesiol. 2018;18:1–11.
</cite> [<a href="https://doi.org/10.1186/s12871-018-0642-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6267821/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30497394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20XD,%20Wang%20LK,%20Wu%20HY,%20Jiao%20L.%20Effects%20of%20prebiotic%20galacto-oligosaccharide%20on%20postoperative%20cognitive%20dysfunction%20and%20neuroinflammation%20through%20targeting%20of%20the%20gut-brain%20axis.%20BMC%20Anesthesiol.%202018;18:1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR189">
<span class="label">189.</span><cite>Chen D, Yang X, Yang J, Lai G, Yong T, Tang X, et al. Prebiotic effect of fructooligosaccharides from Morinda officinalis on alzheimer’s disease in rodent models by targeting the microbiota-gut-brain axis. Front Aging Neurosci. 2017;9:403.
</cite> [<a href="https://doi.org/10.3389/fnagi.2017.00403" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5727096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29276488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20D,%20Yang%20X,%20Yang%20J,%20Lai%20G,%20Yong%20T,%20Tang%20X,%20et%20al.%20Prebiotic%20effect%20of%20fructooligosaccharides%20from%20Morinda%20officinalis%20on%20alzheimer%E2%80%99s%20disease%20in%20rodent%20models%20by%20targeting%20the%20microbiota-gut-brain%20axis.%20Front%20Aging%20Neurosci.%202017;9:403." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR190">
<span class="label">190.</span><cite>Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C, et al. Microbiota modulation counteracts alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep. 2017;7:2426.
</cite> [<a href="https://doi.org/10.1038/s41598-017-02587-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5445077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28546539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bonfili%20L,%20Cecarini%20V,%20Berardi%20S,%20Scarpona%20S,%20Suchodolski%20JS,%20Nasuti%20C,%20et%20al.%20Microbiota%20modulation%20counteracts%20alzheimer%E2%80%99s%20disease%20progression%20influencing%20neuronal%20proteolysis%20and%20gut%20hormones%20plasma%20levels.%20Sci%20Rep.%202017;7:2426." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR191">
<span class="label">191.</span><cite>Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit alzheimer’s disease progression. Cell Res. 2019;29:787–803.
</cite> [<a href="https://doi.org/10.1038/s41422-019-0216-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6796854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31488882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Sun%20G,%20Feng%20T,%20Zhang%20J,%20Huang%20X,%20Wang%20T,%20et%20al.%20Sodium%20oligomannate%20therapeutically%20remodels%20gut%20microbiota%20and%20suppresses%20gut%20bacterial%20amino%20acids-shaped%20neuroinflammation%20to%20inhibit%20alzheimer%E2%80%99s%20disease%20progression.%20Cell%20Res.%202019;29:787%E2%80%93803." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR192">
<span class="label">192.</span><cite>Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, et al. Role of Interleukin-1β in postoperative cognitive dysfunction. Ann Neurol. 2010;68:360–8.
</cite> [<a href="https://doi.org/10.1002/ana.22082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4836445/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20818791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cibelli%20M,%20Fidalgo%20AR,%20Terrando%20N,%20Ma%20D,%20Monaco%20C,%20Feldmann%20M,%20et%20al.%20Role%20of%20Interleukin-1%CE%B2%20in%20postoperative%20cognitive%20dysfunction.%20Ann%20Neurol.%202010;68:360%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR193">
<span class="label">193.</span><cite>Wang P, Yin X, Chen G, Li L, Le Y, Xie Z, et al. Perioperative probiotic treatment decreased the incidence of postoperative cognitive impairment in elderly patients following non-cardiac surgery: A randomised double-blind and placebo-controlled trial. Clin Nutr. 2021;40:64–71.
</cite> [<a href="https://doi.org/10.1016/j.clnu.2020.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32451125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20P,%20Yin%20X,%20Chen%20G,%20Li%20L,%20Le%20Y,%20Xie%20Z,%20et%20al.%20Perioperative%20probiotic%20treatment%20decreased%20the%20incidence%20of%20postoperative%20cognitive%20impairment%20in%20elderly%20patients%20following%20non-cardiac%20surgery:%20A%20randomised%20double-blind%20and%20placebo-controlled%20trial.%20Clin%20Nutr.%202021;40:64%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR194">
<span class="label">194.</span><cite>Takazawa T, Horiuchi T, Orihara M, Nagumo K, Tomioka A, Ideno Y, et al. Prevention of postoperative cognitive dysfunction by Minocycline in elderly patients after total knee arthroplasty: A randomized, Double-blind, Placebo-controlled clinical trial. Anesthesiology. 2023;138:172–83.
</cite> [<a href="https://doi.org/10.1097/ALN.0000000000004439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36538374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Takazawa%20T,%20Horiuchi%20T,%20Orihara%20M,%20Nagumo%20K,%20Tomioka%20A,%20Ideno%20Y,%20et%20al.%20Prevention%20of%20postoperative%20cognitive%20dysfunction%20by%20Minocycline%20in%20elderly%20patients%20after%20total%20knee%20arthroplasty:%20A%20randomized,%20Double-blind,%20Placebo-controlled%20clinical%20trial.%20Anesthesiology.%202023;138:172%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR195">
<span class="label">195.</span><cite>Lim C, Hammond CJ, Hingley ST, Balin BJ. Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in alzheimer’s disease. J Neuroinflammation. 2014;11:1–11.
</cite> [<a href="https://doi.org/10.1186/s12974-014-0217-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4295513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25540075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20C,%20Hammond%20CJ,%20Hingley%20ST,%20Balin%20BJ.%20Chlamydia%20pneumoniae%20infection%20of%20monocytes%20in%20vitro%20stimulates%20innate%20and%20adaptive%20immune%20responses%20relevant%20to%20those%20in%20alzheimer%E2%80%99s%20disease.%20J%20Neuroinflammation.%202014;11:1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR196">
<span class="label">196.</span><cite>Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S, et al. Virus exposure and neurodegenerative disease risk across National biobanks. Neuron. 2023;111:1086–93.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2022.12.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10079561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36669485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Levine%20KS,%20Leonard%20HL,%20Blauwendraat%20C,%20Iwaki%20H,%20Johnson%20N,%20Bandres-Ciga%20S,%20et%20al.%20Virus%20exposure%20and%20neurodegenerative%20disease%20risk%20across%20National%20biobanks.%20Neuron.%202023;111:1086%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR197">
<span class="label">197.</span><cite>Panza F, Lozupone M, Solfrizzi V, Watling M, Imbimbo BP. Time to test antibacterial therapy in alzheimer’s disease. Brain. 2019;142:2905–29.
</cite> [<a href="https://doi.org/10.1093/brain/awz244" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31532495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Panza%20F,%20Lozupone%20M,%20Solfrizzi%20V,%20Watling%20M,%20Imbimbo%20BP.%20Time%20to%20test%20antibacterial%20therapy%20in%20alzheimer%E2%80%99s%20disease.%20Brain.%202019;142:2905%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR198">
<span class="label">198.</span><cite>Vigasova D, Nemergut M, Liskova B, Damborsky J. Multi-pathogen infections and alzheimer’s disease. Microb Cell Fact. 2021;20:1–13.
</cite> [<a href="https://doi.org/10.1186/s12934-021-01520-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7844946/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33509204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vigasova%20D,%20Nemergut%20M,%20Liskova%20B,%20Damborsky%20J.%20Multi-pathogen%20infections%20and%20alzheimer%E2%80%99s%20disease.%20Microb%20Cell%20Fact.%202021;20:1%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR199">
<span class="label">199.</span><cite>Watson AMM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, et al. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med. 2013;43(5):1023–31.
</cite> [<a href="https://doi.org/10.1017/S003329171200195X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22975221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Watson%20AMM,%20Prasad%20KM,%20Klei%20L,%20Wood%20JA,%20Yolken%20RH,%20Gur%20RC,%20et%20al.%20Persistent%20infection%20with%20neurotropic%20herpes%20viruses%20and%20cognitive%20impairment.%20Psychol%20Med.%202013;43(5):1023%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR200">
<span class="label">200.</span><cite>Tzeng NS, Chung CH, Lin FH, Chiang CP, Yeh C, Bin, Huang SY et al. Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. Neurotherapeutics [Internet]. 2018 Apr 1 [cited 2023 Aug 15];15(2):417–29. Available from: <a href="https://pubmed.ncbi.nlm.nih.gov/29488144/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/29488144/</a></cite> [<a href="https://doi.org/10.1007/s13311-018-0611-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5935641/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29488144/" class="usa-link">PubMed</a>]</li>
<li id="CR201">
<span class="label">201.</span><cite>Itzhaki Ruth F, Lin Woan-Ru S, Dazhuang, Wilcock Gordon K. Faragher brian, Jamieson Gordon A. Herpes simplex virus type 1 in brain and risk of alzheimer’s disease. Lancet. 1997;349:241–4.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(96)10149-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9014911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itzhaki%20Ruth%20F,%20Lin%20Woan-Ru%20S,%20Dazhuang,%20Wilcock%20Gordon%20K.%20Faragher%20brian,%20Jamieson%20Gordon%20A.%20Herpes%20simplex%20virus%20type%201%20in%20brain%20and%20risk%20of%20alzheimer%E2%80%99s%20disease.%20Lancet.%201997;349:241%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR202">
<span class="label">202.</span><cite>Linard M, Letenneur L, Garrigue I, Doize A, Dartigues JF, Helmer C. Interaction between APOE4 and herpes simplex virus type 1 in alzheimer’s disease. Alzheimer’s Dement. 2020;16:200–8.
</cite> [<a href="https://doi.org/10.1002/alz.12008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31914220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Linard%20M,%20Letenneur%20L,%20Garrigue%20I,%20Doize%20A,%20Dartigues%20JF,%20Helmer%20C.%20Interaction%20between%20APOE4%20and%20herpes%20simplex%20virus%20type%201%20in%20alzheimer%E2%80%99s%20disease.%20Alzheimer%E2%80%99s%20Dement.%202020;16:200%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR203">
<span class="label">203.</span><cite>Lövheim H, Norman T, Weidung B, Olsson J, Josefsson M, Adolfsson R, et al. Herpes simplex virus, APOE ϵ4, and cognitive decline in old age: results from the Betula cohort study. J Alzheimers Dis. 2019;67:211–20.
</cite> [<a href="https://doi.org/10.3233/JAD-171162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30636735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?L%C3%B6vheim%20H,%20Norman%20T,%20Weidung%20B,%20Olsson%20J,%20Josefsson%20M,%20Adolfsson%20R,%20et%20al.%20Herpes%20simplex%20virus,%20APOE%20%CF%B54,%20and%20cognitive%20decline%20in%20old%20age:%20results%20from%20the%20Betula%20cohort%20study.%20J%20Alzheimers%20Dis.%202019;67:211%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR204">
<span class="label">204.</span><cite>Itzhaki RF, Lin WR. Herpes simplex virus type I in brain and the type 4 allele of the Apolipoprotein E gene are a combined risk factor for alzheimer’s disease. Biochem Soc Trans. 1998;26:273–7.
</cite> [<a href="https://doi.org/10.1042/bst0260273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9649761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itzhaki%20RF,%20Lin%20WR.%20Herpes%20simplex%20virus%20type%20I%20in%20brain%20and%20the%20type%204%20allele%20of%20the%20Apolipoprotein%20E%20gene%20are%20a%20combined%20risk%20factor%20for%20alzheimer%E2%80%99s%20disease.%20Biochem%20Soc%20Trans.%201998;26:273%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR205">
<span class="label">205.</span><cite>Burgos JS, Ramirez C, Sastre I, Valdivieso F. Effect of Apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J Virol. 2006;80:5383–7.
</cite> [<a href="https://doi.org/10.1128/JVI.00006-06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1472141/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16699018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burgos%20JS,%20Ramirez%20C,%20Sastre%20I,%20Valdivieso%20F.%20Effect%20of%20Apolipoprotein%20E%20on%20the%20cerebral%20load%20of%20latent%20herpes%20simplex%20virus%20type%201%20DNA.%20J%20Virol.%202006;80:5383%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR206">
<span class="label">206.</span><cite>Niemeyer CS, Merle L, Bubak AN, Baxter BD, Gentile Polese A, Colon-Reyes K, et al. Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity. J Virol. 2024;98:e01734–23.</cite> [<a href="https://doi.org/10.1128/jvi.00968-24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11575344/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39475273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Niemeyer%20CS,%20Merle%20L,%20Bubak%20AN,%20Baxter%20BD,%20Gentile%20Polese%20A,%20Colon-Reyes%20K,%20et%20al.%20Olfactory%20and%20trigeminal%20routes%20of%20HSV-1%20CNS%20infection%20with%20regional%20microglial%20heterogeneity.%20J%20Virol.%202024;98:e01734%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR207">
<span class="label">207.</span><cite>Bearer EL, Breakefield XO, Schuback D, Reese TS, LaVail JH. Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument. Proc Natl Acad Sci U S A. 2000;97:8146–50.
</cite> [<a href="https://doi.org/10.1073/pnas.97.14.8146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC16684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10884436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bearer%20EL,%20Breakefield%20XO,%20Schuback%20D,%20Reese%20TS,%20LaVail%20JH.%20Retrograde%20axonal%20transport%20of%20herpes%20simplex%20virus:%20evidence%20for%20a%20single%20mechanism%20and%20a%20role%20for%20tegument.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202000;97:8146%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR208">
<span class="label">208.</span><cite>Burgos JS, Ramirez C, Sastre I, Alfaro JM, Valdivieso F. Herpes simplex virus type 1 infection via the bloodstream with Apolipoprotein E dependence in the gonads is influenced by gender. J Virol. 2005;79:1605–8.
</cite> [<a href="https://doi.org/10.1128/JVI.79.3.1605-1612.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC544102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15650186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burgos%20JS,%20Ramirez%20C,%20Sastre%20I,%20Alfaro%20JM,%20Valdivieso%20F.%20Herpes%20simplex%20virus%20type%201%20infection%20via%20the%20bloodstream%20with%20Apolipoprotein%20E%20dependence%20in%20the%20gonads%20is%20influenced%20by%20gender.%20J%20Virol.%202005;79:1605%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR209">
<span class="label">209.</span><cite>Wozniak M, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within alzheimer’s disease amyloid plaques. J Pathol. 2009;217:131–8.
</cite> [<a href="https://doi.org/10.1002/path.2449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18973185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wozniak%20M,%20Mee%20AP,%20Itzhaki%20RF.%20Herpes%20simplex%20virus%20type%201%20DNA%20is%20located%20within%20alzheimer%E2%80%99s%20disease%20amyloid%20plaques.%20J%20Pathol.%202009;217:131%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR210">
<span class="label">210.</span><cite>Itzhaki R, Wozniak M. Herpes simplex virus type 1 in alzheimer’s disease: the enemy within. Br Dent J. 2009;206:267.</cite> [<a href="https://doi.org/10.3233/jad-2008-13405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18487848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itzhaki%20R,%20Wozniak%20M.%20Herpes%20simplex%20virus%20type%201%20in%20alzheimer%E2%80%99s%20disease:%20the%20enemy%20within.%20Br%20Dent%20J.%202009;206:267." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR211">
<span class="label">211.</span><cite>Martin C, Aguila B, Araya P, Vio K, Valdivia S, Zambrano A, et al. Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation. J Alzheimers Dis. 2014;39:849–59.
</cite> [<a href="https://doi.org/10.3233/JAD-131706" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24296813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Martin%20C,%20Aguila%20B,%20Araya%20P,%20Vio%20K,%20Valdivia%20S,%20Zambrano%20A,%20et%20al.%20Inflammatory%20and%20neurodegeneration%20markers%20during%20asymptomatic%20HSV-1%20reactivation.%20J%20Alzheimers%20Dis.%202014;39:849%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR212">
<span class="label">212.</span><cite>Itzhaki RF. Corroboration of a major role for herpes simplex virus type 1 in alzheimer’s disease. Front Aging Neurosci. 2018;10:324.
</cite> [<a href="https://doi.org/10.3389/fnagi.2018.00324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6202583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30405395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itzhaki%20RF.%20Corroboration%20of%20a%20major%20role%20for%20herpes%20simplex%20virus%20type%201%20in%20alzheimer%E2%80%99s%20disease.%20Front%20Aging%20Neurosci.%202018;10:324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR213">
<span class="label">213.</span><cite>Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;429:95–100.
</cite> [<a href="https://doi.org/10.1016/j.neulet.2007.09.077" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17980964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wozniak%20MA,%20Itzhaki%20RF,%20Shipley%20SJ,%20Dobson%20CB.%20Herpes%20simplex%20virus%20infection%20causes%20cellular%20%CE%B2-amyloid%20accumulation%20and%20secretase%20upregulation.%20Neurosci%20Lett.%202007;429:95%E2%80%93100." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR214">
<span class="label">214.</span><cite>Wozniak MA, Itzhaki RF. Antiviral agents in alzheimer’s disease: hope for the future? Ther Adv Neurol Disord. 2010;3:141–52.
</cite> [<a href="https://doi.org/10.1177/1756285610370069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3002652/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21179606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wozniak%20MA,%20Itzhaki%20RF.%20Antiviral%20agents%20in%20alzheimer%E2%80%99s%20disease:%20hope%20for%20the%20future?%20Ther%20Adv%20Neurol%20Disord.%202010;3:141%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR215">
<span class="label">215.</span><cite>Ge T, Yuan Y. Herpes simplex virus infection increases beta-amyloid production and induces the development of alzheimer’s disease. Biomed Res Int. 2022;2022:9740583.</cite> [<a href="https://doi.org/10.1155/2022/8804925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9453006/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36093396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ge%20T,%20Yuan%20Y.%20Herpes%20simplex%20virus%20infection%20increases%20beta-amyloid%20production%20and%20induces%20the%20development%20of%20alzheimer%E2%80%99s%20disease.%20Biomed%20Res%20Int.%202022;2022:9740583." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="/articles/PMC10769693/" class="text-red">Retracted</a>]</li>
<li id="CR216">
<span class="label">216.</span><cite>Bourgade K, Le Page A, Bocti C, Witkowski JM, Dupuis G, Frost EH, et al. Protective effect of amyloid-β peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J Alzheimers Dis. 2016;50:1227–41.
</cite> [<a href="https://doi.org/10.3233/JAD-150652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26836158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bourgade%20K,%20Le%20Page%20A,%20Bocti%20C,%20Witkowski%20JM,%20Dupuis%20G,%20Frost%20EH,%20et%20al.%20Protective%20effect%20of%20amyloid-%CE%B2%20peptides%20against%20herpes%20simplex%20virus-1%20infection%20in%20a%20neuronal%20cell%20culture%20model.%20J%20Alzheimers%20Dis.%202016;50:1227%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR217">
<span class="label">217.</span><cite>Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Biol Sci Med Sci. 2014;69:S4–9.</cite> [<a href="https://doi.org/10.1093/gerona/glu057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24833586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Franceschi%20C,%20Campisi%20J.%20Chronic%20inflammation%20(inflammaging)%20and%20its%20potential%20contribution%20to%20age-associated%20diseases.%20J%20Gerontol%20Biol%20Sci%20Med%20Sci.%202014;69:S4%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR218">
<span class="label">218.</span><cite>Fruhwürth S, Reinert LS, Öberg C, Sakr M, Henricsson M, Zetterberg H, et al. TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain. Sci Adv. 2023;9:eadf5808.
</cite> [<a href="https://doi.org/10.1126/sciadv.adf5808" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10438464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37595041/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fruhw%C3%BCrth%20S,%20Reinert%20LS,%20%C3%96berg%20C,%20Sakr%20M,%20Henricsson%20M,%20Zetterberg%20H,%20et%20al.%20TREM2%20is%20down-regulated%20by%20HSV1%20in%20microglia%20and%20involved%20in%20antiviral%20defense%20in%20the%20brain.%20Sci%20Adv.%202023;9:eadf5808." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR219">
<span class="label">219.</span><cite>Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, et al. Alzheimer’s disease-associated β-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron. 2018;99:56–e633.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2018.06.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6075814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30001512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eimer%20WA,%20Vijaya%20Kumar%20DK,%20Navalpur%20Shanmugam%20NK,%20Rodriguez%20AS,%20Mitchell%20T,%20Washicosky%20KJ,%20et%20al.%20Alzheimer%E2%80%99s%20disease-associated%20%CE%B2-amyloid%20is%20rapidly%20seeded%20by%20herpesviridae%20to%20protect%20against%20brain%20infection.%20Neuron.%202018;99:56%E2%80%93e633." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR220">
<span class="label">220.</span><cite>Wozniak MA, Frost AL, Itzhaki RF. Alzheimer’s disease-specific Tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009;16:341–50.
</cite> [<a href="https://doi.org/10.3233/JAD-2009-0963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19221424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wozniak%20MA,%20Frost%20AL,%20Itzhaki%20RF.%20Alzheimer%E2%80%99s%20disease-specific%20Tau%20phosphorylation%20is%20induced%20by%20herpes%20simplex%20virus%20type%201.%20J%20Alzheimers%20Dis.%202009;16:341%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR221">
<span class="label">221.</span><cite>Powell-Doherty RD, Abbott ARN, Nelson LA, Bertke AS. Amyloid- and p-tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons. J Virol. 2020;94:e01874–19.
</cite> [<a href="https://doi.org/10.1128/JVI.01874-19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7163132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32075924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Powell-Doherty%20RD,%20Abbott%20ARN,%20Nelson%20LA,%20Bertke%20AS.%20Amyloid-%20and%20p-tau%20anti-threat%20response%20to%20herpes%20simplex%20virus%201%20infection%20in%20primary%20adult%20murine%20hippocampal%20neurons.%20J%20Virol.%202020;94:e01874%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR222">
<span class="label">222.</span><cite>Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and alzheimer’s disease? J Neurovirol. 2019;25:634–47.
</cite> [<a href="https://doi.org/10.1007/s13365-019-00732-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30868421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fulop%20T,%20Witkowski%20JM,%20Larbi%20A,%20Khalil%20A,%20Herbein%20G,%20Frost%20EH.%20Does%20HIV%20infection%20contribute%20to%20increased%20beta-amyloid%20synthesis%20and%20plaque%20formation%20leading%20to%20neurodegeneration%20and%20alzheimer%E2%80%99s%20disease?%20J%20Neurovirol.%202019;25:634%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR223">
<span class="label">223.</span><cite>Yu X, Kuo YF, Raji MA, Berenson AB, Baillargeon J, Giordano TP. Dementias among older males and females in the U.S. Medicare system with and without HIV. J Acquir Immune Defic Syndr. 2023;92:405–12.
</cite> [<a href="https://doi.org/10.1097/QAI.0000000000003184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10293071/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36881792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20X,%20Kuo%20YF,%20Raji%20MA,%20Berenson%20AB,%20Baillargeon%20J,%20Giordano%20TP.%20Dementias%20among%20older%20males%20and%20females%20in%20the%20U.S.%20Medicare%20system%20with%20and%20without%20HIV.%20J%20Acquir%20Immune%20Defic%20Syndr.%202023;92:405%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR224">
<span class="label">224.</span><cite>Lin HC, Xirasagar S, Lee HC, Huang CC, Chen CH. Association of alzheimer’s disease with hepatitis C among patients with bipolar disorder. PLoS ONE. 2017;12:e0179413.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0179312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5473552/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28622343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20HC,%20Xirasagar%20S,%20Lee%20HC,%20Huang%20CC,%20Chen%20CH.%20Association%20of%20alzheimer%E2%80%99s%20disease%20with%20hepatitis%20C%20among%20patients%20with%20bipolar%20disorder.%20PLoS%20ONE.%202017;12:e0179413." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR225">
<span class="label">225.</span><cite>Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC. Hepatitis C viral infection and the risk of dementia. Eur J Neurol. 2014;21(8).</cite> [<a href="https://doi.org/10.1111/ene.12317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24313931/" class="usa-link">PubMed</a>]</li>
<li id="CR226">
<span class="label">226.</span><cite>Jha NK, Sharma A, Jha SK, Ojha S, Chellappan DK, Gupta G, et al. Alzheimer’s disease-like perturbations in HIV-mediated neuronal dysfunctions: Understanding mechanisms and developing therapeutic strategies. Open Biol. 2020;10:200286.
</cite> [<a href="https://doi.org/10.1098/rsob.200286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7776571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33352062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jha%20NK,%20Sharma%20A,%20Jha%20SK,%20Ojha%20S,%20Chellappan%20DK,%20Gupta%20G,%20et%20al.%20Alzheimer%E2%80%99s%20disease-like%20perturbations%20in%20HIV-mediated%20neuronal%20dysfunctions:%20Understanding%20mechanisms%20and%20developing%20therapeutic%20strategies.%20Open%20Biol.%202020;10:200286." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR227">
<span class="label">227.</span><cite>Buckley S, Byrnes S, Cochrane C, Roche M, Estes JD, Selemidis S, et al. The role of oxidative stress in HIV-associated neurocognitive disorders. Brain Behav Immun Health. 2021;13:100235.
</cite> [<a href="https://doi.org/10.1016/j.bbih.2021.100235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8474476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34589750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Buckley%20S,%20Byrnes%20S,%20Cochrane%20C,%20Roche%20M,%20Estes%20JD,%20Selemidis%20S,%20et%20al.%20The%20role%20of%20oxidative%20stress%20in%20HIV-associated%20neurocognitive%20disorders.%20Brain%20Behav%20Immun%20Health.%202021;13:100235." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR228">
<span class="label">228.</span><cite>Chai Q, Jovasevic V, Malikov V, Sabo Y, Morham S, Walsh D, et al. HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. Nat Commun. 2017;8:1522.
</cite> [<a href="https://doi.org/10.1038/s41467-017-01795-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5688069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29142315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chai%20Q,%20Jovasevic%20V,%20Malikov%20V,%20Sabo%20Y,%20Morham%20S,%20Walsh%20D,%20et%20al.%20HIV-1%20counteracts%20an%20innate%20restriction%20by%20amyloid%20precursor%20protein%20resulting%20in%20neurodegeneration.%20Nat%20Commun.%202017;8:1522." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR229">
<span class="label">229.</span><cite>András IE, Leda A, Contreras MG, Bertrand L, Park M, Skowronska M, et al. Extracellular vesicles of the blood-brain barrier: role in the HIV-1 associated amyloid beta pathology. Mol Cell Neurosci. 2017;79:12–22.
</cite> [<a href="https://doi.org/10.1016/j.mcn.2016.12.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5315639/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28040512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andr%C3%A1s%20IE,%20Leda%20A,%20Contreras%20MG,%20Bertrand%20L,%20Park%20M,%20Skowronska%20M,%20et%20al.%20Extracellular%20vesicles%20of%20the%20blood-brain%20barrier:%20role%20in%20the%20HIV-1%20associated%20amyloid%20beta%20pathology.%20Mol%20Cell%20Neurosci.%202017;79:12%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR230">
<span class="label">230.</span><cite>Min AK, Fortune T, Rodriguez N, Hedge E, Swartz TH. Inflammasomes as mediators of inflammation in HIV-1 infection. Transl Res. 2023;252:1–8.
</cite> [<a href="https://doi.org/10.1016/j.trsl.2022.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10160852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35917903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Min%20AK,%20Fortune%20T,%20Rodriguez%20N,%20Hedge%20E,%20Swartz%20TH.%20Inflammasomes%20as%20mediators%20of%20inflammation%20in%20HIV-1%20infection.%20Transl%20Res.%202023;252:1%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR231">
<span class="label">231.</span><cite>Zhang H, Tan B, Tang T, Tao J, Jin T, Wu S. Targeting inflammasomes as a therapeutic potential for HIV/AIDS. Cell Mol Life Sci. 2025;82:1–12.</cite> [<a href="https://doi.org/10.1007/s00018-025-05685-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12006635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40244456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20H,%20Tan%20B,%20Tang%20T,%20Tao%20J,%20Jin%20T,%20Wu%20S.%20Targeting%20inflammasomes%20as%20a%20therapeutic%20potential%20for%20HIV/AIDS.%20Cell%20Mol%20Life%20Sci.%202025;82:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR232">
<span class="label">232.</span><cite>Senzolo M, Schiff S, D’Aloiso CM, Crivellin C, Cholongitas E, Burra P, et al. Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J Gastroenterol. 2011;17:3369–74.
</cite> [<a href="https://doi.org/10.3748/wjg.v17.i29.3369" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3160562/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21876628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Senzolo%20M,%20Schiff%20S,%20D%E2%80%99Aloiso%20CM,%20Crivellin%20C,%20Cholongitas%20E,%20Burra%20P,%20et%20al.%20Neuropsychological%20alterations%20in%20hepatitis%20C%20infection:%20the%20role%20of%20inflammation.%20World%20J%20Gastroenterol.%202011;17:3369%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR233">
<span class="label">233.</span><cite>Bae S, Yun SC, Kim MC, Yoon W, Lim JS, Lee SO, et al. Association of herpes Zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021;271:987–97.
</cite> [<a href="https://doi.org/10.1007/s00406-020-01157-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32613564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bae%20S,%20Yun%20SC,%20Kim%20MC,%20Yoon%20W,%20Lim%20JS,%20Lee%20SO,%20et%20al.%20Association%20of%20herpes%20Zoster%20with%20dementia%20and%20effect%20of%20antiviral%20therapy%20on%20dementia:%20a%20population-based%20cohort%20study.%20Eur%20Arch%20Psychiatry%20Clin%20Neurosci.%202021;271:987%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR234">
<span class="label">234.</span><cite>Wozniak MA, Frost AL, Preston CM, Itzhaki RF. Antivirals reduce the formation of key alzheimer’s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS ONE. 2011;6:e25152.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0025152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3189195/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22003387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wozniak%20MA,%20Frost%20AL,%20Preston%20CM,%20Itzhaki%20RF.%20Antivirals%20reduce%20the%20formation%20of%20key%20alzheimer%E2%80%99s%20disease%20molecules%20in%20cell%20cultures%20acutely%20infected%20with%20herpes%20simplex%20virus%20type%201.%20PLoS%20ONE.%202011;6:e25152." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR235">
<span class="label">235.</span><cite>Itzhaki RF, Wozniak MA. Herpes simplex virus type 1 in alzheimer’s disease: the enemy within. J Alzheimers Dis. 2008;13:393–405.
</cite> [<a href="https://doi.org/10.3233/jad-2008-13405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18487848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Itzhaki%20RF,%20Wozniak%20MA.%20Herpes%20simplex%20virus%20type%201%20in%20alzheimer%E2%80%99s%20disease:%20the%20enemy%20within.%20J%20Alzheimers%20Dis.%202008;13:393%E2%80%93405." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR236">
<span class="label">236.</span><cite>MacDonald AB, Miranda JM. Concurrent neocortical borreliosis and alzheimer’s disease. Hum Pathol. 1987;18:759–61.
</cite> [<a href="https://doi.org/10.1016/s0046-8177(87)80252-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3297997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?MacDonald%20AB,%20Miranda%20JM.%20Concurrent%20neocortical%20borreliosis%20and%20alzheimer%E2%80%99s%20disease.%20Hum%20Pathol.%201987;18:759%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR237">
<span class="label">237.</span><cite>Miklossy J. Historic evidence to support a causal relationship between spirochetal infections and alzheimer’s disease. Front Aging Neurosci. 2015;7:46.
</cite> [<a href="https://doi.org/10.3389/fnagi.2015.00046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4399390/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25932012/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miklossy%20J.%20Historic%20evidence%20to%20support%20a%20causal%20relationship%20between%20spirochetal%20infections%20and%20alzheimer%E2%80%99s%20disease.%20Front%20Aging%20Neurosci.%202015;7:46." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR238">
<span class="label">238.</span><cite>Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, et al. Beta-amyloid deposition and alzheimer’s type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006;27:228–36.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2005.01.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15894409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miklossy%20J,%20Kis%20A,%20Radenovic%20A,%20Miller%20L,%20Forro%20L,%20Martins%20R,%20et%20al.%20Beta-amyloid%20deposition%20and%20alzheimer%E2%80%99s%20type%20changes%20induced%20by%20Borrelia%20spirochetes.%20Neurobiol%20Aging.%202006;27:228%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR239">
<span class="label">239.</span><cite>Miklossy J, Khalili K, Gern L, Ericson R, Darekar P, Bolle L, et al. Borrelia burgdorferi persists in the brain in chronic Lyme neuroborreliosis and May be associated with alzheimer disease. J Alzheimers Dis. 2004;6:639–49.
</cite> [<a href="https://doi.org/10.3233/jad-2004-6608" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15665404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miklossy%20J,%20Khalili%20K,%20Gern%20L,%20Ericson%20R,%20Darekar%20P,%20Bolle%20L,%20et%20al.%20Borrelia%20burgdorferi%20persists%20in%20the%20brain%20in%20chronic%20Lyme%20neuroborreliosis%20and%20May%20be%20associated%20with%20alzheimer%20disease.%20J%20Alzheimers%20Dis.%202004;6:639%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR240">
<span class="label">240.</span><cite>Miklossy J. Alzheimer’s disease - a neurospirochetosis. Analysis of the evidence following koch’s and hill’s criteria. J Neuroinflammation. 2011;8:90.
</cite> [<a href="https://doi.org/10.1186/1742-2094-8-90" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3171359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21816039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miklossy%20J.%20Alzheimer%E2%80%99s%20disease%20-%20a%20neurospirochetosis.%20Analysis%20of%20the%20evidence%20following%20koch%E2%80%99s%20and%20hill%E2%80%99s%20criteria.%20J%20Neuroinflammation.%202011;8:90." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR241">
<span class="label">241.</span><cite>Hahn DL, Azenabor AA, Beatty WL, Byrne GI. Chlamydia pneumoniae as a respiratory pathogen. Front Biosci. 2002;7:1030–49.</cite> [<a href="https://doi.org/10.2741/hahn" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11861211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hahn%20DL,%20Azenabor%20AA,%20Beatty%20WL,%20Byrne%20GI.%20Chlamydia%20pneumoniae%20as%20a%20respiratory%20pathogen.%20Front%20Biosci.%202002;7:1030%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR242">
<span class="label">242.</span><cite>Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of balb/c mice. Neurobiol Aging. 2004;25:419–29.
</cite> [<a href="https://doi.org/10.1016/S0197-4580(03)00127-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15013562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Little%20CS,%20Hammond%20CJ,%20MacIntyre%20A,%20Balin%20BJ,%20Appelt%20DM.%20Chlamydia%20pneumoniae%20induces%20Alzheimer-like%20amyloid%20plaques%20in%20brains%20of%20balb/c%20mice.%20Neurobiol%20Aging.%202004;25:419%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR243">
<span class="label">243.</span><cite>Al-Atrache Z, Lopez DB, Hingley ST, Appelt DM. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in alzheimer disease. BMC Neurosci. 2019;20:15.
</cite> [<a href="https://doi.org/10.1186/s12868-019-0489-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6383264/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30786875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Al-Atrache%20Z,%20Lopez%20DB,%20Hingley%20ST,%20Appelt%20DM.%20Astrocytes%20infected%20with%20Chlamydia%20pneumoniae%20demonstrate%20altered%20expression%20and%20activity%20of%20secretases%20involved%20in%20the%20generation%20of%20%CE%B2-amyloid%20found%20in%20alzheimer%20disease.%20BMC%20Neurosci.%202019;20:15." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR244">
<span class="label">244.</span><cite>Ou H, Chien WC, Chung CH, Chang HA, Kao YC, Wu PC, et al. Association between antibiotic treatment of Chlamydia pneumoniae and reduced risk of alzheimer dementia: A nationwide cohort study in Taiwan. Front Aging Neurosci. 2021;13:723284.</cite> [<a href="https://doi.org/10.3389/fnagi.2021.701899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8416516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34489674/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ou%20H,%20Chien%20WC,%20Chung%20CH,%20Chang%20HA,%20Kao%20YC,%20Wu%20PC,%20et%20al.%20Association%20between%20antibiotic%20treatment%20of%20Chlamydia%20pneumoniae%20and%20reduced%20risk%20of%20alzheimer%20dementia:%20A%20nationwide%20cohort%20study%20in%20Taiwan.%20Front%20Aging%20Neurosci.%202021;13:723284." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR245">
<span class="label">245.</span><cite>Balin BJ, Gérard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, et al. Identification and localization of Chlamydia pneumoniae in the alzheimer’s brain. Med Microbiol Immunol. 1998;187:23–42.
</cite> [<a href="https://doi.org/10.1007/s004300050071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9749980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Balin%20BJ,%20G%C3%A9rard%20HC,%20Arking%20EJ,%20Appelt%20DM,%20Branigan%20PJ,%20Abrams%20JT,%20et%20al.%20Identification%20and%20localization%20of%20Chlamydia%20pneumoniae%20in%20the%20alzheimer%E2%80%99s%20brain.%20Med%20Microbiol%20Immunol.%201998;187:23%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR246">
<span class="label">246.</span><cite>Gérard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, et al. Chlamydophila (Chlamydia) pneumoniae in the alzheimer’s brain. FEMS Immunol Med Microbiol. 2006;48:355–66.
</cite> [<a href="https://doi.org/10.1111/j.1574-695X.2006.00154.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17052268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?G%C3%A9rard%20HC,%20Dreses-Werringloer%20U,%20Wildt%20KS,%20Deka%20S,%20Oszust%20C,%20Balin%20BJ,%20et%20al.%20Chlamydophila%20(Chlamydia)%20pneumoniae%20in%20the%20alzheimer%E2%80%99s%20brain.%20FEMS%20Immunol%20Med%20Microbiol.%202006;48:355%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR247">
<span class="label">247.</span><cite>Yulug B, Hanoglu L, Ozansoy M, Isık D, Kilic U, Kilic E, et al. Therapeutic role of rifampicin in alzheimer’s disease. Psychiatry Clin Neurosci. 2018;72:152–9.
</cite> [<a href="https://doi.org/10.1111/pcn.12637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29315976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yulug%20B,%20Hanoglu%20L,%20Ozansoy%20M,%20Is%C4%B1k%20D,%20Kilic%20U,%20Kilic%20E,%20et%20al.%20Therapeutic%20role%20of%20rifampicin%20in%20alzheimer%E2%80%99s%20disease.%20Psychiatry%20Clin%20Neurosci.%202018;72:152%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR248">
<span class="label">248.</span><cite>Yulug B, Hanoglu L, Kilic E, Schabitz WR. Rifampicin: an antibiotic with brain protective function. Brain Res Bull. 2014;107:37–42.
</cite> [<a href="https://doi.org/10.1016/j.brainresbull.2014.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24905548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yulug%20B,%20Hanoglu%20L,%20Kilic%20E,%20Schabitz%20WR.%20Rifampicin:%20an%20antibiotic%20with%20brain%20protective%20function.%20Brain%20Res%20Bull.%202014;107:37%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR249">
<span class="label">249.</span><cite>Tomiyama T, Asano S, Suwa Y, Morita T, Kataoka K, Mori H, et al. Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. Biochem Biophys Res Commun. 1994;204:76–83.
</cite> [<a href="https://doi.org/10.1006/bbrc.1994.2428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7945395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tomiyama%20T,%20Asano%20S,%20Suwa%20Y,%20Morita%20T,%20Kataoka%20K,%20Mori%20H,%20et%20al.%20Rifampicin%20prevents%20the%20aggregation%20and%20neurotoxicity%20of%20amyloid%20beta%20protein%20in%20vitro.%20Biochem%20Biophys%20Res%20Commun.%201994;204:76%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR250">
<span class="label">250.</span><cite>Umeda T, Ono K, Sakai A, Yamashita M, Mizuguchi M, Klein WL, et al. Rifampicin is a candidate preventive medicine against amyloid-β and Tau oligomers. Brain. 2016;139:1568–86.
</cite> [<a href="https://doi.org/10.1093/brain/aww042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27020329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Umeda%20T,%20Ono%20K,%20Sakai%20A,%20Yamashita%20M,%20Mizuguchi%20M,%20Klein%20WL,%20et%20al.%20Rifampicin%20is%20a%20candidate%20preventive%20medicine%20against%20amyloid-%CE%B2%20and%20Tau%20oligomers.%20Brain.%202016;139:1568%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR251">
<span class="label">251.</span><cite>Iizuka T, Morimoto K, Sasaki Y, Kameyama M, Kurashima A, Hayasaka K, et al. Preventive effect of rifampicin on alzheimer disease needs at least 450 mg daily for 1 year: an FDG-PET follow-up study. Dement Geriatr Cogn Dis Extra. 2017;7:204–15.
</cite> [<a href="https://doi.org/10.1159/000477343" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5498941/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28690634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iizuka%20T,%20Morimoto%20K,%20Sasaki%20Y,%20Kameyama%20M,%20Kurashima%20A,%20Hayasaka%20K,%20et%20al.%20Preventive%20effect%20of%20rifampicin%20on%20alzheimer%20disease%20needs%20at%20least%20450%C2%A0mg%20daily%20for%201%20year:%20an%20FDG-PET%20follow-up%20study.%20Dement%20Geriatr%20Cogn%20Dis%20Extra.%202017;7:204%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR252">
<span class="label">252.</span><cite>Forloni G, Colombo L, Girola L, Tagliavini F, Salmona M. Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett. 2001;487:404–7.
</cite> [<a href="https://doi.org/10.1016/s0014-5793(00)02380-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11163366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Forloni%20G,%20Colombo%20L,%20Girola%20L,%20Tagliavini%20F,%20Salmona%20M.%20Anti-amyloidogenic%20activity%20of%20tetracyclines:%20studies%20in%20vitro.%20FEBS%20Lett.%202001;487:404%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR253">
<span class="label">253.</span><cite>Balducci C, Santamaria G, La Vitola P, Brandi E, Grandi F, Viscomi AR, et al. Doxycycline counteracts neuroinflammation restoring memory in alzheimer’s disease mouse models. Neurobiol Aging. 2018;70:128–39.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2018.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30007162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Balducci%20C,%20Santamaria%20G,%20La%20Vitola%20P,%20Brandi%20E,%20Grandi%20F,%20Viscomi%20AR,%20et%20al.%20Doxycycline%20counteracts%20neuroinflammation%20restoring%20memory%20in%20alzheimer%E2%80%99s%20disease%20mouse%20models.%20Neurobiol%20Aging.%202018;70:128%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR254">
<span class="label">254.</span><cite>Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, et al. A randomized, controlled trial of Doxycycline and Rifampin for patients with alzheimer’s disease. J Am Geriatr Soc. 2004;52:381–7.
</cite> [<a href="https://doi.org/10.1111/j.1532-5415.2004.52109.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14962152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Loeb%20MB,%20Molloy%20DW,%20Smieja%20M,%20Standish%20T,%20Goldsmith%20CH,%20Mahony%20J,%20et%20al.%20A%20randomized,%20controlled%20trial%20of%20Doxycycline%20and%20Rifampin%20for%20patients%20with%20alzheimer%E2%80%99s%20disease.%20J%20Am%20Geriatr%20Soc.%202004;52:381%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR255">
<span class="label">255.</span><cite>Molloy DW, Standish TI, Zhou Q, Guyatt G. A multicenter, blinded, randomized, factorial controlled trial of Doxycycline and Rifampin for treatment of alzheimer’s disease: the DARAD trial. Int J Geriatr Psychiatry. 2013;28:463–70.
</cite> [<a href="https://doi.org/10.1002/gps.3846" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22718435/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Molloy%20DW,%20Standish%20TI,%20Zhou%20Q,%20Guyatt%20G.%20A%20multicenter,%20blinded,%20randomized,%20factorial%20controlled%20trial%20of%20Doxycycline%20and%20Rifampin%20for%20treatment%20of%20alzheimer%E2%80%99s%20disease:%20the%20DARAD%20trial.%20Int%20J%20Geriatr%20Psychiatry.%202013;28:463%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR256">
<span class="label">256.</span><cite>Kim M, Park SJ, Choi S, Chang J, Kim SM, Jeong S, et al. Association between antibiotics and dementia risk: A retrospective cohort study. Front Pharmacol. 2022;13:954865.</cite> [<a href="https://doi.org/10.3389/fphar.2022.888333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9548656/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36225572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20M,%20Park%20SJ,%20Choi%20S,%20Chang%20J,%20Kim%20SM,%20Jeong%20S,%20et%20al.%20Association%20between%20antibiotics%20and%20dementia%20risk:%20A%20retrospective%20cohort%20study.%20Front%20Pharmacol.%202022;13:954865." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR257">
<span class="label">257.</span><cite>Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and alzheimer’s disease. J Neuroinflammation. 2019;16:132.
</cite> [<a href="https://doi.org/10.1186/s12974-019-1494-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6530014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31118068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Angelucci%20F,%20Cechova%20K,%20Amlerova%20J,%20Hort%20J.%20Antibiotics,%20gut%20microbiota,%20and%20alzheimer%E2%80%99s%20disease.%20J%20Neuroinflammation.%202019;16:132." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR258">
<span class="label">258.</span><cite>Mehta RS, Lochhead P, Wang Y, Ma W, Nguyen LH, Kochar B, et al. Association of midlife antibiotic use with subsequent cognitive function in women. PLoS ONE. 2022;17:e0264506.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0264649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8942267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35320274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mehta%20RS,%20Lochhead%20P,%20Wang%20Y,%20Ma%20W,%20Nguyen%20LH,%20Kochar%20B,%20et%20al.%20Association%20of%20midlife%20antibiotic%20use%20with%20subsequent%20cognitive%20function%20in%20women.%20PLoS%20ONE.%202022;17:e0264506." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR259">
<span class="label">259.</span><cite>Askarova S, Umbayev B, Masoud AR, Kaiyrlykyzy A, Safarova Y, Tsoy A, et al. The links between the gut microbiome, aging, modern lifestyle and alzheimer’s disease. Front Cell Infect Microbiol. 2020;10:491270.</cite> [<a href="https://doi.org/10.3389/fcimb.2020.00104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7093326/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32257964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Askarova%20S,%20Umbayev%20B,%20Masoud%20AR,%20Kaiyrlykyzy%20A,%20Safarova%20Y,%20Tsoy%20A,%20et%20al.%20The%20links%20between%20the%20gut%20microbiome,%20aging,%20modern%20lifestyle%20and%20alzheimer%E2%80%99s%20disease.%20Front%20Cell%20Infect%20Microbiol.%202020;10:491270." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR260">
<span class="label">260.</span><cite>Wang J, Yan Z, Zhang W, Liu X, Wang J, Peng Q. Upregulation of TREM2 expression in M2 macrophages promotes Brucella abortus chronic infection. Front Immunol. 2024;15:1466520.
</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1466520" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11532147/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39497817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Yan%20Z,%20Zhang%20W,%20Liu%20X,%20Wang%20J,%20Peng%20Q.%20Upregulation%20of%20TREM2%20expression%20in%20M2%20macrophages%20promotes%20Brucella%20abortus%20chronic%20infection.%20Front%20Immunol.%202024;15:1466520." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR261">
<span class="label">261.</span><cite>Dabla A, Liang YC, Rajabalee N, Irwin CJ, Moonen CGJ, Willis JV, et al. TREM2 promotes immune evasion by Mycobacterium tuberculosis in human macrophages. mBio. 2022;13:e01456–22.
</cite> [<a href="https://doi.org/10.1128/mbio.01456-22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9426521/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35924849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dabla%20A,%20Liang%20YC,%20Rajabalee%20N,%20Irwin%20CJ,%20Moonen%20CGJ,%20Willis%20JV,%20et%20al.%20TREM2%20promotes%20immune%20evasion%20by%20Mycobacterium%20tuberculosis%20in%20human%20macrophages.%20mBio.%202022;13:e01456%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR262">
<span class="label">262.</span><cite>Wu Z, Yang S, Fang X, Shu Q, Chen Q. Function and mechanism of TREM2 in bacterial infection. PLoS Pathog. 2024;20:e1011895.
</cite> [<a href="https://doi.org/10.1371/journal.ppat.1011895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10796033/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38236825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20Z,%20Yang%20S,%20Fang%20X,%20Shu%20Q,%20Chen%20Q.%20Function%20and%20mechanism%20of%20TREM2%20in%20bacterial%20infection.%20PLoS%20Pathog.%202024;20:e1011895." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR263">
<span class="label">263.</span><cite>Charles JF, Humphrey MB, Zhao X, Quarles E, Nakamura MC, Aderem A, et al. The innate immune response to Salmonella enterica serovar typhimurium by macrophages is dependent on TREM2-DAP. Infect Immun. 2008;76:2439–47.
</cite> [<a href="https://doi.org/10.1128/IAI.00115-08" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2423085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18391000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Charles%20JF,%20Humphrey%20MB,%20Zhao%20X,%20Quarles%20E,%20Nakamura%20MC,%20Aderem%20A,%20et%20al.%20The%20innate%20immune%20response%20to%20Salmonella%20enterica%20serovar%20typhimurium%20by%20macrophages%20is%20dependent%20on%20TREM2-DAP.%20Infect%20Immun.%202008;76:2439%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR264">
<span class="label">264.</span><cite>Zhu M, Li D, Wu Y, Huang X, Wu M. TREM-2 promotes macrophage-mediated eradication of Pseudomonas aeruginosa via a PI3K/Akt pathway. Scand J Immunol. 2014;79:187–96.
</cite> [<a href="https://doi.org/10.1111/sji.12148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24383713/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20M,%20Li%20D,%20Wu%20Y,%20Huang%20X,%20Wu%20M.%20TREM-2%20promotes%20macrophage-mediated%20eradication%20of%20Pseudomonas%20aeruginosa%20via%20a%20PI3K/Akt%20pathway.%20Scand%20J%20Immunol.%202014;79:187%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR265">
<span class="label">265.</span><cite>Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038.
</cite> [<a href="https://doi.org/10.1038/nrdp.2017.38" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28805207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kinane%20DF,%20Stathopoulou%20PG,%20Papapanou%20PN.%20Periodontal%20diseases.%20Nat%20Rev%20Dis%20Primers.%202017;3:17038." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR266">
<span class="label">266.</span><cite>Wu H, Qiu W, Zhu X, Li X, Xie Z, Carreras I, et al. The periodontal pathogen Fusobacterium nucleatum exacerbates alzheimer’s pathogenesis via specific pathways. Front Aging Neurosci. 2022;14:916303.</cite> [<a href="https://doi.org/10.3389/fnagi.2022.912709" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9260256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35813949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20H,%20Qiu%20W,%20Zhu%20X,%20Li%20X,%20Xie%20Z,%20Carreras%20I,%20et%20al.%20The%20periodontal%20pathogen%20Fusobacterium%20nucleatum%20exacerbates%20alzheimer%E2%80%99s%20pathogenesis%20via%20specific%20pathways.%20Front%20Aging%20Neurosci.%202022;14:916303." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR267">
<span class="label">267.</span><cite>Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJL, Marcenes W. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression. J Dent Res. 2014;93:1045–53.
</cite> [<a href="https://doi.org/10.1177/0022034514552491" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4293771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25261053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kassebaum%20NJ,%20Bernab%C3%A9%20E,%20Dahiya%20M,%20Bhandari%20B,%20Murray%20CJL,%20Marcenes%20W.%20Global%20burden%20of%20severe%20periodontitis%20in%201990%E2%80%932010:%20A%20systematic%20review%20and%20meta-regression.%20J%20Dent%20Res.%202014;93:1045%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR268">
<span class="label">268.</span><cite>Jungbauer G, Stähli A, Zhu X, Auber Alberi L, Sculean A, Eick S. Periodontal microorganisms and alzheimer disease– A causative relationship? Periodontol 2000. 2022;89:59–82.
</cite> [<a href="https://doi.org/10.1111/prd.12429" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9314828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35244967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jungbauer%20G,%20St%C3%A4hli%20A,%20Zhu%20X,%20Auber%20Alberi%20L,%20Sculean%20A,%20Eick%20S.%20Periodontal%20microorganisms%20and%20alzheimer%20disease%E2%80%93%20A%20causative%20relationship?%20Periodontol%202000.%202022;89:59%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR269">
<span class="label">269.</span><cite>Olsen I, Singhrao SK. Can oral infection be a risk factor for alzheimer’s disease? J Oral Microbiol. 2015;7:29143.
</cite> [<a href="https://doi.org/10.3402/jom.v7.29143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4575419/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26385886/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Olsen%20I,%20Singhrao%20SK.%20Can%20oral%20infection%20be%20a%20risk%20factor%20for%20alzheimer%E2%80%99s%20disease?%20J%20Oral%20Microbiol.%202015;7:29143." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR270">
<span class="label">270.</span><cite>Cerajewska TL, Davies M, West NX, Periodontitis. A potential risk factor for alzheimer’s disease. Br Dent J. 2015;218:29–34.
</cite> [<a href="https://doi.org/10.1038/sj.bdj.2014.1137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25571822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cerajewska%20TL,%20Davies%20M,%20West%20NX,%20Periodontitis.%20A%20potential%20risk%20factor%20for%20alzheimer%E2%80%99s%20disease.%20Br%20Dent%20J.%202015;218:29%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR271">
<span class="label">271.</span><cite>Teixeira FB, Saito MT, Matheus FC, Prediger RD, Yamada ES, Maia CSF, et al. Periodontitis and alzheimer’s disease: A possible comorbidity between oral chronic inflammatory condition and neuroinflammation. Front Aging Neurosci. 2017;9:327.
</cite> [<a href="https://doi.org/10.3389/fnagi.2017.00327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5649154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29085294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Teixeira%20FB,%20Saito%20MT,%20Matheus%20FC,%20Prediger%20RD,%20Yamada%20ES,%20Maia%20CSF,%20et%20al.%20Periodontitis%20and%20alzheimer%E2%80%99s%20disease:%20A%20possible%20comorbidity%20between%20oral%20chronic%20inflammatory%20condition%20and%20neuroinflammation.%20Front%20Aging%20Neurosci.%202017;9:327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR272">
<span class="label">272.</span><cite>Cestari JAF, Fabri GMC, Kalil J, Nitrini R, Jacob-Filho W, De Siqueira JTT, et al. Oral infections and cytokine levels in patients with alzheimer’s disease and mild cognitive impairment compared with controls. J Alzheimers Dis. 2016;52:1479–85.
</cite> [<a href="https://doi.org/10.3233/JAD-160212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27104907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cestari%20JAF,%20Fabri%20GMC,%20Kalil%20J,%20Nitrini%20R,%20Jacob-Filho%20W,%20De%20Siqueira%20JTT,%20et%20al.%20Oral%20infections%20and%20cytokine%20levels%20in%20patients%20with%20alzheimer%E2%80%99s%20disease%20and%20mild%20cognitive%20impairment%20compared%20with%20controls.%20J%20Alzheimers%20Dis.%202016;52:1479%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR273">
<span class="label">273.</span><cite>Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D, et al. Periodontitis and cognitive decline in alzheimer’s disease. PLoS ONE. 2016;11:e0151081.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0151081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4786266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26963387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ide%20M,%20Harris%20M,%20Stevens%20A,%20Sussams%20R,%20Hopkins%20V,%20Culliford%20D,%20et%20al.%20Periodontitis%20and%20cognitive%20decline%20in%20alzheimer%E2%80%99s%20disease.%20PLoS%20ONE.%202016;11:e0151081." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR274">
<span class="label">274.</span><cite>Chen CK, Wu YT, Chang YC. Association between chronic periodontitis and the risk of alzheimer’s disease: A retrospective, population-based, matched-cohort study. Alzheimers Res Ther. 2017;9:56.
</cite> [<a href="https://doi.org/10.1186/s13195-017-0282-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5547465/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28784164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20CK,%20Wu%20YT,%20Chang%20YC.%20Association%20between%20chronic%20periodontitis%20and%20the%20risk%20of%20alzheimer%E2%80%99s%20disease:%20A%20retrospective,%20population-based,%20matched-cohort%20study.%20Alzheimers%20Res%20Ther.%202017;9:56." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR275">
<span class="label">275.</span><cite>Choi S, Kim K, Chang J, Kim SM, Kim SJ, Cho HJ, et al. Association of chronic periodontitis on alzheimer’s disease or vascular dementia. J Am Geriatr Soc. 2019;67:1234–9.
</cite> [<a href="https://doi.org/10.1111/jgs.15828" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30874308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Choi%20S,%20Kim%20K,%20Chang%20J,%20Kim%20SM,%20Kim%20SJ,%20Cho%20HJ,%20et%20al.%20Association%20of%20chronic%20periodontitis%20on%20alzheimer%E2%80%99s%20disease%20or%20vascular%20dementia.%20J%20Am%20Geriatr%20Soc.%202019;67:1234%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR276">
<span class="label">276.</span><cite>Panzarella V, Mauceri R, Baschi R, Maniscalco L, Campisi G, Monastero R. Oral health status in subjects with amnestic mild cognitive impairment and alzheimer’s disease: data from the Zabút aging project. J Alzheimers Dis. 2022;87:173–82.
</cite> [<a href="https://doi.org/10.3233/JAD-200385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9277678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32508326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Panzarella%20V,%20Mauceri%20R,%20Baschi%20R,%20Maniscalco%20L,%20Campisi%20G,%20Monastero%20R.%20Oral%20health%20status%20in%20subjects%20with%20amnestic%20mild%20cognitive%20impairment%20and%20alzheimer%E2%80%99s%20disease:%20data%20from%20the%20Zab%C3%BAt%20aging%20project.%20J%20Alzheimers%20Dis.%202022;87:173%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR277">
<span class="label">277.</span><cite>Noble JM, Scarmeas N, Celenti RS, Elkind MSV, Wright CB, Schupf N, et al. Serum IgG antibody levels to periodontal microbiota are associated with incident alzheimer disease. PLoS ONE. 2014;9:e114959.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0114959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4270775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25522313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Noble%20JM,%20Scarmeas%20N,%20Celenti%20RS,%20Elkind%20MSV,%20Wright%20CB,%20Schupf%20N,%20et%20al.%20Serum%20IgG%20antibody%20levels%20to%20periodontal%20microbiota%20are%20associated%20with%20incident%20alzheimer%20disease.%20PLoS%20ONE.%202014;9:e114959." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR278">
<span class="label">278.</span><cite>Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5:eaau3333.
</cite> [<a href="https://doi.org/10.1126/sciadv.aau3333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6357742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30746447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dominy%20SS,%20Lynch%20C,%20Ermini%20F,%20Benedyk%20M,%20Marczyk%20A,%20Konradi%20A,%20et%20al.%20Porphyromonas%20gingivalis%20in%20alzheimer%E2%80%99s%20disease%20brains:%20evidence%20for%20disease%20causation%20and%20treatment%20with%20small-molecule%20inhibitors.%20Sci%20Adv.%202019;5:eaau3333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR279">
<span class="label">279.</span><cite>Ding Y, Ren J, Yu H, Yu W, Zhou Y. Porphyromonas gingivalis, a periodontitis-causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice. Immun Ageing. 2018;15:6.
</cite> [<a href="https://doi.org/10.1186/s12979-017-0110-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5791180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29422938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20Y,%20Ren%20J,%20Yu%20H,%20Yu%20W,%20Zhou%20Y.%20Porphyromonas%20gingivalis,%20a%20periodontitis-causing%20bacterium,%20induces%20memory%20impairment%20and%20age-dependent%20neuroinflammation%20in%20mice.%20Immun%20Ageing.%202018;15:6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR280">
<span class="label">280.</span><cite>Díaz-Zúñiga J, More J, Melgar-Rodríguez S, Jiménez-Unión M, Villalobos-Orchard F, Muñoz-Manríquez C, et al. Alzheimer’s disease-like pathology triggered by Porphyromonas gingivalis in wild type rats is serotype dependent. Front Immunol. 2020;11:588036.
</cite> [<a href="https://doi.org/10.3389/fimmu.2020.588036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7680957/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33240277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?D%C3%ADaz-Z%C3%BA%C3%B1iga%20J,%20More%20J,%20Melgar-Rodr%C3%ADguez%20S,%20Jim%C3%A9nez-Uni%C3%B3n%20M,%20Villalobos-Orchard%20F,%20Mu%C3%B1oz-Manr%C3%ADquez%20C,%20et%20al.%20Alzheimer%E2%80%99s%20disease-like%20pathology%20triggered%20by%20Porphyromonas%20gingivalis%20in%20wild%20type%20rats%20is%20serotype%20dependent.%20Front%20Immunol.%202020;11:588036." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR281">
<span class="label">281.</span><cite>Hu Y, Li H, Zhang J, Zhang X, Xia X, Qiu C, et al. Periodontitis induced by P. gingivalis-LPS is associated with neuroinflammation and learning and memory impairment in Sprague-Dawley rats. Front Neurosci. 2020;14:710.
</cite> [<a href="https://doi.org/10.3389/fnins.2020.00658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7344110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32714134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20Y,%20Li%20H,%20Zhang%20J,%20Zhang%20X,%20Xia%20X,%20Qiu%20C,%20et%20al.%20Periodontitis%20induced%20by%20P.%20gingivalis-LPS%20is%20associated%20with%20neuroinflammation%20and%20learning%20and%20memory%20impairment%20in%20Sprague-Dawley%20rats.%20Front%20Neurosci.%202020;14:710." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR282">
<span class="label">282.</span><cite>Jin R, Ning X, Liu X, Zhao Y, Ye G. Porphyromonas gingivalis-induced periodontitis could contribute to cognitive impairment in Sprague–Dawley rats via the P38 MAPK signaling pathway. Front Cell Neurosci. 2023;17:1141339.
</cite> [<a href="https://doi.org/10.3389/fncel.2023.1141339" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10086325/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37056710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin%20R,%20Ning%20X,%20Liu%20X,%20Zhao%20Y,%20Ye%20G.%20Porphyromonas%20gingivalis-induced%20periodontitis%20could%20contribute%20to%20cognitive%20impairment%20in%20Sprague%E2%80%93Dawley%20rats%20via%20the%20P38%20MAPK%20signaling%20pathway.%20Front%20Cell%20Neurosci.%202023;17:1141339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR283">
<span class="label">283.</span><cite>Li X, Yao C, Lan D, Chen Y, Wang Y, Qi S. Porphyromonas gingivalis promote microglia M1 polarization through the NF-кB signaling pathway. Heliyon. 2024;10:e35340.</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e35340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11336649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39170188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20X,%20Yao%20C,%20Lan%20D,%20Chen%20Y,%20Wang%20Y,%20Qi%20S.%20Porphyromonas%20gingivalis%20promote%20microglia%20M1%20polarization%20through%20the%20NF-%D0%BAB%20signaling%20pathway.%20Heliyon.%202024;10:e35340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR284">
<span class="label">284.</span><cite>Ilievski V, Zuchowska PK, Green SJ, Toth PT, Ragozzino ME, Le K, et al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS ONE. 2018;13:e0204941.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0204941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6169940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30281647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ilievski%20V,%20Zuchowska%20PK,%20Green%20SJ,%20Toth%20PT,%20Ragozzino%20ME,%20Le%20K,%20et%20al.%20Chronic%20oral%20application%20of%20a%20periodontal%20pathogen%20results%20in%20brain%20inflammation,%20neurodegeneration%20and%20amyloid%20beta%20production%20in%20wild%20type%20mice.%20PLoS%20ONE.%202018;13:e0204941." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR285">
<span class="label">285.</span><cite>Wu Z, Ni J, Liu Y, Teeling JL, Takayama F, Collcutt A, et al. Cathepsin B plays a critical role in inducing alzheimer’s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. Brain Behav Immun. 2017;65:350–61.
</cite> [<a href="https://doi.org/10.1016/j.bbi.2017.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28610747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20Z,%20Ni%20J,%20Liu%20Y,%20Teeling%20JL,%20Takayama%20F,%20Collcutt%20A,%20et%20al.%20Cathepsin%20B%20plays%20a%20critical%20role%20in%20inducing%20alzheimer%E2%80%99s%20disease-like%20phenotypes%20following%20chronic%20systemic%20exposure%20to%20lipopolysaccharide%20from%20Porphyromonas%20gingivalis%20in%20mice.%20Brain%20Behav%20Immun.%202017;65:350%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR286">
<span class="label">286.</span><cite>Tze M, Huang H, Taxman DJ, Holley-Guthrie EA, Moore CB, Willingham SB, et al. Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells. J Immunol. 2009;182:2395–404.
</cite> [<a href="https://doi.org/10.4049/jimmunol.0800909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19201894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tze%20M,%20Huang%20H,%20Taxman%20DJ,%20Holley-Guthrie%20EA,%20Moore%20CB,%20Willingham%20SB,%20et%20al.%20Critical%20role%20of%20apoptotic%20speck%20protein%20containing%20a%20caspase%20recruitment%20domain%20(ASC)%20and%20NLRP3%20in%20causing%20necrosis%20and%20ASC%20speck%20formation%20induced%20by%20Porphyromonas%20gingivalis%20in%20human%20cells.%20J%20Immunol.%202009;182:2395%E2%80%93404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR287">
<span class="label">287.</span><cite>Yamaguchi Y, Kurita-Ochiai T, Kobayashi R, Suzuki T, Ando T. Regulation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated periodontal disease. Inflamm Res. 2017;66:59–65.
</cite> [<a href="https://doi.org/10.1007/s00011-016-0992-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27665233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamaguchi%20Y,%20Kurita-Ochiai%20T,%20Kobayashi%20R,%20Suzuki%20T,%20Ando%20T.%20Regulation%20of%20the%20NLRP3%20inflammasome%20in%20Porphyromonas%20gingivalis-accelerated%20periodontal%20disease.%20Inflamm%20Res.%202017;66:59%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR288">
<span class="label">288.</span><cite>Weng Y, Wang H, Li L, Feng Y, Xu S, Wang Z. TREM2-mediated Syk-dependent ROS amplification is essential for osteoclastogenesis in periodontitis microenvironment. Redox Biol. 2020;40:101849.
</cite> [<a href="https://doi.org/10.1016/j.redox.2020.101849" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7823053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33486152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weng%20Y,%20Wang%20H,%20Li%20L,%20Feng%20Y,%20Xu%20S,%20Wang%20Z.%20TREM2-mediated%20Syk-dependent%20ROS%20amplification%20is%20essential%20for%20osteoclastogenesis%20in%20periodontitis%20microenvironment.%20Redox%20Biol.%202020;40:101849." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR289">
<span class="label">289.</span><cite>Kantarci A, Tognoni CM, Yaghmoor W, Marghalani A, Stephens D, Ahn JY, et al. Microglial response to experimental periodontitis in a murine model of alzheimer’s disease. Sci Rep. 2020;10:17999.
</cite> [<a href="https://doi.org/10.1038/s41598-020-75517-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7596239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33122702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kantarci%20A,%20Tognoni%20CM,%20Yaghmoor%20W,%20Marghalani%20A,%20Stephens%20D,%20Ahn%20JY,%20et%20al.%20Microglial%20response%20to%20experimental%20periodontitis%20in%20a%20murine%20model%20of%20alzheimer%E2%80%99s%20disease.%20Sci%20Rep.%202020;10:17999." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR290">
<span class="label">290.</span><cite>Singhrao SK, Chukkapalli S, Poole S, Velsko I, Crean SJ, Kesavalu L. Chronic Porphyromonas gingivalis infection accelerates the occurrence of age-related granules in ApoE–/– mice brains. J Oral Microbiol. 2017;9:1322444.</cite> [<a href="https://doi.org/10.1080/20002297.2016.1270602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5328363/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28326151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singhrao%20SK,%20Chukkapalli%20S,%20Poole%20S,%20Velsko%20I,%20Crean%20SJ,%20Kesavalu%20L.%20Chronic%20Porphyromonas%20gingivalis%20infection%20accelerates%20the%20occurrence%20of%20age-related%20granules%20in%20ApoE%E2%80%93/%E2%80%93%20mice%20brains.%20J%20Oral%20Microbiol.%202017;9:1322444." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR291">
<span class="label">291.</span><cite>Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean SJ. Determining the presence of periodontopathic virulence factors in short-term postmortem alzheimer’s disease brain tissue. J Alzheimers Dis. 2013;36:665–77.
</cite> [<a href="https://doi.org/10.3233/JAD-121918" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23666172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Poole%20S,%20Singhrao%20SK,%20Kesavalu%20L,%20Curtis%20MA,%20Crean%20SJ.%20Determining%20the%20presence%20of%20periodontopathic%20virulence%20factors%20in%20short-term%20postmortem%20alzheimer%E2%80%99s%20disease%20brain%20tissue.%20J%20Alzheimers%20Dis.%202013;36:665%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR292">
<span class="label">292.</span><cite>Zang Y, Song JH, Oh SH, Kim JW, Lee MN, Piao X, et al. Targeting NLRP3 inflammasome reduces age-related experimental alveolar bone loss. J Dent Res. 2020;99:1287–95.
</cite> [<a href="https://doi.org/10.1177/0022034520933533" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32531176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zang%20Y,%20Song%20JH,%20Oh%20SH,%20Kim%20JW,%20Lee%20MN,%20Piao%20X,%20et%20al.%20Targeting%20NLRP3%20inflammasome%20reduces%20age-related%20experimental%20alveolar%20bone%20loss.%20J%20Dent%20Res.%202020;99:1287%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR293">
<span class="label">293.</span><cite>Arita Y, Yoshinaga Y, Kaneko T, Kawahara Y, Nakamura K, Ohgi K, et al. Glyburide inhibits the bone resorption induced by traumatic occlusion in rats. J Periodontal Res. 2020;55:464–71.
</cite> [<a href="https://doi.org/10.1111/jre.12731" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32153049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arita%20Y,%20Yoshinaga%20Y,%20Kaneko%20T,%20Kawahara%20Y,%20Nakamura%20K,%20Ohgi%20K,%20et%20al.%20Glyburide%20inhibits%20the%20bone%20resorption%20induced%20by%20traumatic%20occlusion%20in%20rats.%20J%20Periodontal%20Res.%202020;55:464%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR294">
<span class="label">294.</span><cite>Jiang M, Shang Z, Zhang T, Yin X, Liang X, Sun H. Study on the role of pyroptosis in bone resorption induced by occlusal trauma with or without periodontitis. J Periodontal Res. 2022;57:448–60.
</cite> [<a href="https://doi.org/10.1111/jre.12974" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35141913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20M,%20Shang%20Z,%20Zhang%20T,%20Yin%20X,%20Liang%20X,%20Sun%20H.%20Study%20on%20the%20role%20of%20pyroptosis%20in%20bone%20resorption%20induced%20by%20occlusal%20trauma%20with%20or%20without%20periodontitis.%20J%20Periodontal%20Res.%202022;57:448%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR295">
<span class="label">295.</span><cite>Kamer AR, Fortea JO, Videla S, Mayoral A, Janal M, Carmona-Iragui M, et al. Periodontal disease’s contribution to alzheimer’s disease progression in down syndrome. Alzheimers Dement Diagn Assess Dis Monit. 2016;2:49.</cite> [<a href="https://doi.org/10.1016/j.dadm.2016.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4879643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27239536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kamer%20AR,%20Fortea%20JO,%20Videla%20S,%20Mayoral%20A,%20Janal%20M,%20Carmona-Iragui%20M,%20et%20al.%20Periodontal%20disease%E2%80%99s%20contribution%20to%20alzheimer%E2%80%99s%20disease%20progression%20in%20down%20syndrome.%20Alzheimers%20Dement%20Diagn%20Assess%20Dis%20Monit.%202016;2:49." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR296">
<span class="label">296.</span><cite>Goyal D, Ali SA, Singh RK. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106:110112.
</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2020.110112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32949638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goyal%20D,%20Ali%20SA,%20Singh%20RK.%20Emerging%20role%20of%20gut%20microbiota%20in%20modulation%20of%20neuroinflammation%20and%20neurodegeneration%20with%20emphasis%20on%20alzheimer%E2%80%99s%20disease.%20Prog%20Neuropsychopharmacol%20Biol%20Psychiatry.%202021;106:110112." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR297">
<span class="label">297.</span><cite>Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol. 2022;20:24–37.
</cite> [<a href="https://doi.org/10.1038/s41569-022-00737-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9284488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35840742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Violi%20F,%20Cammisotto%20V,%20Bartimoccia%20S,%20Pignatelli%20P,%20Carnevale%20R,%20Nocella%20C.%20Gut-derived%20low-grade%20endotoxaemia,%20atherothrombosis%20and%20cardiovascular%20disease.%20Nat%20Rev%20Cardiol.%202022;20:24%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR298">
<span class="label">298.</span><cite>Wang J, Gu X, Yang J, Wei Y, Zhao Y. Gut microbiota dysbiosis and increased plasma LPS and TMAO levels in patients with preeclampsia. Front Cell Infect Microbiol. 2019;9:480172.</cite> [<a href="https://doi.org/10.3389/fcimb.2019.00409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6901393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31850241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Gu%20X,%20Yang%20J,%20Wei%20Y,%20Zhao%20Y.%20Gut%20microbiota%20dysbiosis%20and%20increased%20plasma%20LPS%20and%20TMAO%20levels%20in%20patients%20with%20preeclampsia.%20Front%20Cell%20Infect%20Microbiol.%202019;9:480172." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR299">
<span class="label">299.</span><cite>Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of alzheimer’s disease. Sci Rep. 2016;6:30028.
</cite> [<a href="https://doi.org/10.1038/srep30028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4956742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27443609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Minter%20MR,%20Zhang%20C,%20Leone%20V,%20Ringus%20DL,%20Zhang%20X,%20Oyler-Castrillo%20P,%20et%20al.%20Antibiotic-induced%20perturbations%20in%20gut%20microbial%20diversity%20influences%20neuro-inflammation%20and%20amyloidosis%20in%20a%20murine%20model%20of%20alzheimer%E2%80%99s%20disease.%20Sci%20Rep.%202016;6:30028." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR300">
<span class="label">300.</span><cite>Yang D, Wang Z, Chen Y, Guo Q, Dong Y. Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis. Comput Struct Biotechnol J. 2023;21:2215.
</cite> [<a href="https://doi.org/10.1016/j.csbj.2023.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10074411/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37035548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20D,%20Wang%20Z,%20Chen%20Y,%20Guo%20Q,%20Dong%20Y.%20Interactions%20between%20gut%20microbes%20and%20NLRP3%20inflammasome%20in%20the%20gut-brain%20axis.%20Comput%20Struct%20Biotechnol%20J.%202023;21:2215." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR301">
<span class="label">301.</span><cite>Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, et al. New mechanism of neuroinflammation in alzheimer’s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109884.
</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2020.109884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32032696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20H,%20Guan%20Q,%20Zhang%20X,%20Yuan%20C,%20Tan%20Z,%20Zhai%20L,%20et%20al.%20New%20mechanism%20of%20neuroinflammation%20in%20alzheimer%E2%80%99s%20disease:%20the%20activation%20of%20NLRP3%20inflammasome%20mediated%20by%20gut%20microbiota.%20Prog%20Neuropsychopharmacol%20Biol%20Psychiatry.%202020;100:109884." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR302">
<span class="label">302.</span><cite>Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE. 2010;5:10667.</cite> [<a href="https://doi.org/10.1371/journal.pone.0010667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2871786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20498852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Biagi%20E,%20Nylund%20L,%20Candela%20M,%20Ostan%20R,%20Bucci%20L,%20Pini%20E,%20et%20al.%20Through%20ageing,%20and%20beyond:%20gut%20microbiota%20and%20inflammatory%20status%20in%20seniors%20and%20centenarians.%20PLoS%20ONE.%202010;5:10667." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR303">
<span class="label">303.</span><cite>Li B, He Y, Ma J, Huang P, Du J, Cao L, et al. Mild cognitive impairment has similar alterations as alzheimer’s disease in gut microbiota. Alzheimers Dement. 2019;15:1357–66.
</cite> [<a href="https://doi.org/10.1016/j.jalz.2019.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31434623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20B,%20He%20Y,%20Ma%20J,%20Huang%20P,%20Du%20J,%20Cao%20L,%20et%20al.%20Mild%20cognitive%20impairment%20has%20similar%20alterations%20as%20alzheimer%E2%80%99s%20disease%20in%20gut%20microbiota.%20Alzheimers%20Dement.%202019;15:1357%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR304">
<span class="label">304.</span><cite>Saha P, Weigle IQ, Slimmon N, Poli PB, Patel P, Zhang X, et al. Early modulation of the gut Microbiome by female sex hormones alters amyloid pathology and microglial function. Sci Rep. 2024;14:52246.</cite> [<a href="https://doi.org/10.1038/s41598-024-52246-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10800351/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38246956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saha%20P,%20Weigle%20IQ,%20Slimmon%20N,%20Poli%20PB,%20Patel%20P,%20Zhang%20X,%20et%20al.%20Early%20modulation%20of%20the%20gut%20Microbiome%20by%20female%20sex%20hormones%20alters%20amyloid%20pathology%20and%20microglial%20function.%20Sci%20Rep.%202024;14:52246." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR305">
<span class="label">305.</span><cite>Bosch ME, Dodiya HB, Michalkiewicz J, Lee C, Shaik SM, Weigle IQ, et al. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner. Mol Neurodegener. 2024;19:26.
</cite> [<a href="https://doi.org/10.1186/s13024-023-00700-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10874048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38365827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bosch%20ME,%20Dodiya%20HB,%20Michalkiewicz%20J,%20Lee%20C,%20Shaik%20SM,%20Weigle%20IQ,%20et%20al.%20Sodium%20oligomannate%20alters%20gut%20microbiota,%20reduces%20cerebral%20amyloidosis%20and%20reactive%20microglia%20in%20a%20sex-specific%20manner.%20Mol%20Neurodegener.%202024;19:26." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR306">
<span class="label">306.</span><cite>Park G, Kadyan S, Hochuli N, Salazar G, Laitano O, Chakrabarty P, et al. An enteric bacterial infection triggers neuroinflammation and neurobehavioral impairment in 3xTg-AD Transgenic mice. J Infect Dis. 2024;230:S95–108.
</cite> [<a href="https://doi.org/10.1093/infdis/jiae165" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11385593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39255397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Park%20G,%20Kadyan%20S,%20Hochuli%20N,%20Salazar%20G,%20Laitano%20O,%20Chakrabarty%20P,%20et%20al.%20An%20enteric%20bacterial%20infection%20triggers%20neuroinflammation%20and%20neurobehavioral%20impairment%20in%203xTg-AD%20Transgenic%20mice.%20J%20Infect%20Dis.%202024;230:S95%E2%80%93108." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR307">
<span class="label">307.</span><cite>Chen CH, Lin CL, Kao CH. Irritable bowel syndrome is associated with an increased risk of dementia: A nationwide population-based study. PLoS ONE. 2016;11:144589.</cite> [<a href="https://doi.org/10.1371/journal.pone.0144589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4701489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26731277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20CH,%20Lin%20CL,%20Kao%20CH.%20Irritable%20bowel%20syndrome%20is%20associated%20with%20an%20increased%20risk%20of%20dementia:%20A%20nationwide%20population-based%20study.%20PLoS%20ONE.%202016;11:144589." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR308">
<span class="label">308.</span><cite>Caini S, Bagnoli S, Palli D, Saieva C, Ceroti M, Bendinelli B, et al. Total and cancer mortality in a cohort of ulcerative colitis and crohn’s disease patients: the Florence inflammatory bowel disease study, 1978–2010. Dig Liver Dis. 2016;48:1162–7.
</cite> [<a href="https://doi.org/10.1016/j.dld.2016.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27481588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Caini%20S,%20Bagnoli%20S,%20Palli%20D,%20Saieva%20C,%20Ceroti%20M,%20Bendinelli%20B,%20et%20al.%20Total%20and%20cancer%20mortality%20in%20a%20cohort%20of%20ulcerative%20colitis%20and%20crohn%E2%80%99s%20disease%20patients:%20the%20Florence%20inflammatory%20bowel%20disease%20study,%201978%E2%80%932010.%20Dig%20Liver%20Dis.%202016;48:1162%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR309">
<span class="label">309.</span><cite>White L, Petrovitch H, Ross GW, Masaki KH, Abbott RD, Teng EL, et al. Prevalence of dementia in older Japanese-American men in hawaii: the Honolulu-Asia aging study. JAMA. 1996;276:955–60.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8805729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?White%20L,%20Petrovitch%20H,%20Ross%20GW,%20Masaki%20KH,%20Abbott%20RD,%20Teng%20EL,%20et%20al.%20Prevalence%20of%20dementia%20in%20older%20Japanese-American%20men%20in%20hawaii:%20the%20Honolulu-Asia%20aging%20study.%20JAMA.%201996;276:955%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR310">
<span class="label">310.</span><cite>Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H. Probiotics for alzheimer’s disease: A systematic review. Nutrients. 2022;14:20.</cite> [<a href="https://doi.org/10.3390/nu14010020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8746506/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35010895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naomi%20R,%20Embong%20H,%20Othman%20F,%20Ghazi%20HF,%20Maruthey%20N,%20Bahari%20H.%20Probiotics%20for%20alzheimer%E2%80%99s%20disease:%20A%20systematic%20review.%20Nutrients.%202022;14:20." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR311">
<span class="label">311.</span><cite>Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and Tau pathology in an alzheimer’s disease animal model. Gut. 2020;69:283–94.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2018-317431" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31471351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20MS,%20Kim%20Y,%20Choi%20H,%20Kim%20W,%20Park%20S,%20Lee%20D,%20et%20al.%20Transfer%20of%20a%20healthy%20microbiota%20reduces%20amyloid%20and%20Tau%20pathology%20in%20an%20alzheimer%E2%80%99s%20disease%20animal%20model.%20Gut.%202020;69:283%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR312">
<span class="label">312.</span><cite>Webberley TS, Masetti G, Bevan RJ, Kerry-Smith J, Jack AA, Michael DR, et al. The impact of probiotic supplementation on cognitive, pathological and metabolic markers in a Transgenic mouse model of alzheimer’s disease. Front Neurosci. 2022;16:843105.
</cite> [<a href="https://doi.org/10.3389/fnins.2022.843105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9172594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35685773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Webberley%20TS,%20Masetti%20G,%20Bevan%20RJ,%20Kerry-Smith%20J,%20Jack%20AA,%20Michael%20DR,%20et%20al.%20The%20impact%20of%20probiotic%20supplementation%20on%20cognitive,%20pathological%20and%20metabolic%20markers%20in%20a%20Transgenic%20mouse%20model%20of%20alzheimer%E2%80%99s%20disease.%20Front%20Neurosci.%202022;16:843105." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR313">
<span class="label">313.</span><cite>Akbari E, Asemi Z, Kakhaki RD, Bahmani F, Kouchaki E, Tamtaji OR, et al. Effect of probiotic supplementation on cognitive function and metabolic status in alzheimer’s disease: A randomized, double-blind and controlled trial. Front Aging Neurosci. 2016;8:256.
</cite> [<a href="https://doi.org/10.3389/fnagi.2016.00256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5105117/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27891089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akbari%20E,%20Asemi%20Z,%20Kakhaki%20RD,%20Bahmani%20F,%20Kouchaki%20E,%20Tamtaji%20OR,%20et%20al.%20Effect%20of%20probiotic%20supplementation%20on%20cognitive%20function%20and%20metabolic%20status%20in%20alzheimer%E2%80%99s%20disease:%20A%20randomized,%20double-blind%20and%20controlled%20trial.%20Front%20Aging%20Neurosci.%202016;8:256." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR314">
<span class="label">314.</span><cite>Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: A population-based twin study. Neurology. 2011;76:1568.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e3182190d09" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3100125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21536637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20WL,%20Atti%20AR,%20Gatz%20M,%20Pedersen%20NL,%20Johansson%20B,%20Fratiglioni%20L.%20Midlife%20overweight%20and%20obesity%20increase%20late-life%20dementia%20risk:%20A%20population-based%20twin%20study.%20Neurology.%202011;76:1568." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR315">
<span class="label">315.</span><cite>Hassing LB, Dahl AK, Thorvaldsson V, Berg S, Gatz M, Pedersen NL, et al. Overweight in midlife and risk of dementia: A 40-year follow-up study. Int J Obes (Lond). 2009;33:893.
</cite> [<a href="https://doi.org/10.1038/ijo.2009.104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3025291/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19506566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hassing%20LB,%20Dahl%20AK,%20Thorvaldsson%20V,%20Berg%20S,%20Gatz%20M,%20Pedersen%20NL,%20et%20al.%20Overweight%20in%20midlife%20and%20risk%20of%20dementia:%20A%2040-year%20follow-up%20study.%20Int%20J%20Obes%20(Lond).%202009;33:893." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR316">
<span class="label">316.</span><cite>Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of alzheimer disease. Arch Intern Med. 2003;163:1524–8.
</cite> [<a href="https://doi.org/10.1001/archinte.163.13.1524" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12860573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gustafson%20D,%20Rothenberg%20E,%20Blennow%20K,%20Steen%20B,%20Skoog%20I.%20An%2018-year%20follow-up%20of%20overweight%20and%20risk%20of%20alzheimer%20disease.%20Arch%20Intern%20Med.%202003;163:1524%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR317">
<span class="label">317.</span><cite>Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ. 2005;330:1360.
</cite> [<a href="https://doi.org/10.1136/bmj.38446.466238.E0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC558283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15863436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whitmer%20RA,%20Gunderson%20EP,%20Barrett-Connor%20E,%20Quesenberry%20CP,%20Yaffe%20K.%20Obesity%20in%20middle%20age%20and%20future%20risk%20of%20dementia:%20A%2027%20year%20longitudinal%20population%20based%20study.%20BMJ.%202005;330:1360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR318">
<span class="label">318.</span><cite>Sun Z, Wang ZT, Sun FR, Shen XN, Xu W, Ma YH, et al. Late-life obesity is a protective factor for prodromal alzheimer’s disease: A longitudinal study. Aging. 2020;12:2005.
</cite> [<a href="https://doi.org/10.18632/aging.102738" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7053604/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31986486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20Z,%20Wang%20ZT,%20Sun%20FR,%20Shen%20XN,%20Xu%20W,%20Ma%20YH,%20et%20al.%20Late-life%20obesity%20is%20a%20protective%20factor%20for%20prodromal%20alzheimer%E2%80%99s%20disease:%20A%20longitudinal%20study.%20Aging.%202020;12:2005." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR319">
<span class="label">319.</span><cite>Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: Nine-year follow-up data from the kungsholmen project. J Am Geriatr Soc. 2008;56:111–6.
</cite> [<a href="https://doi.org/10.1111/j.1532-5415.2007.01458.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18028342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Atti%20AR,%20Palmer%20K,%20Volpato%20S,%20Winblad%20B,%20De%20Ronchi%20D,%20Fratiglioni%20L.%20Late-life%20body%20mass%20index%20and%20dementia%20incidence:%20Nine-year%20follow-up%20data%20from%20the%20kungsholmen%20project.%20J%20Am%20Geriatr%20Soc.%202008;56:111%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR320">
<span class="label">320.</span><cite>Nourhashémi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P. Body mass index and incidence of dementia: the PAQUID study. Neurology. 2003;60:117–9.
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000038910.46217.aa" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12525731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nourhash%C3%A9mi%20F,%20Deschamps%20V,%20Larrieu%20S,%20Letenneur%20L,%20Dartigues%20JF,%20Barberger-Gateau%20P.%20Body%20mass%20index%20and%20incidence%20of%20dementia:%20the%20PAQUID%20study.%20Neurology.%202003;60:117%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR321">
<span class="label">321.</span><cite>Pegueroles J, Jiménez A, Vilaplana E, Montal V, Carmona-Iragui M, Pané A, et al. Obesity and alzheimer’s disease, does the obesity paradox really exist? A magnetic resonance imaging study. Oncotarget. 2018;9:34691.
</cite> [<a href="https://doi.org/10.18632/oncotarget.26162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6205180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30410669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pegueroles%20J,%20Jim%C3%A9nez%20A,%20Vilaplana%20E,%20Montal%20V,%20Carmona-Iragui%20M,%20Pan%C3%A9%20A,%20et%20al.%20Obesity%20and%20alzheimer%E2%80%99s%20disease,%20does%20the%20obesity%20paradox%20really%20exist?%20A%20magnetic%20resonance%20imaging%20study.%20Oncotarget.%202018;9:34691." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR322">
<span class="label">322.</span><cite>Jimenez A, Pegueroles J, Carmona-Iragui M, Vilaplana E, Montal V, Alcolea D, et al. Weight loss in the healthy elderly might be a non-cognitive sign of preclinical alzheimer’s disease. Oncotarget. 2017;8:104706–16.
</cite> [<a href="https://doi.org/10.18632/oncotarget.22218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5739594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29285207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jimenez%20A,%20Pegueroles%20J,%20Carmona-Iragui%20M,%20Vilaplana%20E,%20Montal%20V,%20Alcolea%20D,%20et%20al.%20Weight%20loss%20in%20the%20healthy%20elderly%20might%20be%20a%20non-cognitive%20sign%20of%20preclinical%20alzheimer%E2%80%99s%20disease.%20Oncotarget.%202017;8:104706%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR323">
<span class="label">323.</span><cite>n Den Berg E, Biessels GJ, De Craen AJM, Gussekloo J, Westendorp RGJ. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 2007;69:979–85.
</cite> [<a href="https://doi.org/10.1212/01.wnl.0000271381.30143.75" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17785666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?n%20Den%20Berg%20E,%20Biessels%20GJ,%20De%20Craen%20AJM,%20Gussekloo%20J,%20Westendorp%20RGJ.%20The%20metabolic%20syndrome%20is%20associated%20with%20decelerated%20cognitive%20decline%20in%20the%20oldest%20old.%20Neurology.%202007;69:979%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR324">
<span class="label">324.</span><cite>Alsuwaidi HN, Ahmed AI, Alkorbi HA, Ali SM, Altarawneh LN, Uddin SI, et al. Association between metabolic syndrome and decline in cognitive function: A cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:849.
</cite> [<a href="https://doi.org/10.2147/DMSO.S393282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10039709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36974329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alsuwaidi%20HN,%20Ahmed%20AI,%20Alkorbi%20HA,%20Ali%20SM,%20Altarawneh%20LN,%20Uddin%20SI,%20et%20al.%20Association%20between%20metabolic%20syndrome%20and%20decline%20in%20cognitive%20function:%20A%20cross-sectional%20study.%20Diabetes%20Metab%20Syndr%20Obes.%202023;16:849." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR325">
<span class="label">325.</span><cite>Ezkurdia A, Ramírez MJ, Solas M. Metabolic syndrome as a risk factor for alzheimer’s disease: A focus on insulin resistance. Int J Mol Sci. 2023;24:4354.
</cite> [<a href="https://doi.org/10.3390/ijms24054354" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10001958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36901787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ezkurdia%20A,%20Ram%C3%ADrez%20MJ,%20Solas%20M.%20Metabolic%20syndrome%20as%20a%20risk%20factor%20for%20alzheimer%E2%80%99s%20disease:%20A%20focus%20on%20insulin%20resistance.%20Int%20J%20Mol%20Sci.%202023;24:4354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR326">
<span class="label">326.</span><cite>Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and alzheimer disease. Arch Neurol. 2007;64:93–6.
</cite> [<a href="https://doi.org/10.1001/archneur.64.1.93" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17210814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Razay%20G,%20Vreugdenhil%20A,%20Wilcock%20G.%20The%20metabolic%20syndrome%20and%20alzheimer%20disease.%20Arch%20Neurol.%202007;64:93%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR327">
<span class="label">327.</span><cite>Qureshi D, Collister J, Allen NE, Kuźma E, Littlejohns T. Association between metabolic syndrome and risk of incident dementia in UK biobank. Alzheimer’s Dement. 2024;20:447–58.
</cite> [<a href="https://doi.org/10.1002/alz.13439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10916994/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37675869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qureshi%20D,%20Collister%20J,%20Allen%20NE,%20Ku%C5%BAma%20E,%20Littlejohns%20T.%20Association%20between%20metabolic%20syndrome%20and%20risk%20of%20incident%20dementia%20in%20UK%20biobank.%20Alzheimer%E2%80%99s%20Dement.%202024;20:447%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR328">
<span class="label">328.</span><cite>Frentz I, Marcolini S, Schneider CCI, Ikram MA, Mondragon J, De Deyn PP. Metabolic syndrome status changes and cognitive functioning: insights from the lifelines cohort study. J Prev Alzheimers Dis. 2024;11:1283.
</cite> [<a href="https://doi.org/10.14283/jpad.2024.90" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11436447/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39350374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Frentz%20I,%20Marcolini%20S,%20Schneider%20CCI,%20Ikram%20MA,%20Mondragon%20J,%20De%20Deyn%20PP.%20Metabolic%20syndrome%20status%20changes%20and%20cognitive%20functioning:%20insights%20from%20the%20lifelines%20cohort%20study.%20J%20Prev%20Alzheimers%20Dis.%202024;11:1283." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR329">
<span class="label">329.</span><cite>Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A chronic Low-Grade inflammation and its markers. Cureus. 2022;14.</cite> [<a href="https://doi.org/10.7759/cureus.22711" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8967417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35386146/" class="usa-link">PubMed</a>]</li>
<li id="CR330">
<span class="label">330.</span><cite>Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract. 2005;69:29–35.
</cite> [<a href="https://doi.org/10.1016/j.diabres.2004.11.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15955385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Park%20HS,%20Park%20JY,%20Yu%20R.%20Relationship%20of%20obesity%20and%20visceral%20adiposity%20with%20serum%20concentrations%20of%20CRP,%20TNF-%CE%B1%20and%20IL-6.%20Diabetes%20Res%20Clin%20Pract.%202005;69:29%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR331">
<span class="label">331.</span><cite>Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008;114:183–94.
</cite> [<a href="https://doi.org/10.1080/13813450802181047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18629684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nieto-Vazquez%20I,%20Fern%C3%A1ndez-Veledo%20S,%20Kr%C3%A4mer%20DK,%20Vila-Bedmar%20R,%20Garcia-Guerra%20L,%20Lorenzo%20M.%20Insulin%20resistance%20associated%20to%20obesity:%20the%20link%20TNF-alpha.%20Arch%20Physiol%20Biochem.%202008;114:183%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR332">
<span class="label">332.</span><cite>Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis Factor-α concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999;84:272–8.
</cite> [<a href="https://doi.org/10.1210/jcem.84.1.5405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9920095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zinman%20B,%20Hanley%20AJG,%20Harris%20SB,%20Kwan%20J,%20Fantus%20IG.%20Circulating%20tumor%20necrosis%20Factor-%CE%B1%20concentrations%20in%20a%20native%20Canadian%20population%20with%20high%20rates%20of%20type%202%20diabetes%20mellitus.%20J%20Clin%20Endocrinol%20Metab.%201999;84:272%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR333">
<span class="label">333.</span><cite>Gupta S, Knight AG, Gupta S, Keller JN, Bruce-Keller AJ. Saturated long chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem. 2012;120:1060.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2012.07660.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3296820/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22248073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gupta%20S,%20Knight%20AG,%20Gupta%20S,%20Keller%20JN,%20Bruce-Keller%20AJ.%20Saturated%20long%20chain%20fatty%20acids%20activate%20inflammatory%20signaling%20in%20astrocytes.%20J%20Neurochem.%202012;120:1060." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR334">
<span class="label">334.</span><cite>Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and alzheimer’s disease. Biochim Biophys Acta. 2017;1863:1037.</cite> [<a href="https://doi.org/10.1016/j.bbadis.2016.04.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5344771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27156888/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pugazhenthi%20S,%20Qin%20L,%20Reddy%20PH.%20Common%20neurodegenerative%20pathways%20in%20obesity,%20diabetes,%20and%20alzheimer%E2%80%99s%20disease.%20Biochim%20Biophys%20Acta.%202017;1863:1037." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR335">
<span class="label">335.</span><cite>Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179–88.
</cite> [<a href="https://doi.org/10.1038/nm.2279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3076025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21217695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vandanmagsar%20B,%20Youm%20YH,%20Ravussin%20A,%20Galgani%20JE,%20Stadler%20K,%20Mynatt%20RL,%20et%20al.%20The%20NLRP3%20inflammasome%20instigates%20obesity-induced%20inflammation%20and%20insulin%20resistance.%20Nat%20Med.%202011;17:179%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR336">
<span class="label">336.</span><cite>Thornton P, Reader V, Digby Z, Smolak P, Lindsay N, Harrison D, et al. Reversal of high fat Diet-Induced obesity, systemic inflammation, and astrogliosis by the NLRP3 inflammasome inhibitors NT-0249 and NT-0796. J Pharmacol Exp Ther. 2024;388:813–26.
</cite> [<a href="https://doi.org/10.1124/jpet.123.002013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38336379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thornton%20P,%20Reader%20V,%20Digby%20Z,%20Smolak%20P,%20Lindsay%20N,%20Harrison%20D,%20et%20al.%20Reversal%20of%20high%20fat%20Diet-Induced%20obesity,%20systemic%20inflammation,%20and%20astrogliosis%20by%20the%20NLRP3%20inflammasome%20inhibitors%20NT-0249%20and%20NT-0796.%20J%20Pharmacol%20Exp%20Ther.%202024;388:813%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR337">
<span class="label">337.</span><cite>Telemaco Contreras Colmenares M, de Oliveira Matos A, Henrique dos Santos Dantas P, Rodrigues do Carmo Neto, Silva-Sales J, Sales-Campos M. H. Unveiling the impact of TREM-2 + Macrophages in metabolic disorders. Cell Immunol. 2024;405:104882.</cite> [<a href="https://doi.org/10.1016/j.cellimm.2024.104882" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39369473/" class="usa-link">PubMed</a>]</li>
<li id="CR338">
<span class="label">338.</span><cite>Zhao C, Qi W, Lv X, Gao X, Liu C, Zheng S. Elucidating the role of Trem2 in lipid metabolism and neuroinflammation. CNS Neurosci Ther. 2025;31:e70338.
</cite> [<a href="https://doi.org/10.1111/cns.70338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11982525/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40205810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20C,%20Qi%20W,%20Lv%20X,%20Gao%20X,%20Liu%20C,%20Zheng%20S.%20Elucidating%20the%20role%20of%20Trem2%20in%20lipid%20metabolism%20and%20neuroinflammation.%20CNS%20Neurosci%20Ther.%202025;31:e70338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR339">
<span class="label">339.</span><cite>Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, et al. Enhanced risk for alzheimer disease in persons with type 2 diabetes and APOE ε4: the cardiovascular health study cognition study. Arch Neurol. 2008;65:89–93.
</cite> [<a href="https://doi.org/10.1001/archneurol.2007.29" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11070951/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18195144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Irie%20F,%20Fitzpatrick%20AL,%20Lopez%20OL,%20Kuller%20LH,%20Peila%20R,%20Newman%20AB,%20et%20al.%20Enhanced%20risk%20for%20alzheimer%20disease%20in%20persons%20with%20type%202%20diabetes%20and%20APOE%20%CE%B54:%20the%20cardiovascular%20health%20study%20cognition%20study.%20Arch%20Neurol.%202008;65:89%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR340">
<span class="label">340.</span><cite>Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661–6.
</cite> [<a href="https://doi.org/10.1001/archneur.61.5.661" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15148141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arvanitakis%20Z,%20Wilson%20RS,%20Bienias%20JL,%20Evans%20DA,%20Bennett%20DA.%20Diabetes%20mellitus%20and%20risk%20of%20alzheimer%20disease%20and%20decline%20in%20cognitive%20function.%20Arch%20Neurol.%202004;61:661%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR341">
<span class="label">341.</span><cite>Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O’Brien PC, et al. The risk of dementia among persons with diabetes mellitus: A Population-Based cohort studya. Ann N Y Acad Sci. 1997;826:422–7.
</cite> [<a href="https://doi.org/10.1111/j.1749-6632.1997.tb48496.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9329716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leibson%20CL,%20Rocca%20WA,%20Hanson%20VA,%20Cha%20R,%20Kokmen%20E,%20O%E2%80%99Brien%20PC,%20et%20al.%20The%20risk%20of%20dementia%20among%20persons%20with%20diabetes%20mellitus:%20A%20Population-Based%20cohort%20studya.%20Ann%20N%20Y%20Acad%20Sci.%201997;826:422%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR342">
<span class="label">342.</span><cite>Ott A, Stolk RP, Van Harskamp F, Pols HAP, Hofman A, Breteler MMB. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53:1937–42.
</cite> [<a href="https://doi.org/10.1212/wnl.53.9.1937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10599761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ott%20A,%20Stolk%20RP,%20Van%20Harskamp%20F,%20Pols%20HAP,%20Hofman%20A,%20Breteler%20MMB.%20Diabetes%20mellitus%20and%20the%20risk%20of%20dementia:%20the%20Rotterdam%20study.%20Neurology.%201999;53:1937%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR343">
<span class="label">343.</span><cite>Neth BJ, Craft S. Insulin resistance and alzheimer’s disease: bioenergetic linkages. Front Aging Neurosci. 2017;9:309307.</cite> [<a href="https://doi.org/10.3389/fnagi.2017.00345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5671587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29163128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neth%20BJ,%20Craft%20S.%20Insulin%20resistance%20and%20alzheimer%E2%80%99s%20disease:%20bioenergetic%20linkages.%20Front%20Aging%20Neurosci.%202017;9:309307." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR344">
<span class="label">344.</span><cite>Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in alzheimer’s disease? Trends Pharmacol Sci. 2002;23:288–93.
</cite> [<a href="https://doi.org/10.1016/s0165-6147(02)02037-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12084635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gasparini%20L,%20Netzer%20WJ,%20Greengard%20P,%20Xu%20H.%20Does%20insulin%20dysfunction%20play%20a%20role%20in%20alzheimer%E2%80%99s%20disease?%20Trends%20Pharmacol%20Sci.%202002;23:288%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR345">
<span class="label">345.</span><cite>Devi L, Alldred MJ, Ginsberg SD, Ohno M. Mechanisms underlying insulin Deficiency-Induced acceleration of β-Amyloidosis in a mouse model of alzheimer’s disease. PLoS ONE. 2012;7:e32792.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0032792" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3293895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22403710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Devi%20L,%20Alldred%20MJ,%20Ginsberg%20SD,%20Ohno%20M.%20Mechanisms%20underlying%20insulin%20Deficiency-Induced%20acceleration%20of%20%CE%B2-Amyloidosis%20in%20a%20mouse%20model%20of%20alzheimer%E2%80%99s%20disease.%20PLoS%20ONE.%202012;7:e32792." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR346">
<span class="label">346.</span><cite>Kurochkin IV, Goto S. Alzheimer’s β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 1994;345:33–7.
</cite> [<a href="https://doi.org/10.1016/0014-5793(94)00387-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8194595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kurochkin%20IV,%20Goto%20S.%20Alzheimer%E2%80%99s%20%CE%B2-amyloid%20peptide%20specifically%20interacts%20with%20and%20is%20degraded%20by%20insulin%20degrading%20enzyme.%20FEBS%20Lett.%201994;345:33%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR347">
<span class="label">347.</span><cite>Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J Biol Chem. 1998;273:32730–8.
</cite> [<a href="https://doi.org/10.1074/jbc.273.49.32730" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9830016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20WQ,%20Walsh%20DM,%20Ye%20Z,%20Vekrellis%20K,%20Zhang%20J,%20Podlisny%20MB,%20et%20al.%20Insulin-degrading%20enzyme%20regulates%20extracellular%20levels%20of%20amyloid%20%CE%B2-protein%20by%20degradation.%20J%20Biol%20Chem.%201998;273:32730%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR348">
<span class="label">348.</span><cite>Corraliza-Gomez M, Bermejo T, Lilue J, Rodriguez-Iglesias N, Valero J, Cozar-Castellano I, et al. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of alzheimer’s disease and brain aging. J Neuroinflamm. 2023;20:1–21.</cite> [<a href="https://doi.org/10.1186/s12974-023-02914-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10566021/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37817156/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corraliza-Gomez%20M,%20Bermejo%20T,%20Lilue%20J,%20Rodriguez-Iglesias%20N,%20Valero%20J,%20Cozar-Castellano%20I,%20et%20al.%20Insulin-degrading%20enzyme%20(IDE)%20as%20a%20modulator%20of%20microglial%20phenotypes%20in%20the%20context%20of%20alzheimer%E2%80%99s%20disease%20and%20brain%20aging.%20J%20Neuroinflamm.%202023;20:1%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR349">
<span class="label">349.</span><cite>Miklossy J, McGeer PL. Common mechanisms involved in alzheimer’s disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation. Aging. 2016;8:575.
</cite> [<a href="https://doi.org/10.18632/aging.100921" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4925815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26961231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miklossy%20J,%20McGeer%20PL.%20Common%20mechanisms%20involved%20in%20alzheimer%E2%80%99s%20disease%20and%20type%202%20diabetes:%20a%20key%20role%20of%20chronic%20bacterial%20infection%20and%20inflammation.%20Aging.%202016;8:575." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR350">
<span class="label">350.</span><cite>Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis Factor-α: direct role in Obesity-Linked insulin. Science. 1993;259:87–91.
</cite> [<a href="https://doi.org/10.1126/science.7678183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7678183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hotamisligil%20GS,%20Shargill%20NS,%20Spiegelman%20BM.%20Adipose%20expression%20of%20tumor%20necrosis%20Factor-%CE%B1:%20direct%20role%20in%20Obesity-Linked%20insulin.%20Science.%201993;259:87%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR351">
<span class="label">351.</span><cite>Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes. 2003;27:S53–5.</cite> [<a href="https://doi.org/10.1038/sj.ijo.0802502" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14704746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hotamisligil%20GS.%20Inflammatory%20pathways%20and%20insulin%20action.%20Int%20J%20Obes.%202003;27:S53%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR352">
<span class="label">352.</span><cite>Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62:194–204.
</cite> [<a href="https://doi.org/10.2337/db12-0420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3526026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23086037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20HM,%20Kim%20JJ,%20Kim%20HJ,%20Shong%20M,%20Ku%20BJ,%20Jo%20EK.%20Upregulated%20NLRP3%20inflammasome%20activation%20in%20patients%20with%20type%202%20diabetes.%20Diabetes.%202013;62:194%E2%80%93204." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR353">
<span class="label">353.</span><cite>De Felice FG, Ferreira ST. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to alzheimer disease. Diabetes. 2014;63:2262–72.
</cite> [<a href="https://doi.org/10.2337/db13-1954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24931033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Felice%20FG,%20Ferreira%20ST.%20Inflammation,%20defective%20insulin%20signaling,%20and%20mitochondrial%20dysfunction%20as%20common%20molecular%20denominators%20connecting%20type%202%20diabetes%20to%20alzheimer%20disease.%20Diabetes.%202014;63:2262%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR354">
<span class="label">354.</span><cite>Sluggett JK, Koponen M, Simon Bell J, Taipale H, Tanskanen A, Tiihonen J, et al. Metformin and risk of alzheimer’s disease among community-dwelling people with diabetes: a National case-control study. J Clin Endocrinol Metab. 2020;105:E963–72.</cite> [<a href="https://doi.org/10.1210/clinem/dgz234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31778170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sluggett%20JK,%20Koponen%20M,%20Simon%20Bell%20J,%20Taipale%20H,%20Tanskanen%20A,%20Tiihonen%20J,%20et%20al.%20Metformin%20and%20risk%20of%20alzheimer%E2%80%99s%20disease%20among%20community-dwelling%20people%20with%20diabetes:%20a%20National%20case-control%20study.%20J%20Clin%20Endocrinol%20Metab.%202020;105:E963%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR355">
<span class="label">355.</span><cite>Hsu CC, Wahlqvist ML, Lee MS, Tsai HN. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and Metformin. J Alzheimer’s Disease. 2011;24:485–93.
</cite> [<a href="https://doi.org/10.3233/JAD-2011-101524" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21297276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hsu%20CC,%20Wahlqvist%20ML,%20Lee%20MS,%20Tsai%20HN.%20Incidence%20of%20dementia%20is%20increased%20in%20type%202%20diabetes%20and%20reduced%20by%20the%20use%20of%20sulfonylureas%20and%20Metformin.%20J%20Alzheimer%E2%80%99s%20Disease.%202011;24:485%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR356">
<span class="label">356.</span><cite>Leszek J, Mikhaylenko EV, Belousov DM, Koutsouraki E, Szczechowiak K, Kobusiak-Prokopowicz M, et al. The links between cardiovascular diseases and alzheimer’s disease. Curr Neuropharmacol. 2021;19:152–65.
</cite> [<a href="https://doi.org/10.2174/1570159X18666200729093724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8033981/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32727331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leszek%20J,%20Mikhaylenko%20EV,%20Belousov%20DM,%20Koutsouraki%20E,%20Szczechowiak%20K,%20Kobusiak-Prokopowicz%20M,%20et%20al.%20The%20links%20between%20cardiovascular%20diseases%20and%20alzheimer%E2%80%99s%20disease.%20Curr%20Neuropharmacol.%202021;19:152%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR357">
<span class="label">357.</span><cite>Wolters FJ, Segufa RA, Darweesh SKL, Bos D, Ikram MA, Sabayan B, et al. Coronary heart disease, heart failure, and the risk of dementia: a systematic review and meta-analysis. Alzheimer’s Dement. 2018;14:1493–504.
</cite> [<a href="https://doi.org/10.1016/j.jalz.2018.01.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29494808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wolters%20FJ,%20Segufa%20RA,%20Darweesh%20SKL,%20Bos%20D,%20Ikram%20MA,%20Sabayan%20B,%20et%20al.%20Coronary%20heart%20disease,%20heart%20failure,%20and%20the%20risk%20of%20dementia:%20a%20systematic%20review%20and%20meta-analysis.%20Alzheimer%E2%80%99s%20Dement.%202018;14:1493%E2%80%93504." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR358">
<span class="label">358.</span><cite>Liu W, Weng S, Liu H, Cao C, Wang S, Wu S, et al. Serum soluble TREM2 is an independent biomarker associated with coronary heart disease. Clin Chim Acta. 2023;548:1–9.</cite> [<a href="https://doi.org/10.1016/j.cca.2023.117499" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37536519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20W,%20Weng%20S,%20Liu%20H,%20Cao%20C,%20Wang%20S,%20Wu%20S,%20et%20al.%20Serum%20soluble%20TREM2%20is%20an%20independent%20biomarker%20associated%20with%20coronary%20heart%20disease.%20Clin%20Chim%20Acta.%202023;548:1%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR359">
<span class="label">359.</span><cite>Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and alzheimer’s disease in later life: longitudinal, population based study. BMJ. 2001;322:1447.
</cite> [<a href="https://doi.org/10.1136/bmj.322.7300.1447" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC32306/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11408299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kivipelto%20M,%20Helkala%20EL,%20Laakso%20MP,%20H%C3%A4nninen%20T,%20Hallikainen%20M,%20Alhainen%20K,%20et%20al.%20Midlife%20vascular%20risk%20factors%20and%20alzheimer%E2%80%99s%20disease%20in%20later%20life:%20longitudinal,%20population%20based%20study.%20BMJ.%202001;322:1447." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR360">
<span class="label">360.</span><cite>Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49–55.
</cite> [<a href="https://doi.org/10.1016/s0197-4580(00)00096-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10794848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Launer%20LJ,%20Ross%20GW,%20Petrovitch%20H,%20Masaki%20K,%20Foley%20D,%20White%20LR,%20et%20al.%20Midlife%20blood%20pressure%20and%20dementia:%20the%20Honolulu-Asia%20aging%20study.%20Neurobiol%20Aging.%202000;21:49%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR361">
<span class="label">361.</span><cite>Whitmer RA, Sidney S, Selby J, Claiborne Johnston S, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–81.
</cite> [<a href="https://doi.org/10.1212/01.WNL.0000149519.47454.F2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15668425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whitmer%20RA,%20Sidney%20S,%20Selby%20J,%20Claiborne%20Johnston%20S,%20Yaffe%20K.%20Midlife%20cardiovascular%20risk%20factors%20and%20risk%20of%20dementia%20in%20late%20life.%20Neurology.%202005;64:277%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR362">
<span class="label">362.</span><cite>Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging. 2000;21:57–62.
</cite> [<a href="https://doi.org/10.1016/s0197-4580(00)00106-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10794849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Petrovitch%20H,%20White%20LR,%20Izmirilian%20G,%20Ross%20GW,%20Havlik%20RJ,%20Markesbery%20W,%20et%20al.%20Midlife%20blood%20pressure%20and%20neuritic%20plaques,%20neurofibrillary%20tangles,%20and%20brain%20weight%20at%20death:%20the%20HAAS.%20Neurobiol%20Aging.%202000;21:57%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR363">
<span class="label">363.</span><cite>Shah NS, Vidal JS, Masaki K, Petrovitch H, Webster Ross G, Tilley C, et al. Midlife blood pressure, plasma β-amyloid, and the risk for alzheimer disease. Hypertension. 2012;59:780–6.
</cite> [<a href="https://doi.org/10.1161/HYPERTENSIONAHA.111.178962" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3319436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22392902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shah%20NS,%20Vidal%20JS,%20Masaki%20K,%20Petrovitch%20H,%20Webster%20Ross%20G,%20Tilley%20C,%20et%20al.%20Midlife%20blood%20pressure,%20plasma%20%CE%B2-amyloid,%20and%20the%20risk%20for%20alzheimer%20disease.%20Hypertension.%202012;59:780%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR364">
<span class="label">364.</span><cite>Montecucco F, Pende A, Quercioli A, Mach F. Inflammation in the pathophysiology of essential hypertension. J Nephrol. 2011;24:23–34.
</cite> [<a href="https://doi.org/10.5301/jn.2010.4729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20437401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montecucco%20F,%20Pende%20A,%20Quercioli%20A,%20Mach%20F.%20Inflammation%20in%20the%20pathophysiology%20of%20essential%20hypertension.%20J%20Nephrol.%202011;24:23%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR365">
<span class="label">365.</span><cite>Youwakim J, Girouard H. Inflammation: a mediator between hypertension and neurodegenerative diseases. Am J Hypertens. 2021;34:1014–30.
</cite> [<a href="https://doi.org/10.1093/ajh/hpab094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34136907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Youwakim%20J,%20Girouard%20H.%20Inflammation:%20a%20mediator%20between%20hypertension%20and%20neurodegenerative%20diseases.%20Am%20J%20Hypertens.%202021;34:1014%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR366">
<span class="label">366.</span><cite>Hendrickx JO, Martinet W, Van Dam D, De Meyer GRY. Inflammation, nitro-oxidative stress, impaired autophagy, and insulin resistance as a mechanistic convergence between arterial stiffness and alzheimer’s disease. Front Mol Biosci. 2021;8:651215.
</cite> [<a href="https://doi.org/10.3389/fmolb.2021.651215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8039307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33855048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hendrickx%20JO,%20Martinet%20W,%20Van%20Dam%20D,%20De%20Meyer%20GRY.%20Inflammation,%20nitro-oxidative%20stress,%20impaired%20autophagy,%20and%20insulin%20resistance%20as%20a%20mechanistic%20convergence%20between%20arterial%20stiffness%20and%20alzheimer%E2%80%99s%20disease.%20Front%20Mol%20Biosci.%202021;8:651215." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR367">
<span class="label">367.</span><cite>De Alves TF, Ferreira TC, Wajngarten LK, Busatto M. Cardiac disorders as risk factors for alzheimer’s disease. J Alzheimer’s Disease. 2010;20:749–63.
</cite> [<a href="https://doi.org/10.3233/JAD-2010-091561" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20413875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Alves%20TF,%20Ferreira%20TC,%20Wajngarten%20LK,%20Busatto%20M.%20Cardiac%20disorders%20as%20risk%20factors%20for%20alzheimer%E2%80%99s%20disease.%20J%20Alzheimer%E2%80%99s%20Disease.%202010;20:749%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR368">
<span class="label">368.</span><cite>Stampfer MJ. Cardiovascular disease and alzheimer’s disease: common links. J Intern Med. 2006;260:211–23.
</cite> [<a href="https://doi.org/10.1111/j.1365-2796.2006.01687.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16918818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stampfer%20MJ.%20Cardiovascular%20disease%20and%20alzheimer%E2%80%99s%20disease:%20common%20links.%20J%20Intern%20Med.%202006;260:211%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR369">
<span class="label">369.</span><cite>’t Veld BA, Ruitenberg A, Hofman A, Stricker BHC, Breteler MMB, editors. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiology of Aging. 2001;22:407–12.</cite> [<a href="https://doi.org/10.1016/s0197-4580(00)00241-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11378246/" class="usa-link">PubMed</a>]</li>
<li id="CR370">
<span class="label">370.</span><cite>Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–51.
</cite> [<a href="https://doi.org/10.1016/s0140-6736(98)03086-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9802273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Forette%20F,%20Seux%20ML,%20Staessen%20JA,%20Thijs%20L,%20Birkenh%C3%A4ger%20WH,%20Babarskiene%20MR,%20et%20al.%20Prevention%20of%20dementia%20in%20randomised%20double-blind%20placebo-controlled%20systolic%20hypertension%20in%20Europe%20(Syst-Eur)%20trial.%20Lancet.%201998;352:1347%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR371">
<span class="label">371.</span><cite>Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure Lowering with Perindopril and Indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069–75.
</cite> [<a href="https://doi.org/10.1001/archinte.163.9.1069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12742805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tzourio%20C,%20Anderson%20C,%20Chapman%20N,%20Woodward%20M,%20Neal%20B,%20MacMahon%20S,%20et%20al.%20Effects%20of%20blood%20pressure%20Lowering%20with%20Perindopril%20and%20Indapamide%20therapy%20on%20dementia%20and%20cognitive%20decline%20in%20patients%20with%20cerebrovascular%20disease.%20Arch%20Intern%20Med.%202003;163:1069%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR372">
<span class="label">372.</span><cite>Ohrui T, Matsui T, Yamaya M, Arai H, Ebihara S, Maruyama M, et al. Angiotensin-converting enzyme inhibitors and incidence of alzheimer’s disease in Japan. J Am Geriatr Soc. 2004;52:649–50.
</cite> [<a href="https://doi.org/10.1111/j.1532-5415.2004.52178_7.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15066094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ohrui%20T,%20Matsui%20T,%20Yamaya%20M,%20Arai%20H,%20Ebihara%20S,%20Maruyama%20M,%20et%20al.%20Angiotensin-converting%20enzyme%20inhibitors%20and%20incidence%20of%20alzheimer%E2%80%99s%20disease%20in%20Japan.%20J%20Am%20Geriatr%20Soc.%202004;52:649%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR373">
<span class="label">373.</span><cite>Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, et al. Antihypertensive medication use and incident alzheimer disease: the cache County study. Arch Neurol. 2006;63:686–92.
</cite> [<a href="https://doi.org/10.1001/archneur.63.5.noc60013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16533956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khachaturian%20AS,%20Zandi%20PP,%20Lyketsos%20CG,%20Hayden%20KM,%20Skoog%20I,%20Norton%20MC,%20et%20al.%20Antihypertensive%20medication%20use%20and%20incident%20alzheimer%20disease:%20the%20cache%20County%20study.%20Arch%20Neurol.%202006;63:686%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR374">
<span class="label">374.</span><cite>Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166:1003–8.
</cite> [<a href="https://doi.org/10.1001/archinte.166.9.1003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16682574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20C,%20Winblad%20B,%20Marengoni%20A,%20Klarin%20I,%20Fastbom%20J,%20Fratiglioni%20L.%20Heart%20failure%20and%20risk%20of%20dementia%20and%20alzheimer%20disease:%20a%20population-based%20cohort%20study.%20Arch%20Intern%20Med.%202006;166:1003%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR375">
<span class="label">375.</span><cite>Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, et al. Nutraceutical properties of mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimer’s Disease. 2010;22:715–40.
</cite> [<a href="https://doi.org/10.3233/JAD-2010-100942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20858954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Frisardi%20V,%20Panza%20F,%20Seripa%20D,%20Imbimbo%20BP,%20Vendemiale%20G,%20Pilotto%20A,%20et%20al.%20Nutraceutical%20properties%20of%20mediterranean%20diet%20and%20cognitive%20decline:%20possible%20underlying%20mechanisms.%20J%20Alzheimer%E2%80%99s%20Disease.%202010;22:715%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR376">
<span class="label">376.</span><cite>Scarmeas N, Stern Y, Mayeux R, Luchsinger JA. Mediterranean diet, alzheimer disease, and vascular mediation. Arch Neurol. 2006;63:1709–17.
</cite> [<a href="https://doi.org/10.1001/archneur.63.12.noc60109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3024906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17030648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scarmeas%20N,%20Stern%20Y,%20Mayeux%20R,%20Luchsinger%20JA.%20Mediterranean%20diet,%20alzheimer%20disease,%20and%20vascular%20mediation.%20Arch%20Neurol.%202006;63:1709%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR377">
<span class="label">377.</span><cite>n Den Brink AC, Brouwer-Brolsma EM, Van De Berendsen AAM. The mediterranean, DASH, and MIND diets are associated with less cognitive decline and a lower risk of alzheimer’s disease—A review. Adv Nutr. 2019;10:1040–65.
</cite> [<a href="https://doi.org/10.1093/advances/nmz054" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6855954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31209456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?n%20Den%20Brink%20AC,%20Brouwer-Brolsma%20EM,%20Van%20De%20Berendsen%20AAM.%20The%20mediterranean,%20DASH,%20and%20MIND%20diets%20are%20associated%20with%20less%20cognitive%20decline%20and%20a%20lower%20risk%20of%20alzheimer%E2%80%99s%20disease%E2%80%94A%20review.%20Adv%20Nutr.%202019;10:1040%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR378">
<span class="label">378.</span><cite>Shannon OM, Ranson JM, Gregory S, Macpherson H, Milte C, Lentjes M, et al. Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK biobank prospective cohort study. BMC Med. 2023;21:1–13.
</cite> [<a href="https://doi.org/10.1186/s12916-023-02772-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10012551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36915130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shannon%20OM,%20Ranson%20JM,%20Gregory%20S,%20Macpherson%20H,%20Milte%20C,%20Lentjes%20M,%20et%20al.%20Mediterranean%20diet%20adherence%20is%20associated%20with%20lower%20dementia%20risk,%20independent%20of%20genetic%20predisposition:%20findings%20from%20the%20UK%20biobank%20prospective%20cohort%20study.%20BMC%20Med.%202023;21:1%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR379">
<span class="label">379.</span><cite>Agarwal P, Leurgans SE, Agrawal S, Aggarwal NT, Cherian LJ, James BD, et al. Association of mediterranean-DASH intervention for neurodegenerative delay and mediterranean diets with alzheimer disease pathology. Neurology. 2023;100:E2259–68.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000207176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10259273/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36889921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Agarwal%20P,%20Leurgans%20SE,%20Agrawal%20S,%20Aggarwal%20NT,%20Cherian%20LJ,%20James%20BD,%20et%20al.%20Association%20of%20mediterranean-DASH%20intervention%20for%20neurodegenerative%20delay%20and%20mediterranean%20diets%20with%20alzheimer%20disease%20pathology.%20Neurology.%202023;100:E2259%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR380">
<span class="label">380.</span><cite>Ewers M, Franzmeier N, Suárez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in alzheimer’s disease. Sci Transl Med. 2019;11:6221.</cite> [<a href="https://doi.org/10.1126/scitranslmed.aav6221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7050285/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31462511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ewers%20M,%20Franzmeier%20N,%20Su%C3%A1rez-Calvet%20M,%20Morenas-Rodriguez%20E,%20Caballero%20MAA,%20Kleinberger%20G,%20et%20al.%20Increased%20soluble%20TREM2%20in%20cerebrospinal%20fluid%20is%20associated%20with%20reduced%20cognitive%20and%20clinical%20decline%20in%20alzheimer%E2%80%99s%20disease.%20Sci%20Transl%20Med.%202019;11:6221." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR381">
<span class="label">381.</span><cite>Brown GC, St George-Hyslop P. Does soluble TREM2 protect against alzheimer’s disease?? Front Aging Neurosci. 2022;13:834697.
</cite> [<a href="https://doi.org/10.3389/fnagi.2021.834697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8831327/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35153729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brown%20GC,%20St%20George-Hyslop%20P.%20Does%20soluble%20TREM2%20protect%20against%20alzheimer%E2%80%99s%20disease??%20Front%20Aging%20Neurosci.%202022;13:834697." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR382">
<span class="label">382.</span><cite>Okuzono Y, Sakuma H, Miyakawa S, Ifuku M, Lee J, Das D, et al. Reduced TREM2 activation in microglia of patients with alzheimer’s disease. FEBS Open Bio. 2021;11:3063–80.</cite> [<a href="https://doi.org/10.1002/2211-5463.13300" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8564098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34523252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Okuzono%20Y,%20Sakuma%20H,%20Miyakawa%20S,%20Ifuku%20M,%20Lee%20J,%20Das%20D,%20et%20al.%20Reduced%20TREM2%20activation%20in%20microglia%20of%20patients%20with%20alzheimer%E2%80%99s%20disease.%20FEBS%20Open%20Bio.%202021;11:3063%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR383">
<span class="label">383.</span><cite>Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in alzheimer’s disease. N Engl J Med. 2013;368:117–27.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1211851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3631573/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23150934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guerreiro%20R,%20Wojtas%20A,%20Bras%20J,%20Carrasquillo%20M,%20Rogaeva%20E,%20Majounie%20E,%20et%20al.%20TREM2%20variants%20in%20alzheimer%E2%80%99s%20disease.%20N%20Engl%20J%20Med.%202013;368:117%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR384">
<span class="label">384.</span><cite>Jonsson T, Stefansson H, Steinberg S, Jonsdottir IV, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of alzheimer’s disease. N Engl J Med. 2013;368:107–15.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1211103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3677583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23150908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jonsson%20T,%20Stefansson%20H,%20Steinberg%20S,%20Jonsdottir%20IV,%20Jonsson%20PV,%20Snaedal%20J,%20et%20al.%20Variant%20of%20TREM2%20associated%20with%20the%20risk%20of%20alzheimer%E2%80%99s%20disease.%20N%20Engl%20J%20Med.%202013;368:107%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR385">
<span class="label">385.</span><cite>Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, et al. Upregulation of TREM2 ameliorates neuropathology and rescues Spatial cognitive impairment in a Transgenic mouse model of alzheimer’s disease. Neuropsychopharmacology. 2014;39:2949–62.
</cite> [<a href="https://doi.org/10.1038/npp.2014.164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4229581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25047746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20T,%20Tan%20L,%20Zhu%20XC,%20Zhang%20QQ,%20Cao%20L,%20Tan%20MS,%20et%20al.%20Upregulation%20of%20TREM2%20ameliorates%20neuropathology%20and%20rescues%20Spatial%20cognitive%20impairment%20in%20a%20Transgenic%20mouse%20model%20of%20alzheimer%E2%80%99s%20disease.%20Neuropsychopharmacology.%202014;39:2949%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR386">
<span class="label">386.</span><cite>Zhao P, Xu Y, Jiang LL, Fan X, Li L, Li X, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of alzheimer’s disease. Sci Transl Med. 2022;14:95.</cite> [<a href="https://doi.org/10.1126/scitranslmed.abq0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36070367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20P,%20Xu%20Y,%20Jiang%20LL,%20Fan%20X,%20Li%20L,%20Li%20X,%20et%20al.%20A%20tetravalent%20TREM2%20agonistic%20antibody%20reduced%20amyloid%20pathology%20in%20a%20mouse%20model%20of%20alzheimer%E2%80%99s%20disease.%20Sci%20Transl%20Med.%202022;14:95." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR387">
<span class="label">387.</span><cite>Fassler M, Rappaport MS, Cuño CB, George J. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in alzheimer’s disease models. J Neuroinflammation. 2021;18:1–18.
</cite> [<a href="https://doi.org/10.1186/s12974-020-01980-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7796541/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33422057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fassler%20M,%20Rappaport%20MS,%20Cu%C3%B1o%20CB,%20George%20J.%20Engagement%20of%20TREM2%20by%20a%20novel%20monoclonal%20antibody%20induces%20activation%20of%20microglia%20and%20improves%20cognitive%20function%20in%20alzheimer%E2%80%99s%20disease%20models.%20J%20Neuroinflammation.%202021;18:1%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR388">
<span class="label">388.</span><cite>Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an alzheimer’s disease model. J Exp Med. 2020;217.</cite> [<a href="https://doi.org/10.1084/jem.20200785" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7478730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32579671/" class="usa-link">PubMed</a>]</li>
<li id="CR389">
<span class="label">389.</span><cite>Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12.</cite> [<a href="https://doi.org/10.15252/emmm.201911227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7136959/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32154671/" class="usa-link">PubMed</a>]</li>
<li id="CR390">
<span class="label">390.</span><cite>Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C. Emerging microglia biology defines novel therapeutic approaches for alzheimer’s disease. Neuron. 2020;108:801–21.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2020.09.029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33096024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lewcock%20JW,%20Schlepckow%20K,%20Di%20Paolo%20G,%20Tahirovic%20S,%20Monroe%20KM,%20Haass%20C.%20Emerging%20microglia%20biology%20defines%20novel%20therapeutic%20approaches%20for%20alzheimer%E2%80%99s%20disease.%20Neuron.%202020;108:801%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR391">
<span class="label">391.</span><cite>Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, et al. Therapeutic TREM2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflammation. 2020;17:1–13.
</cite> [<a href="https://doi.org/10.1186/s12974-020-01915-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7427742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32795308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Price%20BR,%20Sudduth%20TL,%20Weekman%20EM,%20Johnson%20S,%20Hawthorne%20D,%20Woolums%20A,%20et%20al.%20Therapeutic%20TREM2%20activation%20ameliorates%20amyloid-beta%20deposition%20and%20improves%20cognition%20in%20the%205XFAD%20model%20of%20amyloid%20deposition.%20J%20Neuroinflammation.%202020;17:1%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR392">
<span class="label">392.</span><cite>van Lengerich B, Zhan L, Xia D, Chan D, Joy DA, Park JI, et al. A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in alzheimer’s disease models. Nat Neurosci. 2023;26:416–29.
</cite> [<a href="https://doi.org/10.1038/s41593-022-01240-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9991924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36635496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Lengerich%20B,%20Zhan%20L,%20Xia%20D,%20Chan%20D,%20Joy%20DA,%20Park%20JI,%20et%20al.%20A%20TREM2-activating%20antibody%20with%20a%20blood%E2%80%93brain%20barrier%20transport%20vehicle%20enhances%20microglial%20metabolism%20in%20alzheimer%E2%80%99s%20disease%20models.%20Nat%20Neurosci.%202023;26:416%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR393">
<span class="label">393.</span><cite>Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674–8.
</cite> [<a href="https://doi.org/10.1038/nature11729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3812809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23254930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heneka%20MT,%20Kummer%20MP,%20Stutz%20A,%20Delekate%20A,%20Schwartz%20S,%20Vieira-Saecker%20A,%20et%20al.%20NLRP3%20is%20activated%20in%20alzheimer%E2%80%99s%20disease%20and%20contributes%20to%20pathology%20in%20APP/PS1%20mice.%20Nature.%202013;493:674%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR394">
<span class="label">394.</span><cite>Dansokho C, Heneka MT. Neuroinflammatory responses in alzheimer’s disease. J Neural Transm. 2017;125:771–9.
</cite> [<a href="https://doi.org/10.1007/s00702-017-1831-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29273951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dansokho%20C,%20Heneka%20MT.%20Neuroinflammatory%20responses%20in%20alzheimer%E2%80%99s%20disease.%20J%20Neural%20Transm.%202017;125:771%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR395">
<span class="label">395.</span><cite>Tejera D, Mercan D, Sanchez-Caro JM, Hanan M, Greenberg D, Soreq H et al. Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome. EMBO J. 2019;38.</cite> [<a href="https://doi.org/10.15252/embj.2018101064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6717897/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31359456/" class="usa-link">PubMed</a>]</li>
<li id="CR396">
<span class="label">396.</span><cite>Jha D, Bakker ENTP, Kumar R. Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of alzheimer’s disease. J Neurochem. 2023;168:3574–98.
</cite> [<a href="https://doi.org/10.1111/jnc.15788" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36802053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jha%20D,%20Bakker%20ENTP,%20Kumar%20R.%20Mechanistic%20and%20therapeutic%20role%20of%20NLRP3%20inflammasome%20in%20the%20pathogenesis%20of%20alzheimer%E2%80%99s%20disease.%20J%20Neurochem.%202023;168:3574%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR397">
<span class="label">397.</span><cite>Yehualashet AS, Melaku EE, Gebreyes DS, Wassie TA, Sahilu BY. The bilateral cross communication in microbiota-gut-brain axis as a promising therapeutic target for alzheimer’s disease: a focus on neuroinflammation. Discover Med. 2025;2:1–14.</cite> [<a href="https://scholar.google.com/scholar_lookup?Yehualashet%20AS,%20Melaku%20EE,%20Gebreyes%20DS,%20Wassie%20TA,%20Sahilu%20BY.%20The%20bilateral%20cross%20communication%20in%20microbiota-gut-brain%20axis%20as%20a%20promising%20therapeutic%20target%20for%20alzheimer%E2%80%99s%20disease:%20a%20focus%20on%20neuroinflammation.%20Discover%20Med.%202025;2:1%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR398">
<span class="label">398.</span><cite>Beyer MMS, Lonnemann N, Remus A, Latz E, Heneka MT, Korte M. Enduring changes in neuronal function upon systemic inflammation are NLRP3 inflammasome dependent. J Neurosci. 2020;40:5480–94.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.0200-20.2020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7343321/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32499379/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Beyer%20MMS,%20Lonnemann%20N,%20Remus%20A,%20Latz%20E,%20Heneka%20MT,%20Korte%20M.%20Enduring%20changes%20in%20neuronal%20function%20upon%20systemic%20inflammation%20are%20NLRP3%20inflammasome%20dependent.%20J%20Neurosci.%202020;40:5480%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR399">
<span class="label">399.</span><cite>Ismael S, Zhao L, Nasoohi S, Ishrat T. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8:1–9.
</cite> [<a href="https://doi.org/10.1038/s41598-018-24350-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5899150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29654318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ismael%20S,%20Zhao%20L,%20Nasoohi%20S,%20Ishrat%20T.%20Inhibition%20of%20the%20NLRP3-inflammasome%20as%20a%20potential%20approach%20for%20neuroprotection%20after%20stroke.%20Sci%20Rep.%202018;8:1%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR400">
<span class="label">400.</span><cite>Hou B, Yin J, Liu S, Guo J, Zhang B, Zhang Z, et al. Inhibiting the NLRP3 inflammasome with MCC950 alleviates neurological impairment in the brain of EAE mice. Mol Neurobiol. 2024;61:1318–30.
</cite> [<a href="https://doi.org/10.1007/s12035-023-03618-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10896958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37702910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hou%20B,%20Yin%20J,%20Liu%20S,%20Guo%20J,%20Zhang%20B,%20Zhang%20Z,%20et%20al.%20Inhibiting%20the%20NLRP3%20inflammasome%20with%20MCC950%20alleviates%20neurological%20impairment%20in%20the%20brain%20of%20EAE%20mice.%20Mol%20Neurobiol.%202024;61:1318%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR401">
<span class="label">401.</span><cite>Daniels MJD, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against alzheimer’s disease in rodent models. Nat Commun. 2016;7.</cite> [<a href="https://doi.org/10.1038/ncomms12504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4987536/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27509875/" class="usa-link">PubMed</a>]</li>
<li id="CR402">
<span class="label">402.</span><cite>Bouwman FH, Frisoni GB, Johnson SC, Chen X, Engelborghs S, Ikeuchi T, et al. Clinical application of CSF biomarkers for alzheimer’s disease: from rationale to ratios. Alzheimer’s Dement. 2022;14:e12314.</cite> [<a href="https://doi.org/10.1002/dad2.12314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9044123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35496374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bouwman%20FH,%20Frisoni%20GB,%20Johnson%20SC,%20Chen%20X,%20Engelborghs%20S,%20Ikeuchi%20T,%20et%20al.%20Clinical%20application%20of%20CSF%20biomarkers%20for%20alzheimer%E2%80%99s%20disease:%20from%20rationale%20to%20ratios.%20Alzheimer%E2%80%99s%20Dement.%202022;14:e12314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR403">
<span class="label">403.</span><cite>Lobanova E, Zhang YP, Emin D, Brelstaff J, Kahanawita L, Malpetti M, Quaegebeur A, Triantafilou K, Triantafilou M, Zetterberg H, Rowe JB, Williams-Gray CH, Bryant CE, Klenerman D. ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases. Nat Commun. 2024;15:9690.
</cite> [<a href="https://doi.org/10.1038/s41467-024-53547-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11555386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39528447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lobanova%20E,%20Zhang%20YP,%20Emin%20D,%20Brelstaff%20J,%20Kahanawita%20L,%20Malpetti%20M,%20Quaegebeur%20A,%20Triantafilou%20K,%20Triantafilou%20M,%20Zetterberg%20H,%20Rowe%20JB,%20Williams-Gray%20CH,%20Bryant%20CE,%20Klenerman%20D.%20ASC%20specks%20as%20a%20single-molecule%20fluid%20biomarker%20of%20inflammation%20in%20neurodegenerative%20diseases.%20Nat%20Commun.%202024;15:9690." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR404">
<span class="label">404.</span><cite>Cyr B, Curiel Cid R, Loewenstein D, Vontell RT, Dietrich WD, Keane RW, de Rivero Vaccari JP. The inflammasome adaptor protein ASC in plasma as a biomarker of early cognitive changes. Int J Mol Sci. 2024;25:7758.
</cite> [<a href="https://doi.org/10.3390/ijms25147758" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11276719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39063000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cyr%20B,%20Curiel%20Cid%20R,%20Loewenstein%20D,%20Vontell%20RT,%20Dietrich%20WD,%20Keane%20RW,%20de%20Rivero%20Vaccari%20JP.%20The%20inflammasome%20adaptor%20protein%20ASC%20in%20plasma%20as%20a%20biomarker%20of%20early%20cognitive%20changes.%20Int%20J%20Mol%20Sci.%202024;25:7758." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR405">
<span class="label">405.</span><cite>Scott XO, Stephens ME, Desir MC, Dietrich WD, Keane RW, de Rivero Vaccari JP. The inflammasome adaptor protein ASC in mild cognitive impairment and alzheimer’s disease. Int J Mol Sci. 2020;21:4674.
</cite> [<a href="https://doi.org/10.3390/ijms21134674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7370034/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32630059/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scott%20XO,%20Stephens%20ME,%20Desir%20MC,%20Dietrich%20WD,%20Keane%20RW,%20de%20Rivero%20Vaccari%20JP.%20The%20inflammasome%20adaptor%20protein%20ASC%20in%20mild%20cognitive%20impairment%20and%20alzheimer%E2%80%99s%20disease.%20Int%20J%20Mol%20Sci.%202020;21:4674." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR406">
<span class="label">406.</span><cite>Suárez-Calvet M, Kleinberger G, Araque Caballero MÁ, Brendel M, Rominger A, Alcolea D, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage alzheimer’s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8:466–76.
</cite> [<a href="https://doi.org/10.15252/emmm.201506123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5120370/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26941262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%C3%A1rez-Calvet%20M,%20Kleinberger%20G,%20Araque%20Caballero%20M%C3%81,%20Brendel%20M,%20Rominger%20A,%20Alcolea%20D,%20et%20al.%20sTREM2%20cerebrospinal%20fluid%20levels%20are%20a%20potential%20biomarker%20for%20microglia%20activity%20in%20early-stage%20alzheimer%E2%80%99s%20disease%20and%20associate%20with%20neuronal%20injury%20markers.%20EMBO%20Mol%20Med.%202016;8:466%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR407">
<span class="label">407.</span><cite>Duara R, Barker W. Heterogeneity in alzheimer’s disease diagnosis and progression rates: implications for therapeutic trials. Neurotherapeutics. 2022;19:8–18.
</cite> [<a href="https://doi.org/10.1007/s13311-022-01185-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9130395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35084721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duara%20R,%20Barker%20W.%20Heterogeneity%20in%20alzheimer%E2%80%99s%20disease%20diagnosis%20and%20progression%20rates:%20implications%20for%20therapeutic%20trials.%20Neurotherapeutics.%202022;19:8%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Immunity &amp; Ageing : I &amp; A are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12979-025-00529-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12979_2025_Article_529.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12369153/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12369153/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369153%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369153/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12369153/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12369153/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841660/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12369153/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841660/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12369153/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12369153/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="qFVcJXt524ff7kOxgEOnSpZNdI2Kmepdt7jFBD323VBIfcyoImhgbDi3R9MGEBdc">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
